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ABSTRACT 
 
 
In biopharmaceutical manufacturing there have been significant increases in drug 
complexity, risk of clinical failure, regulatory pressures and demand.  Compounded 
with the rise in competition and pressures of maintaining high profit margins this 
means that manufacturers have to produce more efficient and lower capital intensive 
processes. More are opting to use simulation tools to perform such revisions and to 
experiment with various process alternatives, activities which would be time 
consuming and expensive to carry out within the real system.  
 
A review of existing models created for different biopharmaceutical activities using 
the Extend® (ImagineThat!, CA) platform led to the development of a standard 
framework to guide the design and construct of a more efficient model. The premise 
of the framework was that any ‘good’ model should meet five requirement 
specifications: 1) Intuitive to the user, 2) Short Run-Time, 3) Short Development 
Time, 4) Relevant and has Ease of Data Input/Output, and 5) Maximised Reusability 
and Sustainability. Three different case studies were used to test the framework, two 
biotechnology manufacturing and one fill/finish, with each adding a new layer of 
understanding and depth to the standard due to the challenges faced. These Included 
procedures and constraints related to complex resource allocation, multi-product 
scheduling and complex ‘lookahead’ logic for scheduling activities such as buffer 
makeup and difficulties surrounding data availability. Subsequently, in order to 
review the relevance of the models, various analyses were carried out including 
schedule optimisation, debottlenecking and Monte Carlo simulations, using various 
data representation tools to deterministically and stochastically answer the different 
questions within each case study scope. 
 
The work in this thesis demonstrated the benefits of using the developed standard as 
an aid to building decision-making tools for biopharmaceutical manufacturing 
capacity management, so as to increase the quality and efficiency of decision making 
to produce less capital intensive processes. 
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1 CHAPTER 1 
Scope and Background 
 
1.1 Introduction 
The philosophy of biopharmaceutical manufacture has changed over the years 
shifting from a heavy focus on accelerating time to market to improving process 
economics (Farid, 2009). This shift can be attributed to the continuously changing 
trends in biopharmaceuticals with the likelihood of finding blockbuster indications 
having diminished greatly over the last decade due to increased competition, dosage 
reductions and diagnostic improvements (Jagschies, 2008). The lack of blockbuster 
scale market share and the resulting high profit margins compounded with problems 
such as increased drug complexity and risk of clinical failure (Berg et al, 2005), 
regulatory pressures and increasing demand (Ransohoff, 2009) means that 
manufacturers are having to produce more efficient and lower capital intensive 
processes as early on in the development stages as possible.  
Such requirements call for design or revision procedures which may be required in 
the early stages of process development (preferably) or at the height of operational 
activities but will always incur some degree of costs. Consequently, some 
biopharmaceutical manufacturers are seeking to use simulation tools to assess such 
revisions and to experiment with various process alternatives, activities which could 
be time consuming and expensive to carry out in real life experiments. With the 
adoption of such simulation techniques has arisen some issues as discussed by 
Mclean and Leong (2005); for example in the semiconductor industry they state that 
due to the fact that each simulation software vendor offers its own unique approach 
to modelling (i.e. data and graphical formats), the non-existence of standards 
increases the difficulties surrounding the simulation process. This particularly applies 
to the biopharmaceutical industry, a relative newcomer to the use of simulation 
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methods. The use of process simulation software in the biopharmaceutical industry is 
less developed than in other industries (Lim 2004, Johnston 2010). In order for these 
simulation techniques to add value as decision-support tools it is therefore necessary 
to standardize the way in which the modelling process is approached. The work in 
this thesis will propose such a standard. 
 
The purpose of this chapter is to provide an overview of biopharmaceutical 
manufacturing and to review some of the key issues necessitating simulation. Section 
1.2 highlights some of the problems faced by today’s biopharmaceutical companies 
in greater detail and the role played by general simulation techniques while Section 
1.3 highlights the complexities inherent to biopharmaceutical manufacturing. Section 
1.4 discusses the aims and objectives of this thesis and Section 1.5 presents its 
outline.  
1.2 Current Issues Facing Biopharmaceutical Companies 
Figures for the commercialisation of drugs differ somewhat between information 
sources however all agree that the sums are enormous and growing. Less than a 
decade ago published figures stood at 7-12 years to take a drug from discovery to 
market with investments totalling $802 million (DiMasi, 2003). More recent sources 
state this figure now stands closer to $1.3 billion (Collier, 2009). Of these drugs 80-
85% fail somewhere in the development pipeline (Polastro, 1996). The implication of 
this costly and risky business environment is that it is necessary for key decisions 
relating to process design and capacity management to be made with the goal of 
creating cost-effective bioprocesses that enable material to be supplied to the clinic 
and market on time, thus scheduling of activities should be such that demands are 
met with minimal delay, particularly when delay penalties are in place.  
Furthermore, uncertainties in biopharmaceutical manufacture are one feature of the 
industry that set it apart from the more traditional pharmaceutical or the 
semiconductor industries (Johnston, 2010). The level of variability such as in titre, 
yields and cycle times means that often it is difficult to fully understand the overall 
impact that even minor changes or events can have. For example, the purification 
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requirements in terms of membrane size, with fluctuating upstream titres or the 
effects of random buffer equipment breakdowns on the overall process.  
Regulatory constraints, particularly in cases where live organisms are used, require 
that additional precautions are taken with respect to facilities and equipment, such as 
the use of dedicated facilities and equipment, production on a campaign basis and the 
use of closed systems. These present a challenge with regards to facility design and 
process scheduling as manufacturers must overcome the complexities of area 
restrictions and shared resources whilst maintaining optimal scheduling. The best 
example of this is in the case of multi-product facilities (which are discussed further 
in section 1.3.1) whereby due to capacity constraints a manufacturer may have to use 
the same downstream processing stream for all products. Regulatory guidelines 
require that turnaround activities take place between different product campaigns 
which comprise of various shutdown and cleaning procedures. Depending on the 
nature of the products and the adjacent campaigns different turnaround procedures 
may be needed with varying cycle times and labour requirements thus giving rise to a 
level of complexity in process scheduling in order to minimise cost of production 
while meeting demand on time.  
1.3 Capacity 
In the 1980s more and more companies were globally investing heavily in R&D and 
the 1990s saw a significant overall investment boost in the biopharmaceutical 
industry. Too many drug failures however left the market all revved up with nowhere 
to go (Roth, 2001).  
At the turn of the millennium however there were a large number of successes, with 
65 biopharmaceuticals having gained approval between 2000 and 2004, 64 of which 
were protein based (Walsh, 2005). Publications of the time stated that due to the fact 
that many new drugs on the market required such high volumes of bio-manufacturing 
capacity, there was little available capacity remaining worldwide (Fox, 2001). With a 
significant proportion being biotechnology therapeutics such as monoclonal 
antibodies, the size of the recommended dose and the chronic nature of the diseases 
they treated meant that the volumes required were very large. As figures in 2002 
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showed the global cell-culture capacity seemed to be almost fully utilised (Mallik, 
2002) and the industry was facing a major drought of manufacturing capacity (Thiel, 
2004), with 35% of bio manufacturers outsourcing at least some of their biologics 
production in 2004 (Langer, 2004).   
Further concerns were that not only was demand for manufacturing space already 
exceeding supply but the problem was expected to be at its worst in 2005(Connolly, 
2001). In 2000 Immunex Corp. was forced to scale back production of its drug 
Enbrel due to a shortage of capacity with an estimated loss of over $200 million in 
revenue in 2001 (Mallik, 2002). In 2002 Roche and Trimeris announced that they 
would be unable to meet demand for their new HIV treatment drug (an injectable 
fusion inhibitor) and would have to ration supply following market launch (Fonendo, 
2002). 
Due to what seemed like a worldwide crisis in capacity big pharmaceutical firms 
went on to invest heavily in production facilities simply to meet the anticipated 
demands. While some companies were investing heavily in new in-house facilities, 
others were relying more on their relationships with contract manufacturers. Today 
there remains exceptionally high numbers of drugs and biologics in pharmaceutical 
pipelines however the capacity crunch expected to hit pharmaceutical manufacture in 
2005 did not occur, partly due to the investments in capacity increases but largely 
due to the development of higher yielding cell systems which meant that lower 
volumes could yield higher product concentrations. The Second Annual Survey of 
Biopharmaceutical Manufacturing Capacity carried out in late 2003 indicated that the 
single most significant barrier to biopharmaceutical manufacture was financial while 
inadequacy of capacity was one of many less significant issues, falling within the 
same category as inadequate availability of skilled personnel. 
In recent years however, factors such as the inability to find experienced staff have 
fallen and a more recent survey carried out put physical capacity higher up on the list 
of manufacturing constraints as industry titres began to increase. It is now expected 
that contract manufacturers will increase capacity of mammalian cell culture 
facilities by 91% by the year 2012, while for the biopharmaceutical developers, this 
figure is 43% (Langer, 2008). 
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As well as the costs associated with penalties (when demands are not met), market 
share losses or losses in potential revenues and outsourcing activities, the cost 
implications of creating capacity must also be taken into consideration. According to 
Kamarck (2006), the cost of building a new facility could be in the region of $200-
$400 million while in 2005 Lonza extended its clinical-scale mammalian 
manufacturing capacity at a cost of £6.1 million (Winder, 2005). It could be argued 
that additional capacity could be built at a later stage with relatively low cost 
implications. However there are consequences of over- or underestimating capacity. 
In a study of a hypothetical monoclonal antibody product for an oncology indication, 
the cost to a company of 50% under-utilization of capacity was compared to the cost 
of a 50% shortage of capacity.  The result showed that the estimated carrying cost of 
a facility operating at 50% capacity was $2-3million/month (based on a 500kg/yr 
facility) compared to an estimated loss of $40-50million/month in operating profit 
(Ransohoff, 2004). Thus it is necessary to not only be able to project quite accurately 
the future requirements of a facility but to also plan and schedule the production 
activities in order to maximise the capacity utilisation and thus maximise the 
facility’s cost effectiveness.  
1.3.1 Multi-product Facilities 
The increase in the number of drugs in manufacture and the associated capacity 
constraints has meant an increase in the number of multi-product facilities (Lakhdar, 
2005) of which one may consider there being two kinds. The first being whereby 
different products are made in parallel, simultaneously and in different production 
suites, and the other whereby different products are made on a campaign basis in the 
same part of the production facility (provided no bacterial/mammalian cell culture 
mix).  
In order to understand the nature of such facilities one can look at contract 
manufacturers, the biggest adopters of multiproduct manufacturing due to the nature 
of their diverse product portfolios; in 2007 the global market for biopharmaceutical 
contract manufacturing had reached $2.4 billion, a 14% increase on the previous year 
and a growth expected to continue for the following year (Downey, 2008). As more 
and more companies are employing outside help, contractors have to cope with the 
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varying operations due to the variations in product demands and requirements. Some 
plants may use dozens of equipment to produce several different types of products 
leading to a myriad of ways in which a plant can be operated and finding the best 
operating plan and schedule has become a challenge. In order to optimise 
productivity in multi-product facilities where processes are run in parallel requires 
effective scheduling of batch overlap and efficient utilisation of shared resources 
(Gosling, 2003). These issues are not isolated to contract manufacturers but apply to 
all multiproduct scenarios. The correct design and scheduling of such processes is 
therefore vital to the production optimisation of such facilities. Simulation techniques 
can be a cost-effective way of achieving this. 
1.4 Simulation Modelling in Biopharmaceutical 
Manufacturing 
There is a growing need for simulation tools to be used during process development 
and manufacturing so as to minimise the potential of business losses (e.g. Farid et al 
2009, Petrides 2002). Potential applications of simulation tools in biopharmaceutical 
manufacturing are discussed below and summarised in Figure 1.1. 
1) During the idea generation stages, of both the drug and the process, project 
selection based on initial feasibility and economic analyses is required 
2) Design of the manufacturing process and facility should be initially carried out 
virtually i.e. via simulations, so that any losses due to product failure at any stage 
during development may be minimised.  
3) Scale-up from pilot plant and technology transfer typically also require further 
consideration of capital required, capacity utilisation and site selection; such 
decisions can be facilitated by simulation and optimisation studies.     
4) During actual large scale manufacturing continuous process optimisation in terms 
of scheduling, resource utilisation and debottlenecking is required to maintain 
process and plant efficiency.  
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5) More generally, drug discovery and development times impact on the patent 
protection period of the commercialised drug and on the potential market figures due 
to changing markets and competition. Simulation techniques aid in speeding up the 
drug commercialisation time by allowing for quicker and more efficient process 
design and specification without the need for real cost and time consuming 
experimentations.   
6) Initiatives such as Six Sigma are highlighting the importance of simulation 
modelling in evaluation and optimisation across the whole spectrum of 
pharmaceutical activities.  Such activities include transactional flow and supply chain 
which includes transportation and logistics, procurement and supply, and marketing. 
 
Figure 1.1 shows how simulation techniques can be used in the development stages. 
While manufacturing at both development and commercialisation stages remains a 
significant area for the use of decision support tools,  
 
Figure 1.1 Various uses of simulation techniques in stages of drug development 
 
 
The modelling of biopharmaceutical manufacturing activities however is not a 
simple task. Saraph (2001) states some key complexities:  
- The manufacturing process is a mix of discrete and continuous processes.  
- The batch sizes vary from stage to stage.  
- Different production stages are physically and temporally separated by 
intermediate quality control and quality assurance processes.  
- Storage capacities at each stage differ.  
- Product has limited shelf life at each stage of production and product potency is 
adversely affected by storage. 
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- Production capacity differs from stage to stage and so does staffing (in terms of 
operating shifts and days of the week).  
- There are issues of product rejection and process yield. 
- There are elaborate controls to ensure required cleanliness, which create further 
operational constraints as well as other regulatory constraints 
- Sharing of common utilities 
 
Due to these complexities and those issues highlighted in section 1.2, decisional 
support tools play a major part in biopharmaceutical manufacturing. However, 
despite this, the industry has had little associated simulation work in the past 
compared to other industries, for example, the chemical or semiconductor industries. 
As a result, simulation modelling in the biopharmaceutical industry has become very 
much an ad hoc activity, with very little guidance offered on the approach to creating 
these decisional support tools.  
1.5 Aims and Objectives 
The aim of this work is to provide a standard framework to be used as a guideline for 
the construction of simulation models in biopharmaceutical manufacturing capacity 
management. The motivation behind this is to create a more cost-effective and 
efficient way of creating models which meet a certain set of requirement 
specifications as listed below: 
- Intuitive to User 
- Relevance and Ease of Data Input/Output 
- Short Run Time 
- Maximised Reusability and Sustainability 
- Minimised Development Time 
In order to achieve this, various biopharmaceutical manufacturing case studies will 
be carried out, addressing both deterministic and stochastic issues involving capacity 
management.  
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1.6 Thesis Outline 
The structure of this thesis is as follows: 
Chapter 2 presents a literature review of different simulation techniques, current 
platforms available and a critique of their use as decisional support tools. This is 
followed by a review of current standards available across different industries. 
Chapter 3 presents the Standard Framework proposed in this work, presenting its 
development as part of an evolutionary process. It will highlight the various versions 
of the standard and the case studies used to test them. 
Chapter 4 presents the first of the in-depth case studies used to test the Standard 
Framework Version 1. The case presented is that of a biosynthetic therapeutic 
manufacturing facility, looking at scheduling and resource utilisation. Both 
deterministic and stochastic methods are used to perform process debottlenecking, 
using Monte Carlo techniques to model inherent risks. 
Chapter 5 presents the second in-depth case study used to test the standard 
Framework Version 2. The case presented is that of a monoclonal antibody 
production facility, looking at scheduling and resource utilisation. The chapter 
discusses the scenario analyses used to determine the best strategy to deal with 
process variability and uncertainty while minimising the downstream cost of column 
repack and maximising process throughput. 
Chapter 6 presents the third and final in-depth case study, using the monoclonal 
antibody process to look at scheduling in a multiproduct facility to test the Standard 
Framework Version 2. The scenarios presented here explore multiproduct 
campaigning, product changeover procedures and operating shifts, looking at the 
optimal campaigning schedule of multiple products, given a set of constraints, 
according to three quantitative measures.  
Chapter 7 considers the commercialisation of this work and Chapter 8 goes on to 
discuss the related validation and regulatory issues. 
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Finally, Chapter 9 concludes the thesis, giving a summary of the work that has been 
done and discusses possible directions for future work in the area of standardisation 
in biopharmaceutical manufacturing capacity management modelling. 
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2 CHAPTER 2 
Literature Review 
 
2.1 Introduction 
As discussed in the previous chapter, biopharmaceutical manufacturers are 
increasingly turning to simulation tools to assist in many design, development and 
optimisation activities, particularly those related to capacity management, in their 
endeavour to produce more cost effective and highly productive processes. 
Simulation tools due to their graphical representations and inbuilt functionalities 
(often specific to application area) are popular among simulation analysts and are 
used at various points throughout the product life cycle. The increased use of these 
tools in the biopharmaceutical industry has highlighted the need to optimise the 
actual simulation process, that is, to improve the process by which the models are 
built. This improvement would mean a quicker model construction time frame, by 
means of a more efficient use of inbuilt tools and functionality and perhaps a central 
framework which would provide the foundations for all future models with certain 
recognised commonalities.   
Section 2.2 will review the key aspects of simulation modelling, including model 
characterisation according to system definition and model dimension. It will then go 
on to discuss simulation software selection. Section 2.3 will review the current 
simulation solutions available for both the biopharmaceutical and other industries 
facing similar problems, analysing the differences and similarities between these 
solutions. Finally, Section 2.4 will examine the different standardisation approaches 
available in creating a more uniform approach to the simulation modelling, providing 
a review of their use in creating useful models.  
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2.2 Simulation Basics 
2.2.1 Systems 
This section discusses the basic features of simulation, looking at the different 
systems and dimensions which can be used to define the different types. 
- Discrete simulation systems have instantaneously changing variables at separate 
points in time (Law and Kelton, 1991). That is, the system state variables remain 
constant and change only at certain points in time called ‘events’ (Banks, 
1998).Examples are queuing systems containing entities, resources, and the 
queue (e.g. a bank) and manufacturing systems with production parts competing 
for resources. 
- Continuous simulation systems involve continuously changing variables with 
respect to time (Banks, 1998). For example a weather event such as a storm 
would be a continuous system, or the movement of water through a series of 
reservoirs and pipes. 
2.2.2 Dimensions 
When aiming to develop a simulation tool it is also necessary to consider the 
different dimensions, of which there are three (Law and Kelton 1991): 
- Static versus Dynamic Simulation Models: Time distinguishes these types of 
model. Static models represent a particular moment in time or represent systems 
in which time plays no role. Spreadsheet models created in Excel are an example 
of this. Dynamic models however represent systems as they evolve over time 
such as the movement of product through the manufacturing process. A process 
modelled in Extend would be an example. 
- Deterministic versus Stochastic Simulation Models: Deterministic models do not 
contain any random components. The output is determined once the inputs and 
relationships have been specified. Stochastic models have some random input 
components and the outputs produced are themselves random.  
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- Continuous versus Discrete Simulation Models: Discrete and continuous 
simulation models are defined similarly to discrete and continuous systems. 
However discrete models are not necessarily used to model discrete systems and 
vice versa. For example, continuous simulations can also be used to simulate 
systems consisting of discrete entities if the number of entities is large enough so 
that the movement can be treated as a flow. 
2.2.3 Simulation Studies 
When presented with a situation deemed suitable for simulation it would be helpful 
to go through a predefined and tested route for model creation. This route should 
clearly define the series of steps leading to the implementation of the model. Banks 
(1998) suggests the steps shown in Figure 2.1.  
 
Figure 2.1 Steps in a Simulation Study (Source: Banks, 1998) 
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Ryan and Heavey (2006) present a slightly different view of the modelling process as 
shown in Figure 2.2.  Applying the ‘‘40–20–40’’ rule they state that, in model 
development, the modeller’s time should be divided into: 40% to requirements 
gathering, 20% model translation and 40% experimentation such as validation and 
verification. Although the main steps are very similar to those presented by Banks 
(1998), the main difference are the highly iterative nature and the increased emphasis 
on continuous verification and validation.  
 
 
Figure 2.2 The life cycle of a simulation study (Ryan and Heavey, 2006) 
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2.2.4 Types of Simulation Environment 
The term simulation environment is used to describe the platform on which the 
simulation is carried out, or the type of software used. Figure 2.3 shows the three 
main types: spreadsheets-based, simulation languages and simulators, which can be 
further broken down into sub-categories. The following section will discuss the types 
of simulation environment.  
 
Figure 2.3 Types of Simulation Environment: Spreadsheets, Simulation Languages 
and Simulators, with the sub-types object-oriented and discrete event simulators. 
2.2.5 Spreadsheet-based models 
Spreadsheet modelling describes the use of software such as Microsoft Excel to 
perform comparatively basic system calculations. This type of modelling 
environment allows for both deterministic and stochastic analysis and optimisation, 
more so with add-ons such as Crystal Ball (Oracle), @Risk(Palisade) or 
RiskOptimiser (Palisade). Also, it has the advantage that almost all users will have a 
spreadsheet tool available to them. However there are limitations to this type of 
simulation environment. For example, spreadsheets are static in that they cannot 
model time elements of a system. Thus any dynamic requirements are not met. 
Furthermore, complex algorithms are difficult to implement, spreadsheets are slower 
than some alternatives and data storage is limited (Seila, 2001)  
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2.2.6 Simulation Languages and Simulators 
A simulation language uses a computer package that is general in that any system 
may potentially be modelled on it. A program is written using the language’s model 
constructs which means that extensive knowledge of the language is required.   
A simulator however is parameter driven and requires little or no programming 
(Banks, 1991). Simulators have various types; object-oriented, discrete event, non-
object- non-discrete event and object oriented-discrete event. Object oriented 
simulators model the interacting behaviour of objects over time (Joines, 1998) while 
discrete event simulators model the state changes which occur at specific points in 
time.  
In recent years there has been a movement towards environments which use 
simulation languages and a graphical model-building approach, offering a hybrid 
form of the two simulation techniques. Programme development time is greatly 
reduced as models are constructed using inbuilt system component libraries. Those 
simulation packages which do not allow for additional programming have a major 
drawback in that the models are limited to the system configurations offered by the 
package. There are however many packages (such as Extend, Imagine That!) which 
contain their own vast libraries of system components and also allow for 
programming (using the ModL language) to alter components or to create entirely 
new ones. 
2.2.6.1 Object Oriented Simulation 
In this type of simulation the system dynamics are expressed in terms of objects 
(actors) that exist in parallel and that interact with each other. Every object is 
represented by: parameters, attributes (also called internal attributes or value 
attributes) and methods (also called actions or procedure attributes). 
2.2.6.2 Discrete Event Simulation 
Law and Kelton (1991) describe this as the modelling of a system as it evolves over 
time by representing the instantaneous change in the state variables at separate points 
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in time where events will occur. The most common modelling elements in a discrete 
event simulation system are described as follows 
- Entity: This can be a dynamic item that arrives to a system and usually exits it. 
For example, in a model of the downstream processing of an antibody, the entity 
would be the fermenter harvest stream which would move from unit operation to 
unit operation eventually leaving via the final step (perhaps a chromatography 
step depending on the scope of the model).  
- Attribute (or parameter): A piece of information that describes an entity. Entities 
may share common attributes, for example the components of a fermenter feed 
will all share the same fermenter arrival time.  
- Resource: Resources provide a service to dynamic entities (Banks, 1998) and are 
required to run the system. Examples include people, machines and buffers. 
- Queue: If a dynamic entity is denied a resource because it is being used 
elsewhere then that entity will join a queue for that resource. 
2.2.7 Simulation Software Selection 
Simulation software must meet certain criteria in order to be of use to the modeller 
and the ‘client’ (internal or external). In other words, the software should provide the 
functionality required to a) create a sufficiently true representation of the real system 
and b) provide a ‘user-friendly’ modelling environment.  
According to Banks (1998) the following should be taken into consideration when 
choosing simulation software: 
Input 
- File Importability - In more complex systems or processes it is useful to be 
able to import files containing the information rather than re-entering again. 
- File Exportability - This feature may be useful when for example graphical 
representation of the output data is required. 
- Syntax - Easily understood, consistent and unambiguous. For example a 
queue block represents an actual wait in line. 
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- Interactive Runner Controller (IRC) or Debugger - This assists in finding and 
correcting errors 
Process 
- Powerful Constructs – To aid in the representation of the real system. 
- Speed - This should remain within reason even for highly complex systems with 
many entities. 
- Random Variable Generator - Usually from a selection of 12 distributions. Law 
and Kelton (1991) state that statistical capabilities are needed as real world 
systems show random behaviour, a simulation package should contain a variety 
of standard distributions to generate random inputs.  
- Attributes and Global Variables - Attributes are associated with local entities 
while global variables are associated with all entities.  
- Programming - For a model to truly represent a complex real system a degree of 
internal programming is required to code the ‘complex decision logic’ (Gibson). 
Simply using inbuilt representations will limit the validity of the model. 
Output 
- Standardised Reports - These can be produced automatically or by request. 
- Customised Reports - Tailored to the specific needs of the project. 
- Business Graphics - For example bar charts and histograms. 
- Database Maintenance.  
- Custom Performance Measures.  
- Write to a file - It may be useful for the simulator to be able to import a file 
containing data, events or system variables into a spreadsheet for further analysis 
or manipulation. 
Environmental 
- Ease of Use.  
- Ease of Learning. 
- Quality of Documentation. 
- Animation Capability - Elements of a system are represented by icons that alter 
in some way when there is a change in state in the simulation. According to Law 
and Kelton (1991) some advantages of having animation are: 
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• Debugging 
• Model validation 
• Suggesting improved operational procedures 
• Understanding the dynamic nature of the system 
• Training personnel 
2.3 Current Solutions 
2.3.1 Overview 
While the focus of this chapter is on biopharmaceutical manufacturing it is useful to 
consider that industries such as the chemical and food & drink industries face similar 
problems and therefore adopt simulation techniques in much the same way. 
This section reviews the applications of some available commercial simulation 
packages. 
2.3.2 Application of Simulators 
ProModel from ProModel Corp (Orem, UT)  is a discrete-event (i.e. dynamic) 
simulation software used for evaluating, planning or designing manufacturing, 
warehousing and logistics. It is a Windows-based system with a graphical interface 
and object-oriented modelling constructs that can eliminate the need for 
programming (Benson, 1997).  
The user interface is in ‘spreadsheet’ format. While complex features of 
manufacturing systems can be built from pre-existing model elements within the 
software, programming using languages such as C may be carried out externally and 
linked to ProModel and accessed any time during runtime for increased flexibility 
(www.promodel.com). 
Companies who have used the software include Pfizer, Johnson & Johnson and 
Bristol Myers Squibb. A case study released by ProModel Solutions (formed from 
2000 merger of ProModel Corp and QuestOne Decision Sciences) describes the use 
of ProModel by independent consultants to increase the efficiency of a generic 
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pharmaceutical firm’s QC laboratory throughput. A series of ‘what if’ scenarios were 
used as a form of sensitivity analysis of the performance of the lab, answering such 
questions as  
- The impact of changing the mix of sample releases on lab efficiency 
- Staff shift assignments and team organisation of the operating efficiency 
- Identification of production bottlenecks 
- Effect of planned and unplanned equipment downtime on lab workflow 
(www.promodel.com). 
 
ExtendSim (Imagine That!) is another visual simulation tool which allows model 
building using pre-built components without the need for programming (Krahl, 
2000).  
Extend models are built using blocks which describe calculations or process steps. 
Groups of blocks with similar characteristics can be found in block libraries 
incorporated in the software. The internal database also allows for a large amount of 
parameter storage within the software itself and can be accessed by all library blocks. 
There are certain features of the ExtendSim software which include reusability of 
blocks within each model and the ability to save within the system for other models, 
ability to process large scale system models, simple graphical representation and 
interactivity with other applications such as Excel. Extend also has an optimisation 
block which determines the best model configuration. Further flexibility comes from 
its programmability feature – its built-in C-based language, ModL, can be used to 
develop new modelling components (Krahl 2000) thus allowing for greater 
specificity for the user and the project. This integrated programming feature 
distinguishes it from simulation tools such as ProModel which allow for external 
programming of model components which are then linked to the model.  
An example of the application of ExtendSim is given by Sharda and Bury (2008) 
where they used the simulation software to determine the reliability of a chemical 
plant by understanding the key equipment components that contribute towards 
maximum production losses. According to the Sharda and Bury, Extend was chosen 
for this application due to its capabilities in modelling both discrete and continuous 
process elements simultaneously and also it’s hierarchical structure, allowing for 
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intuitive model. In order to determine plant reliability they ran a series of scenarios 
based analysis, using the Extend database to store and export data for analysis. As a 
result they were able to determine areas of concern with regard to component 
efficiency.   
Lim et al (2004) describe the use of Extend to model and compare perfusion-based 
and fed-batch based processes in the production of monoclonal antibodies, looking at 
features such as resource management, mass balance analysis, in-process testing and 
costing. Lim et al (2004) use the database SDI tool to transfer data via the interface 
with Excel. This is a complex method of data transfer and it requires an expensive 
plug-in for Excel. However for the more complex models with a great number of 
Excel tables which need to be linked it is the better choice as it allows for automatic 
importation of all similarly structured tables and ease of use when relating the data or 
attributes to items. With regards to calculations, instead of carrying these out in 
Excel and then linking the results of those calculations to the Extend model via 
tables, calculations are carried out in Extend. Lim (2004) comments on the 
limitations of this approach.For a complex model calculations done in Extend slow 
the simulation runs down significantly. In fact a run of this particular model took 10 
minutes on an average processor rather than a few seconds. Calculations done in 
Extend also often cause the software to crash which is highly inconvenient. 
However, Lim et al (2004) also comment on the advantages of using the Extend 
simulation tool stating that the graphical representation creates an intuitive 
simulation environment while the animation during model runs enables the user to 
view events as they occur and allows for debugging. 
Rajapakse et al (2004) use Extend to map the development, manufacture and testing 
stages of the three clinical trial phases along with the proceeding 20 years in market 
for 6 drugs. The fundamental aim of the model is to calculate the estimated number 
of drug successes and NPV based on development times, capital and human resource 
constraints and taking into account the implications of contract manufacturing. Here, 
Rajapakse et al (2004) introduce stochastic modelling, adding probability 
distributions to uncertain input parameters, to perform sensitivity analyses. No 
limitations of the software tool are stated.  
 
Literature Review 
  
- 35 -  
 
Simul8™ (Simul8 Corporation) is a discrete event simulator which interfaces to 
common external programs such as Excel or Visio. It is targeted at many industries 
including manufacturing and capacity planning. A Simul8 simulation involves 
processing work items. These enter the system via work entry points, pass through 
work centres, may temporarily reside in storage areas and leave via work exit points 
(Hauge and Paige, 2001). Hauge and Paige (2001) state that when creating a model 
using the Simul8 platform, the starting point is to add a few items onto the 
workspace and connect them, creating the basic logic of the simulation.Further 
details can then be specified via dialogue boxes, including changing the names of the 
objects. This functionality is very similar to other discrete event simulators. SIMUL8 
can also be used to conduct extensive trial runs. When a trial is complete the 
software automatically prepares summary reports of the results. Specific areas can 
then be picked from the summary and further analysed by the various statistical tools 
and diagrams made available. 
The Simul8 simulation tool allows analysis of manufacturing processes without the 
requirement of programming knowledge. However, importantly, its simplicity 
creates a utility threshold beyond which more complex workbench tools such as 
Extend would serve a company better in seeking answers to more in-depth design 
and manufacturing questions. 
2.3.3 Application of Spreadsheet Based Models 
Superpro Designer (IntelligenInc) is a static modelling tool which is spreadsheet-
based with a graphical interface.  
Gosling (2003) describes the use of Intelligen’sSuperPro Designer to construct a 
flowsheet for the fermentation train of a biopharmaceutical manufacturing process. 
The resulting flowsheet contains fermenter, storage and media prep vessels with 
intermediate pumps and also all input and output streams. SuperPro Designer’s use 
of inbuilt bioprocess icons allows for user friendly flowsheet diagrams for simpler 
models however for more complex systems the flowsheets become far too busy.  
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Gosling then describes the use of Intelligen’sSchedulePro to generate equipment 
occupancy profiles for the overall production schedule based on the process and 
utility information provided by SuperPro Designer.  
Petrides (2002) describes the use of SuperPro Designer for simulating the production 
of an intermediate pharmaceutical compound, looking at the process scheduling, 
resource tracking, capacity utilisation and economic evaluation of the process using 
tools provided by the simulation package. One important functionality of SuperPro 
highlighted here is ability to perform equipment sizing calculations based on material 
balances and to calculate batch cycle time by estimating the cycle-time of scale-
dependent unit operations. Furthermore Petrides (2002) also discusses the tracking of 
volumetric utilisation of all vessels throughout the batch cycle - this differs from 
packages such as Extend which calculate utilisation based on time-in-operation 
during simulation runs. 
Biwer et al (2005) describe the use of SuperPro in the uncertainty analysis of 
penicillin V production, usingthe platform to provide the material balance and key 
economic parameters. The output was then exported to Excel in order to run Monte 
Carlo simulations using Crystal Ball. They state since most computations in 
SuperPro can also be done in spreadsheet calculations, thus transfer from the 
simulator platform to Excel is made possible, however they also state that it is the 
most time consuming part and has a certain risk of transcription errors. This means 
that validation is necessary between the SuperPro outputs and the constructed Excel 
spreadsheet. 
Jully et al (2004) further describe the use of SuperPro Designer to model, optimise 
and debottleneck a pharmaceutical production process. The experiment largely 
focuses on the ability to manipulate process parameters such as cooling time and 
filling rate by replacing actual unit procedures. This highlights a fundamental 
difference between Superpro and again, Extend. Superpro’s in-built unit procedures 
which represent activities such as fermentation, blending and so on are provided with 
dialog boxes in which various parameters and variables can be entered. For example 
material mass balances, temperature, rates etc. In Extend however activities can be 
represented by one or a series of blocks which do not contain such integrated 
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attributes per se. Instead combinations of blocks and data inputs allow for activity 
modelling and other functions such as simple mass balancing.  
 
BioSolve (Biopharm Services UK) is an Excel based bioprocess modelling tool 
designed for operating costs analysis such as cost of goods, utility sizing and waste 
generation.Due to relatively new market age of the software there is no literature 
published as yet which provides an unbiased analysis of the tool (all publications are 
in collaboration with the vendor) however some conclusions can be reached in 
review of the software. Firstly, due to the spreadsheet driven nature of the tool, 
models can be generated relatively quickly when compared to simulators such as 
Extend. Secondly, what sets the BioSolve software apart from some other 
spreadsheet based tools such as SuperPro is that the cost and process data is provided 
and updated by the vendor company. However since the models are static theydo not 
capture the dynamic nature of the systems they are used to model, such as the 
complexities of scheduling. 
2.3.4 Optimisation Models 
An alternative to simulation is the use of optimisation models which primarily rely 
on mathematical algorithms.  
An example of an optimisation approach is given by Lakhdar (2005) where mixed 
integer linear programming is used on the GAMS platform to determine optimal 
scheduling of a multi-product facility given variability in parameters and constraints, 
as defined by the modeller. Although the paper concludes that the model was 
successfully used to deliver an optimal schedule (with operating profit being the 
objective function) it is believed that this approach is not as appropriate for all 
simulation scenarios for the following reasons. Firstly, the heavy reliance on 
mathematical algorithms requires the problem to be modelled in a very rigid 
structure. Secondly the question of capacity management and optimal scheduling 
relies on the interaction of a series of events and constraints which can be better 
represented using fully dynamic object oriented or discrete event simulators.  
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Miller et al (2010) describe the use of a biologics facility model built using the 
VirtECS version 7.1 software system (Advanced Process Combinatorics, Inc., West 
Lafayette, IN) in order to generate an automated production schedule based on the 
variability and constraints inherent to the process. The software used consists of a 
core mathematical programming solver and a customized outer layer that is 
specifically tailored to address biologics process behaviour. The core solver, which 
solves a mixed integer linear program (MILP), is used by the outer algorithm which 
is required to address stochastic variability, through a sampling of distributions, of 
uncertain parameters such as titre. Miller et al (2010) compare the use of 
mathematical model to the use of discrete event simulators, stating that the former 
approach offers two main advantages to the DES method. Firstly, that the level of 
complexity which arises with simulators is great, due to the high number of 
equipment and tasks. Secondly, that due to the fact that discrete event simulators 
only allow events to be processed in chronological order, no events earlier than an 
occurred event can be considered. They argue that with the mathematical approach 
considering different demands is a simpler operation due to this functionality, as the 
solution strategy can range over the timeline moving back and forth until a complete 
solution is generated. 
2.4 Standardisation Approaches 
2.4.1 Motivation 
The simulation tools described in this review are highly capable of modelling 
complex systems and have been used across different industries for various purposes.  
However many companies and industries in general have recognised the need for a 
more standardised approach. For example, imagine a large pharmaceutical company. 
whose manufacturing facilities in America, Europe and Asia each require high 
degrees of simulation whether for new projects or existing manufacturing systems. 
Over time this company has accumulated a large number of models each specific to 
the individual system and problem scope built entirely from scratch each time, thus 
proving costly in terms of time and labour intensity. With a standard approach in 
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place that takes advantage of system commonalities, the development time could be 
significantly reduced allowing for a framework initially applied in a US facility 
model to be applied in the UK.  
A possible solution this problem is to perform an extensive study, identifying areas 
of commonality between a vast array of models previously built by UCL and other 
organisations. This will allow for the construction of a model infrastructure, a 
generic model template which can be used and built upon for almost any aspect of a 
biopharmaceutical manufacturing activities, thus reducing the cost and time 
associated with building each new model on an ad hoc basis. 
In order to create such a framework it is first necessary to understand the current 
standardisation approaches available. 
This section reviews the current standardisation approaches available, discussing 
their potential application within the context of the work in this thesis. 
2.4.1.1 Manufacturing Simulation and Visualisation Program 
The Manufacturing Simulation and Visualization Program at the National Institute of 
Standards and Technology (NIST) is a US institution developing a framework for 
manufacturing simulation data standards. They propose that the Banks approach to 
modelling described in section 2.2.3 leaves too much to the skill of the individual 
analyst and allows little opportunity for the analyst to build upon the work of others 
since each simulation is built as a custom solution to a uniquely defined problem 
(McLean and Leong, 2002). Instead a modularisation approach is proposed whereby 
re-usable model building blocks are created which can be used for all models 
reducing the duplication of simulation work. Furthermore an interface for 
transferring data between simulation and other manufacturing applications is 
proposed to accelerate the simulation process. A standardisation in language would 
perhaps be a requisite to the modularisation approach as the standard blocks would 
only be re-usable if compatible with every application used by simulation analysts.  
McLean and Leong (2002) suggest a hierarchical classification approach in looking 
at a modelling problem, with the major aspects being those described below. 
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The Industrial Market Sector 
This defines the manufacturing industry and describes the end product. 
 
Hierarchical Level of the Manufacturing Organisations System or Process 
A meta-hierarchical approach is proposed which attempts to generalise the modelling 
area. McLean and Leong (2002) justify the partitioning of the meta-hierarchy with 
the significant differences in the models and data required to simulate each level, 
however realise that one model may encompass more than one of the levels. The 
simulation meta-hierarchy from highest to lowest is:  
- Economy 
- Market – corresponding to the individual sectors, group of sectors, etc. May be 
used for forecasting demand, prices etc. 
- Supply chain  
- Enterprise – here this defines the boundaries of the company. Large 
pharmaceutical companies for example have many facilities many of which are 
integrated in one supply chain 
- Facility – the modelling of departments, activities, equipment at one facility  
- Department – engineering, finance etc 
- Line, area, or cell – grouping of stations and/or equipment for manufacturing a 
product 
- Station – place where work is performed by person or robot.  
- Equipment  
- Device – separable elements of equipment e.g. sensors, membranes  
- Process – the physical manufacturing process is the lowest level of the hierarchy 
 
The Simulation Case Study 
This describes the question that the model would be answering. The following case 
studies proposed by McLean and Leong (2002) are some areas which a model would 
be used in: 
 
- Market forecast 
- Logistics network 
- Site selection 
- Work force 
- Product mix 
- Capacity Analysis 
- Tolerance analysis 
- Ergonomic analysis 
- Tooling 
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- Business process 
- Scheduling 
- Plant layout 
- Capital equipment 
- Line balancing 
- Cost estimation 
- Process validation 
- Process capability 
 
- Inventory 
- Material handling 
- Maintenance 
 
Model Elements, Input, and Output Data 
The detail level of a model and therefore the data required to construct it greatly 
depends of the case study and the hierarchical level of the organisation or process. 
The data formats developed by NIST have been divided into: 
- General and miscellaneous, e.g. units of measurements, probability distributions 
- Organizational structures 
- Product and process specifications 
- Production operations 
- Resource definitions 
- Layout 
2.4.1.2 Process Specification Language (PSL) 
The use of computer software is becoming increasingly commonplace in 
manufacturing operations and is used in a vast number of areas. As demand of 
applications has multiplied the information has become more complex with many 
manufacturing engineering and business software applications using process 
information, including manufacturing simulation, production scheduling, 
manufacturing process planning, workflow, business process reengineering, product 
realisation process modelling, and project management. Each of these applications 
uses process information in a different way, and therefore their representations of 
process information are also different. Often they associate different meanings with 
the terms representing the information they are exchanging (Schlenoff et al, 2000) 
thus there has been recognised a need for a standard neutral translator to allow these 
applications to interoperate taking into account their semantics (meanings of their 
terminologies) and their syntax. 
 PSL is an undertaking by the National Institute of Standards and Technology 
(NIST), the aim of the project being to create a process specification language which 
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will be common to all manufacturing applications and robust enough to represent the 
required process information. PSL should act as a medium, facilitating 
communication between different organisations or different branches or sites of the 
same organisation; currently these organisations have to use the same software so as 
to be able to communicate process representations between them, a problematic 
solution if one of the organisations is not familiar with the package. The concept 
behind PSL is that the organisations will be able to use two different packages which 
are ‘PSL compliant’ and be able to transfer files with common language and 
representation components with ease facilitated by using the PSL ontology, that is, 
the set of terminology along with their meanings existing in the PSL lexicon. 
 
Schlenoff (2000) defines a language as a set of symbols and a grammar (a 
specification of how these symbols can be combined to make well-formed formulas). 
The PSL lexicon consists of logical symbols (such as Boolean connectives and 
quantifiers) and non-logical symbols. For PSL, the non-logical part of the lexicon 
consists of expressions (constants, function symbols, and predicates) chosen to 
represent the basic concepts in the PSL ontology.  
 
The PSL project findings offer a gathering of requirements necessary for modelling a 
manufacturing process. According to Knutilla (1998) there are 4 major categories of 
requirements: 
- Core: Most basic and intrinsic to all processes. Provide basis for representing 
only simplest of processes e.g. resource, task 
- Outer Core: Pervasive but not critical. These requirements describe processes 
such as resource grouping and task alternatives.  
- Extensions: Grouping of related requirements which together give added 
functionality. Six extensions are Admin/Business, Planning/Scheduling/Quality/ 
Analysis, Real-Time/Dynamic, Process Intent, Aggregate Resources/Processes, 
and Stochastics/Statistics. 
- Application Specific: Only relevant within specific applications e.g., dynamic 
rescheduling for the production scheduling environment 
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Although PSL is targeted at manufacturers who need to exchange process 
information, ultimately it is the software vendors who would need to develop and 
incorporate the PSL translators into the simulation tools (www.mel.nist.gov/psl). 
However the concept of PSL is still applicable to the modelling process; a standard 
ontology for a standard framework can aid in its consistency and its intuitiveness to 
the modeller and end user. 
2.4.1.3 Unified Modelling Language (UML) 
The Unified Modelling Language (UML) is an object-oriented specification language 
that began in the mid 1990s as a solution to the vast number of languages which 
individually failed to completely satisfy the requirements of object oriented methods. 
It is a standard language for specifying, visualising, constructing and documenting 
the artefacts of software design (Siau and Cao, 2001) by using a standardised set of 
symbols and ways of arranging them. Its use in systems engineering is of particular 
interest here as it focuses on using a set of diagrams to represent a system from 
different viewpoints (Ramos 2003), implicating a potential as a tool during the 
design phase of the modelling activity. 
Ramos (2003) describes the use of UML as a structural modelling tool, used to 
identify the key operational components of a cellular manufacturing system for the 
construction of a system template. Split into two phases, the initial identification of 
operating parameters and their relations was done through the use of UML class 
diagrams. The second phase, the definition of the simulation modelling constructs 
was done through the use of the UML components diagrams. Therefore the standard 
was used both in the system definition and the model design stages, allowing for 
model component selection i.e. definition of the scope of the template, allowing for 
the construction of a template that was reusable, extendable and intuitive to the user 
(Ramos, 2003). 
Glinz (2000) describes a case study looking at the application of UML to the 
Teleservices and Remote Medical Care System (TRMCS) which has a certain set of 
systems requirements. The TRMCS provides medical assistance to at home or 
mobile patients and Figure 2.4 shows the use case diagram for the system: 
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Figure 2.4 Use Case diagram of the TRMCS 
 
In reality the TRMCS should warn a mobile patient when a service becomes 
unavailable because she or he is moving out of range of the mobile communication 
network. So an active model element, for example, an active object is needed which 
is able to initiate communication between the system and an actor (circled area in 
Figure 2.4). However, such an element cannot be modelled in UML: a use case by 
definition describes a sequence of actor stimuli and system responses that is initiated 
by an actor (OMG, 1999). Active objects are not allowed in UML use case diagrams. 
Therefore the first deficiency of UML is that a use case model cannot specify the 
interaction requirements where the system initiates an interaction between the system 
and an external actor (Glinz, 2000). Another problem highlighted is that UML cannot 
model rich system context i.e. because UML does not allow associations between 
actors it is not possible to model the important necessary external interactions such as 
a Dispatcher communicating with a Physician. Put into a pharmaceutical context this 
would mean that for example the communication between departments could not be 
modelled in a SOP workflow model. However, UML is not a software process.  
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Furthermore Seila (2005) argues that the many graphical representations are quite 
abstract and none can be used directly to model the operational dynamics of the 
system from a discrete event simulation perspective.  
Ryan and Heavey (2006) state that while UML activity diagrams are capable of 
representing workflow and dataflow within a discrete process they do not visually 
account for detailed interactions or the complex use of resources within a detailed 
simulation model.  
A conclusion that can be made from this review is that the UML standard, 
specifically the class diagrams, can be used in system definition phase of the model 
construction process, helping to clearly define the model scope. Barjis and Shishkov 
(2001) also propose the use of the UML activity diagrams as a pre-simulation 
technique. However the standard is limited in its ability to fully define the actual 
model construct.  
2.4.1.4 Integrate DEFinition, IDEF0 
The purpose of this standard is to aid in the construction of a system model that 
consists of a series of hierarchical diagrams with the primary modelling components 
being functions (boxes) and data objects which link the functions (arrows). While the 
detailed concept of the IDEF0 standard cannot be applied to all object oriented DE 
simulation modelling, there are some useful guidelines provided which can be used 
to construct a more standardised model. The main rules have been listed: 
Top-level Context diagram: The standard states that the top level contains a single 
box to represent the subject of the model. The standard also states that inputs and 
outputs to this block should represent the broader picture, in order to represent the 
context of the system being modelled.  
Child Diagram: This is how the standard refers to the sub-levels i.e. when a function 
is decomposed into its sub-functions. So the workspace visible below the top-level 
diagram will be the child diagram of the top level parent diagram. Each level can be 
both a parent diagram and a child diagram (except the top level which can only be a 
parent). 
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Numbering blocks at each level: A node number is based on the position of a box in 
the model hierarchy.  
Number of child boxes per child diagram: The standard states that there should be 3-
6 child boxes on each child diagram. In other words, 3-6 sub-functions on the 
workspace for each decomposed function. 
Connections: The standard states that boxes be connected by solid arrows 
 
Al-Ahmari and Ridgway (1999) describe the use of IDEF0 to create a modelling 
method for manufacturing systems analysis and design, applying the standard in the 
creation of a static model during the design phase of the modelling process and also 
the simulation construct. They specifically use the IDEF0 standard to analysis 
different sub-activities and their inputs, outputs, controls and mechanisms. The 
IDEF0 model of every activity is decomposed into more detailed diagrams until the 
activity is described in the necessary level of detail (as defined by the scope). The 
resulting IDEF0 model is a hierarchy of diagrams derived from the decomposition of 
the activity. The conclusions reached with regard to this use of the modelling method 
are that 1) the conceptual views define the system functions and their internal 
activities which outlines decision problems and general configuration difficulties and 
2) the functional structure summarises system activities and sub-activities illustrating 
their relationships, indicating any misinterpretations and inconsistencies in the model 
upon model validation (Al-Ahmari and Ridgway, 1999). 
Ryan and Heavey (2006) discuss the use of the IDEF0 standard as a descriptive 
method in discrete event simulation modelling. They state that although the standard 
allows for the visual modelling of the decision and activities of a system, it lacks the 
ability to model some aspects of a complex discrete event system such as workflow 
or control flow. They also state that the method doesn’t allow graphical 
representation of the division of a system into multiple processes. 
2.4.1.5 Industry Standard Architecture, ISA-88 
The purpose of this standard is to provide a standard terminology and a consistent set 
of concepts and models for batch manufacturing facilities in order to improve 
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communications between all parties involved (ISA 1995). ISA-88 describes a process 
or a facility in a physical model, defines what needs to be done through batch 
recipes, implements recipes using equipment logic and coordinates these steps in a 
reusable way.    
The standard first describes the hierarchical subdivisions of a batch process. This 
hierarchical breakdown divides the process into stages, operations and actions and 
the overall process model describes the process requirements. 
It then goes on to define the physical model which describes the physical assets of an 
enterprise  
- Unit: One or more major processing activities take place in a unit e.g. cell 
disruption. Also it is presumed that a unit will operate on only one batch at any 
one time. 
- Equipment Module: This may be part of a unit or a stand-alone equipment 
grouping within a process cell. An equipment model can carry out a finite 
number of minor processing activities such as dosing and can be shared between 
units. 
- Control Module: Typically a collection of sensors, actuators and other control 
modules. 
 
So if taking the production of a monoclonal antibody as an example this ISA-88 
terminology can be used in the following way: 
- Unit: e.g. Fermenter 
- Equipment Modules: agitation system, probes 
- Process Cell: Process chain consisting of fermenter, centrifuge, chromatography 
columns etc 
 
ISA-88 also describes the way in which resources should be allocated and arbitrated. 
It states that resources are assigned to a batch or a unit as they are needed to 
complete or to continue required processing with allocation controlling these 
assignments. When more than one candidate for allocation exists, a selection 
algorithm such as "select lowest duty time" might be used as a basis for choosing the 
resource. When more than one request for a single resource is made, arbitration is 
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needed to determine which requester will be granted the resource. An algorithm such 
as "first come/first served" might be used as a basis for arbitration (ISA 1995). This 
is a functionality which can be found in Extend; set priority blocks and decisions 
blocks decide upon resource usage and item process path.    
Pandiana (2002) describes the use of ISA-88 in the hierarchical decomposition of the 
process model for a margarine plant. First the IDEF0 process definition is used to 
decompose the production process into subsequent sub-process stages as shown in 
Figure 2.5. 
 
 
 
 
 
 
 
Figure 2.5 IDEF0 Decomposition of Overall Process for Margarine Production 
(Source: Pandiana, 2002) 
 
Following on from the IDEF0 process model a tree structure depicting the process 
steps can be drawn. The activities, according to the ISA-88 terminology can be 
considered to be operations performed by a unit. The ISA-88 units by the standards 
definition should be able to contain material. For the determination of units therefore 
it is useless to decompose activities performed by equipment which do not contain 
material such as control activities. According to Pandiana (2002) this method of 
decomposition and unit determination allows for more efficient measurement of 
performance indicators by avoiding too much detail and concentrating on the areas of 
the production process which should be checked. 
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2.4.1.6 Industry Standard Architecture, ISA-95 
The ISA-95 standard is in large part an extension of the concepts and terminology 
defined under ISA-88. While ISA-88 defines the models and terminology on the 
factory floor, ISA-95 is a standard between the factory floor and the enterprise It 
therefore addresses the interface between Business Planning and Logistics level 
(level 4) and the Manufacturing Operations and Control level (level 3) of the 
functional hierarchy defined within the standard (ISA 2000). 
There are currently three parts to the standard: 
 
- Part 1: Models and Terminology 
- Part 2: Object Model Attributes 
- Part 3: Manufacturing Operations and Control 
 
Part 1 is of particular interest here as it offers a set of terms and models which can be 
applied to the pre-model construct and model construct stages. Figure 2.6 shows the 
ISA-95 equipment hierarchy which defines the different organisation levels leading 
down to the process and equipment. Again, ISA-95 deals with level 4 while ISA-88 
deals with level 3.  
 
Figure 2.6 ISA-95 Equipment Hierarchy 
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Walker (http://www.idef.com/idef0.html) briefly describes how Dupont Engineering 
used the ISA-95 operations diagrams to map out a project scope, decomposing this 
further, constructing a spreadsheet defining manufacturing operations and their 
breakdown into processes, functions and tasks. Walker goes on to describe how the 
standard was used to measure the business value of the project and to analyse 
supplier capabilities using part 2 and 3. 
2.4.1.7 The Business Process Modelling Notation 
The Business Process Modelling Notation (BPMN) is a standard graphical notation. 
Through a limited set of shapes, associated semantics and connectors, it is a method 
of standardising the way in which business processes are modelled. The following 
describes the main features of the BPMN standard. 
 
Events 
There are three types of event:  
- Start : An event which will trigger the execution of a business process model 
instance  
- Intermediate: This event indicates when an event might happen during the 
execution of an instance  
- End: Indicates where and how a process flow ends.  
 
Activities 
The standard defines an activity as a unit of work to be performed. It might be a task, 
a process or a sub-process. They are represented by a rectangular shape. Markers are 
defined as well to specify additional semantics such as loops.  
The BPMN specifications give the following definitions  
- A Task is an atomic activity that is included within a Process. A Task is used 
when the work in the Process is not broken down to a finer level of Process 
Model detail. Generally, an end-user and/or an application are used to perform 
the Task when it is executed.  
- A Sub-Process is Process that is included within another Process. The Sub-
Process can be in a collapsed view that hides its details. A Sub-Process can be in 
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an expanded view that shows its details within the view of the Process in which 
it is contained.  
 
Gateways 
The BPMN defines gateways as decision points used to constrain the execution flow, 
fork an execution point into several or merge several into one.  
 
Workflow Patterns 
BPMN defines this as the different situations where a specific state of process is used 
to affect its execution. The following describes the different basic control flows: 
- Sequence: The sequencing of activities in a series formation. The majority of 
activities in biopharmaceutical process chains will be of this type. 
- Parallel Split: The parallel formation of activities. In biopharmaceutical 
activities, this parallel formation takes place where there a single process 
function is carried out by more than one equipment,  
- Synchronisation: used to merge two parallel flows. This method is used when 
two activities must not only begin together but end together 
- Exclusive Choice: where an exclusive gateway is used to create a decision point 
or the routing of flow based on a decision.  
 
Onggo (2009) describes the use of the BPMN standard in a unified conceptual model 
representation of a healthcare system with specific application to the problem 
formulation stage i.e. the pre construct modelling phase. The study concludes that the 
standard has the ability to model complex business processes, it is a process-centric 
approach is intuitive and easy to understand, it is scalable by supporting hierarchical 
decomposition of the processes and allows plausibility checks to be carried out on 
the diagrams thus allowing verification of problem formation. 
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2.5 Conclusions 
In conclusion, there are a number of different modelling methods, namely simulators, 
spreadsheet-based tools and optimisation methods. The application of these in the 
bioprocess industry has increased over the last few decades and a number of case 
studies carried out. Due to the rigidity in structure of the mathematical approaches 
and the limited dynamicity of the spreadsheet-based tools, discrete event simulators 
are the preferred platforms for creating dynamic models capable of representing 
uncertainties and constraints along with a more user friendly modelling environment. 
Furthermore, it seems that there are various existing standards to aid in the 
simulation process. However, as the next chapter will discuss more fully, only a 
small proportion of their components can be applied to the standard being proposed 
in this thesis. The most significant factor being that while these standards may be 
suitable for other industries, they do not take into account the complexities of 
biopharmaceutical manufacturing which were highlighted in Section 1.3. 
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3 CHAPTER 3 
Development of the Standard 
Framework: An Evolutionary 
Process 
 
3.1 Introduction 
As indicated in Chapters 1 and 2, there is a growing need in the biotechnology 
industry for simulation tools to manage and improve capacity utilisation in 
manufacturing facilities across a range of areas such as bulk product manufacture, 
fill-finish operations and QC lab operations. This chapter presents the design of a 
standard framework for building such tools so as to facilitate rapid development of 
models that are easy to understand, re-use and extend by other model developers.  
The latest generation of DES packages such as Extend, Simul8, ProModel and 
Simple++ have graphical user interfaces (GUIs) and in built block structures which 
means that more people are able to develop models with little or no programming 
skills required. The nature of the new packages also means that customers and users 
of the models are more easily able to understand them, increasing their value as 
decision support tools. It is important to note however that whilst the GUI and in-
built functions are useful, the benefits do not occur simply by using these alone. 
They instead have to be designed into the models using these new characteristics and 
whilst model development is a much simpler task than prior to the existence of new 
generation DES packages, the task of developing a useful and appropriate model for 
the intended use remains far trickier than one would like. Therefore a structured 
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approach to DES model building is required. Having to create new models from 
scratch results in a portfolio of models varying vastly in design and yet representing 
systems which may have commonalities which would allow for common model 
elements and/or structure. Therefore a structured approach or framework for DES 
modelling supported by guidelines, standards and software tools and blocks is 
required which will lead to more efficient and rapid development of well constructed 
models which take into account these commonalities. These models must also be 
understood, updated, re-used and inherited by others (Oscarsson and Moris 2002). In 
order to form the structured approach an understanding is required of the objectives 
of any biopharmaceutical model. 
This chapter will specifically focus on the DES software Extend (ImagineThat!, San 
Hose, California). Extend allows the use of inbuilt blocks to represent any dynamic, 
real system with the added availability of code manipulation for more specific and 
tailored modelling using the ModL language. 
The following sections will discuss the general features of a biopharmaceutical 
process, an understanding of which will allow definition of the scope of the proposed 
framework designed to aid in meeting a defined set of requirement specifications.  
This work will describe the development of the standard framework as part of an 
evolutionary process. Sections 3.2 to 3.4 will describe the features of the standard 
framework which are the domain description, model requirement specifications and 
the model and system elements which contribute in meeting them.  Section 3.5 will 
describe the evolution of the standard framework. 
3.2 Domain Description 
DES models are used to create representations of ‘systems’.  It is important to note 
that for the purposes of this work, system refers to the specific dynamic domain 
which any particular model will represent. Thus a clear understanding of this domain 
is required in order to define a comprehensive and relevant set of standards and 
guidelines.  
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McLean and Leong (2002) suggest a hierarchical classification approach in looking 
at a modelling problem, with four major aspects: The Industrial Market Sector, the 
Hierarchical Level of Manufacturing Organisations, Systems or Process, the Model 
Elements, Input and Output Data and the Simulation Case Study. Application of 
Mclean and Leong approach has been proposed for the semiconductor industry by Li 
et al (2005), extending their definition to cover Supply Chain.  
While the above hierarchical approach covers the basic stages of tackling a 
modelling problem, consideration of actual real-world modelling projects suggests 
that it is by no means comprehensive, giving little guidance as to the link between 
the system and its representative model or the level of detail required. Thus a new 
hierarchical approach is proposed based on the same concepts however attempting to 
distinguish between the hierarchical levels inherent to the real problem and the 
modelling solution. Importantly it shows that there are further levels of an 
organisations hierarchy which must be taken into account. According to the standard 
ISA-88 an organisation can be broken down into seven levels: Enterprise, Site, Area, 
Process Cell, Unit, Equipment Module and Control Module. Adapting this definition 
to the biopharmaceutical environment gives the following levels in a pharmaceutical 
organisational hierarchy: Supply Chain, Enterprise, Product, Site, Department, 
Process and Equipment.  
Furthermore in dynamic systems modelling, at each level any model will represent 
the flow of object(s) (items, resources etc). Depending on the intended use and the 
level of detail required to satisfactorily answer the question being asked, this entity 
flow will only require modelling of a maximum of 4 levels in the hierarchy. The 
number of levels will decrease higher up. For instance, if the ISA-88 method of 
decomposition is to be followed then every model should be ultimately decomposed 
to the unit operations or in this case the equipment level. However it is important to 
note that a simulation problem classified at the top of the organisation hierarchy does 
not necessarily model all those levels below it. For example a model looking at 
supply chain will probably never require the level of detail which would entail 
modelling the process and equipment. A model looking at a site may require 
modelling of the building and/or the processes however, again, not the equipment. 
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The level of organisational hierarchy along with the type of system and the scope of 
the problem ultimately help define the level of detail and specifications of the model 
needed in order to give a true representation of the real system. 
As Figure 3.1 shows, in order to classify the model and therefore define the type of 
model required (simulation, spread-sheet based or optimisation and platform to be 
used) it is first necessary to classify the system i.e. manufacturing, transactional flow, 
QC laboratory and so on.  The system classification and the scope, as defined by the 
client or model user, will define the data requirements. For example, a query into the 
number of freeze dryers needed to reduce campaign cycle time by 20% in a fill-finish 
facility will require data such as cycle times, labour requirements and rules regarding 
dryer usage. Once clearly defined, the level of detail in the model is intrinsically 
decided by the scope and data requirements. 
 
Organisational Hierarchy Level
Query Area/Scope
Data Requirements Level of Detail
Specificiations
Real System Model
Supply Chain
Enterprise 
Product
Site
Dept/building
Process
Equipment
System Classification Model Classification
 
Figure 3.1 Proposed hierarchical framework for domain description and model 
definition 
 
This work will focus on the ‘Process’ level of the hierarchy, more specifically on 
biopharmaceutical batch processes, looking at the manufacture of bulk products. 
These processes have many features in common which have been listed below:  
• RESOURCES (e.g. labour, buffer, equipment) 
• ENTITIES (e.g. batches) 
• ACTIVITIES 
 - Product Handling Activities (e.g. fermentation, chromatography) 
- Preparation of Intermediates (e.g. buffers) 
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- Preparation of Equipment (e.g. CIP, SIP) 
- Support functions (assays, documentation)  
  (Farid et al., 2000) 
- Ancillary Activities(e.g. CIP, SIP) 
 
At a higher level of definition, these features are common amongst processes. 
However if reduced to a lower level, then differences begin to emerge which can 
impact the way in which these features are modelled. For example a fermentation 
unit will be similar to a chromatography unit in terms of both having sub-activities 
and requiring resources such as media or buffer. Although the actual sub-activities or 
resources will be different, they can be modelled in the same way. However, a 
chromatography unit will have cycles whereas a fermenter will not, therefore a 
difference emerges in the way in which the two activities are fundamentally 
modelled. Differences such as this are the reason for the complexity in trying to 
standardise the modelling of such systems.  
3.3 Scope of Framework 
The standard framework described in this work can potentially be applied to any 
platform and any modelling activity, providing a simple code of practice in 
approaching model design and construct. The theory behind the framework is that a 
structured approach to modelling will reduce development time by reducing the 
likelihood for mistakes in construct and ensure that the client defined scope is fully 
and relevantly covered, a theory tried and tested in this work.  Figure 3.2 shows the 
route taken. 
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Figure 3.2 Flow chart showing application route taken for the Standard Framework 
 
The reason for taking this route has been two fold. Firstly, with the high cost of 
manufacture and ever increasing pressures to reduce development time and costs, 
biopharmaceutical management, in particular capacity management, is where much 
of the industry’s modelling takes place. Secondly and largely due to the former, the 
case studies carried out during the course of this work were all real client based 
projects and therefore the nature of each study was inevitably dictated by the client 
company’s modelling needs.  
There are a number of capacity management questions which could form the scope 
of a modelling problem to which the standard framework can be applied. Some 
examples are given below. 
 
Production Schedule 
• When volume exceeds DSP throughput capacity should the manufacturer: 
 (1) Scale up DSP to handle full throughput or… 
 (2) Increase inventory – store what cannot go through DSP until it’s free 
 (3) Use more than one DSP. If there are multiple products, do you stagger 
production to process  on a ‘first come, first out’ basis or pool the products? 
• Variations in demand have an impact on the production schedule. If goods are 
standard should you   
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(1) Produce to stock in times of low demand to offset capacity requirements 
in times of high demand? 
 (2) Produce according to demand and avoid inventory?  
 
Product Mix  
• Single product: generate in a single suite according to:  
 (1) demand- may mean working below capacity and therefore inefficient 
utilisation or  
 (2) capability - make full use of capacity and store product for times of 
increased demand 
• Multi-product : generate on a  
 (1) campaign basis – perhaps according to demand timings. In which case, 
what should the sequence of campaigns be? What are the campaign 
durations? What are the campaign changeover costs?  
 (2) dedicated production line in parallel. In different suites? Are resources 
shared between the suites? 
 
Resource Management 
• CIP/SIP. There are various questions such as: 
- Take the equipment to the CIP rig or bring the CIP rig to the equipment? 
- Use dedicated CIP rig for each equipment or for each process? 
- Preparation of CIP ‘ingredients’?   
- Single-Use or Re-Use (Recycle cleaning solutions)? 
• Buffers and other materials 
- Prepare and store for when needed or prepare only when needed? If store, 
for how long? 
• Storage of raw materials 
 
Resource Utilisation 
• Changes in utilities utilisation (e.g. WFI for CIP or buffers) after process 
change/expansion?  
• Equipment selection based on 
 (1) start from the top and pick the first one that is free  
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 (2) if all busy, which will finish processing first?  
(3) based on utilisation – pick the one with the lowest utilisation for balanced 
approach.  
 
Operational Assumptions  
• Pooling 
- Pool products as they arrive then release or operate in a responsive mode 
i.e. send through on a first come first serve (FIFO) basis?  
- If batching, what is the best batch size? 
• Impact of product shelf life/stability on the schedule? 
• Shifts, both labour and operational, have an impact on scheduling. For example if 
equipment must be shut down for the weekend this means that batches must be 
stored until start up on Monday morning. Therefore operational shifts have an 
impact on inventory and equipment utilisation. Also, batches must be scheduled 
such that only those which will be finished before shutdown are allowed to go 
ahead for processing.  
 
Process Changes / Capacity Constraints 
• Fixed capacity scheduling or expansion of facilities / outsource to CMO  
• Addition of equipment – what effect will there be on physical space capacity, 
piping, utilities, CIP access, waste treatment?   
• Upstream yield improvements such as increases in titres. What will the DSP 
effects be? For example on columns? 
• Changes in downstream performance i.e. yield/throughput 
 
Disposable versus reusable 
• Changes in CIP, waste management, capacity, yield 
• How many times can be the disposable be used? i.e. lifetime 
• Does the disposable affect the throughput/performance? 
 
Chapters 4-6 describe case studies which look at various capacity management 
questions. Chapter 4 looks at a case determining how fast a certain number of 
batches (the demand) can be run through a single product biotechnology facility 
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taking into consideration resource constraints and process changes. The case study 
described in Chapter 5 looks at single product manufacture, specifically defining the 
cycling of batches through downstream process unit in order to maximise facility 
efficiency (i.e. increase throughput) given constraints such as labour availability and 
uncertainties such as equipment failure and titre fluctuations. Finally, Chapter 6 
considers the introduction of multiple products to the facility described in Chapter 5, 
looking at the impact of different product changeover procedures and operating shifts 
on the process throughput. 
3.4 Requirement Specifications of a Simulation Model 
At the process level, 9 existing DES models were reviewed, all representing various 
process systems for a large pharmaceutical company including Biotechnology 
Processes and Logistics, Quality Control Lab Operations, Fill/Finish Operations and 
Control Rooms for biotech production. Several common elements were found 
amongst all of these process level models which can be found in Tables 3.1 and 3.2. 
In this table it can be seen that the features defined under domain description 
common to biopharmaceutical batch processes have been listed under ‘real process 
features’ elements.    
In order to truly represent a system it is necessary to model the common elements 
listed under the Domain Description, that is, all types of activities, resources and 
entities. Furthermore, in the pharmaceutical industry or indeed any industry with 
similar activities, there are certain requirements for DES model construction which 
contribute to the ‘Flexible Model Environment’.  The features of the flexible model 
environment form the objectives or requirement specifications of a DES model and 
there are certain methods available in meeting these objectives using the recognised 
model elements including the activities, resources and entities.  
Following Tables 3.1 and 3.2 are the requirement specifications of a DES model 
which are platform-independent and state the basic approach to modelling and why 
that approach is adopted.  
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Table 3.1 Model elements 
Element Definition 
LAYOUT 
Physical Layout The position of blocks on the workspace and what they represent 
Logical Layout Relates the physical layout of the model to the real world layout of the process, area or network being modelled.   
Parallel Activities Those identical or very similar activities which happen simultaneously. 
Main Block Construct The main functional blocks which form the stream through which the main items flow. Can be activity, equipment or other 
functional representation depending on the model scope.  
Item Transfer Refers to the way in which blocks are connected and how items move from one block to another.  
MODEL INITIATION 
Items Generated / 
Primary Item 
The main items generated and sent through the model. Different to initialisation or trigger items as they are the main items upon 
which the simulation depends. For example they will hold the important attributes and will in most cases be the model outputs.  
MODEL LOGIC 
Metrics Each model, depending on the nature of the case study, will measure certain parameters. These can be attached to the items, 
stored in the database or an external file. The type of metrics will in most cases affect how a model is constructed as the 
measurement of parameters will usually require configuration of blocks and a degree of coding.  
Look ahead The logic used to make decisions based on what is happening in other parts of the model ahead of current time, t.  
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Table 3.2 Model elements 
Element Definition 
REAL ‘PROCESS’ FEATURES – system constructs which must be mapped to the model construct 
Activities The components of the system which have time attributes and can be associated with the product and/or resources. These 
activities can be categorised into Product Handling Activities, Preparation of Buffers/Media, Preparation of Equipment, Support 
functions and Ancillary Activities  
Entities This is the product units to be modelled. Most likely to be batches. 
Resources Resources can be anything used to perform the model activities for example workers, raw materials, equipment and so on 
DATA 
Data transfer The way in which data required or generated within the model is transferred. Data may be held in the modelling platform or in 
an external application. 
Database The way in which the database is used and to what extent. Not all models use the database function. 
Tracking The way in which information from one part of the model is used to control another part. It may appear in various forms, for 
example the tracking of equipment status, the tracking of queue contents and so on. 
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• Intuitive to User 
It is important for a model to be clear to the intended user otherwise its usability 
becomes somewhat diminished. The layout of the model along with the hierarchical 
structure, the interactions between blocksand nomenclature should make sense to the 
intended user. The model should also be representative of the physical or logical 
nature of the system being modelled. 
In their paper Valentin and Verbraceck (2002) propose several guidelines for the 
design of a model to overcome the problems in complex simulation studies by 
introducing reusability and maintainability. They illustrate this using a case for 
passenger modelling at airports however the main principles can be applied to 
modelling of any system. Three of the guidelines are of particular interest here:  
 
‘Interactions between model parts…should represent interactions in the real system’ 
Comprehensibility for the user of a simulation model depends greatly on the user 
identifying with the model components. In order for this to happen the model must 
have interactions between components which clearly represent interactions between 
objects in the real system. Interactions between model components are related to item 
transfer which is the way in which blocks are connected and how items move from 
one block to another. Any material/item flow should be clearly defined and 
consistent. The item itself should be one that the user is familiar with e.g. batch of 
product, pallet of material, document, worker and so on. Resources should also be 
used and tracked in a manner that makes sense to the user. 
 
‘Use concepts that represent functionalities as found in reality and that can be used 
for visualisation purposes’ 
The functionalities in reality can be defined as the activities which take place in the 
real system and whose representation is required to meet the first and third 
guidelines. Linking directly to the first guideline, this provides an intuitive model by 
creating a true representation of the real system. In other words the functions in the 
real system within the scope of the case study should be defined in the model.  
Existing models reviewed thus far have illustrated this characteristic by modelling 
activities as the main blocks construct, defined as the main functional blocks which 
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form the stream through which the main items flow. That is, the blocks on the top 
most level of the model which are the main hierarchical blocks. Block constructs can 
be activities, equipment or other functional representation depending on the model 
context. 
 
‘Visualise a system in such a way that complexity is reduced but the essential 
processes are still shown’ 
In order to create an intuitive and useful model it is important to only model the most 
essential components of the real system. Those activities which have no bearing on 
the model input and outputs will not add value but only complexity, also adding to 
model run time.  
 
• Relevance and Ease of Data Input/Output 
Linking directly to the last guideline above the model should have the sufficient 
complexity and data input to be relevant and useful to the user. It is also important 
that the user be able to run scenarios without modifying the model structure and 
therefore all user input parameters should be accessible without going deep into the 
model.  This links also to the importance of model output; each model, depending on 
the nature of the case study, will measure certain parameters. These can be attached 
to the items, stored in the database or an external file and may be used to plot 
graphical representation within package (if that functionality exists) or exported to a 
package such as Excel for manipulation. Whichever method used, retrieval and 
storage with scenario description should be straightforward and without the 
prerequisite for detailed knowledge of the model. 
 
• Short Run Time 
Firstly let us imagine two types of model complexity. The first, visible complexity, 
comes about from the use of too many blocks within one model. The second, hidden 
complexity, is the use of underlying discrete event coding as part of the model logic.  
In a perfect world, a model should take a matter of seconds to run. In order to reduce 
the run time the visible complexity must be reduced i.e. the number of blocks in the 
model which must be executed during a run. This of course means that in some 
cases, longer and more complex coding is required to maintain the functionality of 
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the blocks thus increasing the hidden complexity. As a result this in most cases will 
somewhat diminish the intuitiveness of the model along with reusability and 
sustainability by anyone other than the creator of the model. Therefore a balance 
must be created between the need for fewer blocks and feasible coding.  
 
• Maximised Reusability and Sustainability 
Although most models are created to address specific issues reusability of a model 
can be important especially with rapidly evolving systems. If a model can be reused 
for a system which has gone through various degrees of change then it will negate 
the need for model rebuild such as through the use of standard building blocks and 
nomenclature. Furthermore it is anticipated that similar issues could be addressed in 
related business units, and so models should be constructed and developed in a way 
that would make model transfer to a related area efficient.  
 
• Minimised DevelopmentTime 
Starting new models from scratch is very time consuming and typically the model 
developer is under a time constraint to meet the business needs. Therefore there 
should be a structured approach to the model development that minimises 
development time and the need for user input (by focussed approach). Once the 
effort has been put into modelling a process, to maximise the return on that 
investment the model should be capable of further use, and ideally incorporated into 
the business of running the process (e.g. business planning, change control, 
improvement projects including 6σ). 
This supports some of the previous requirements in that the model must be usable by 
non modelling users. 
To help ensure models are reusable, maintainable, and suitable for future 
development the use of “custom code” should be minimised. Though the use of 
discrete event code can significantly help streamline models both in size and run 
time, it adds considerably to the difficulty in maintaining models, and trying to 
understand how they work thus a need for a trade off between use of code and model 
size.  
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3.4.1 Meeting the Requirement Specifications in Extend 
Tables 3.1 and 3.2 summarised the elements of a DES model along with a brief 
definition for each. This list of model elements was compiled following a review of 
eleven existing models, constructed by modellers at an academic institute (UCL) and 
at a multinational pharmaceutical company. There were five categories of elements 
given: Layout, Model Initiation, Model Logic, ’Real Process Features’ and Data. 
Table 3.3 shows the same list of model elements and the correlation of each to the 
requirement specifications. 
It shows that if the structured framework is applied to the modelling process then 
each element will contribute to meeting the requirements in one or more ways i.e. it 
maps the relevance of each element to the requirement specifications. For example, 
the standard framework will give guidance on the modelling techniques to be used in 
resource utilisation which will lead to a lower number of blocks being used. This will 
contribute to the intuitiveness of the model. 
 
The following describes how each of the elements can contribute to the meeting of 
one or more of the six requirement specifications. 
 
Layout 
Physical Layout / Main Block Construct 
The physical layout of a model includes the arrangement of blocks on the workspace 
(the white area on which the model is built), the hierarchical structure and what the 
blocks represent.   
DES modelling in Extend involves hierarchal levels containing blocks. For an 
intuitive model it is necessary to reduce complexity at each level. IDEF0 describes 
the Top-Level Context Diagram where the top level of a model contains a single box 
to represent the subject of the model. This is useful in giving the model context, 
especially at the lower levels of the organization hierarchy. 
The standard also refers to the sub levels of a model as Child Diagrams, whereby 
functions are decomposed into their sub-functions. According to the standard, the 
number of child boxes on each child diagram should be limited to 3-6.   
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Table 3.3 Summary of Model Elements and Contribution to Requirement 
Specifications 
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Finally IDEF0 describes three types of decomposition: Functional Decomposition 
(breaks down activities according to what is done), Role Decomposition (breaks 
down things according to who does what) and Lifecycle Decomposition (breaks 
down a system first by the phases of activity). The former two are the most common 
methods in bioprocess modelling however the model construct elements such as 
resources, item tracking and so on differ quite significantly between the methods of 
decomposition. Imagine a granulation system whereby batches are dispensed into 
bins, granulated, and then sent through to compression.  According to IDEF0 there 
are two ways in which the system would be modelled: 
Method 1: Functional decomposition whereby the main block constructs would be 
the activities: ‘granulation’, ‘dispensing’ and ‘compressing’ with the actual 
equipment held in resource pools. 
Method 2: Role decomposition whereby the main block constructs would be the 
equipment: ‘granulator’, ‘dispenser’ and ‘compressor’.  
At the process level functionalities found in reality should be represented in the 
model as the main block constructs i.e. Functional Decomposition, for both 
visualization purposes and for resource management. Using this method the 
availability of equipment can be easily tracked without the use of global arrays (these 
are essentially matrices which hold information within the model), thus reducing the 
number of blocks necessary for the running of the model. Furthermore modelling 
main objects like equipment as resources will allow for the externalisation of 
ancillary activities such as CIP and SIP, a beneficial modelling method as described 
in a later section.   
 
Logical Layout 
The logical layout links the physical layout of a model to the real system. In order for 
a model to be intuitive and for a user to relate to what he/she is seeing on the screen, 
it is best to logically place system components as they would be relative to each other 
in the real system. When the main process chain is modelled this logical layout 
should be naturally built-in, with a left to right convention used as the flow direction 
(unless backward flow is an integral part of the system/model).  
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For an intuitive model functions should also ideally be hierarchically modelled 
together. E.g. if two pieces of equipment / activities perform the same function, there 
should only be one hierarchical block representing that function to contain them; a 
hierarchical block is a block which contains sub levels. Those on the top parent 
diagram are the functional hierarchical blocks as they represent functions.    
 
Parallel Activities 
When identical activities occur in parallel, in order to reduce model visible 
complexity and size it is usually desirable to compress them much in the same way 
as modelling the same functions under one hierarchical block. Furthermore if less 
cutting and pasting is required to duplicate the activity blocks there will be a 
reduction in the time taken for constructing the model, albeit a small reduction. 
Importantly, however it is not possible to compress parallel activities when 
lookahead logic requires separate activity blocks (for example, unique and 
distinguishable queues required to sit within the blocks). 
Item Transfer 
The IDEF0 standard states that boxes must be connected by conventional solid 
arrows. This representation of components and their links results in an intuitive 
model as flow is clearly represented. Within the Extend environment it is possible to 
use arrows or simply straight lines to link blocks. There is very little difference 
between the two methods and if the left to right convention has been adhered to, the 
direction of flow will be apparent without the use of arrow heads.  
 
Model Initiation 
Items Generated / Primary Item 
The primary item should represent the key physical entity being modelled (and thus 
be relevant), often in manufacturing this will be a batch or part of a batch (section). 
Tracking items should be relatively easy i.e. none or very limited use of catch/throw 
blocks. This is due to the fact that these blocks have no visible connections between 
them and can be placed in any window anywhere in the model. If an item is thrown 
across windows, it is near impossible to track its movement thus making debugging 
extremely difficult. The ability to visually track the movement of items also creates a 
more intuitive model. 
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Model Logic 
Metrics/Outputs 
The metrics will depend on the case study or scope of the model and will therefore 
vary. In those models using equipment, utilization seems to be a common metric and 
therefore may be a constant associated with all equipment based models. In terms of 
viewing the data collected there are two methods: 
Method 1: within the Extend model during or after a run 
Method 2: within an external application such as Excel 
Many of the models analysed used graphs at various stages within the model to 
represent metrics such as resource utilization i.e. method 1. Placing the plots next to 
the corresponding pools, equipment and so on seems to be convenient for simple and 
immediate analysis. However it is ultimately best to output all data into a separate 
application such as Excel for more complex data manipulation. As the requirements 
of the metrics is variable according to the model and case study, sending all data to 
an external file allows for categorisation of outputs according to scope, thus allowing 
a single model to be used for various capacity management questions. For example, 
if a data sink file is created in Excel, all attributes and data collected during the run 
can be sent to that file. Ultimately, using method 2, different combinations of data 
can be copied to pivot tables, each corresponding to a different scope, extending the 
reusability of the model. 
 
Look-ahead 
This is a modelling concept which is actually quite complex. Imagine a Fill/Finish 
model for a freeze drying process, whereby the dryer needs to be prepared for 
unloading its contents 24 hours before it has finished processing them. The simplest 
method of modelling this would be to subtract 24 hours from the processing time and 
to then create and send a trigger item to enter the unload preparation activity blocks. 
However a far more sophisticated method of lookahead logic is required whereby it 
may be used in circumstances where:    
- processing time is 0 or less than the ‘prepare ahead’ time 
- the processing time is unknown 
- the look ahead is not dependent on processing time 
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Two possible methods of a creating a more flexible and generic look-ahead would 
be: 
Method 1: Run a parallel logic which looks up all the future processing times (if 
available), and minuses the ‘prepare ahead’ time from that to give the start time of 
the trigger activity. This information is then conveyed to the main process chain.  
Method 2: At some point early on in the model a discrete event equation block is 
used to calculate the time at which the preparation of the dryer should begin by 
calculating the current Extend system time, adding the dryer processing time to that 
and subtracting the preparation time from the result. This gives a system time for 
when the dryer should be prepared for that item. This information is sent to a created 
database schedule table which is used for the generation of the trigger item.   
It is believed that method 2 or a similar variation should be used. Firstly the main 
problem with method 1 is that the additional logic running in parallel increases the 
model run time.  Secondly method 2 is a highly generic method which can be used 
for any model (the input times can easily be changed), when the processing is less 
than 0 or the ‘prepare ahead’ time and when the logic is not based on the processing 
time. Both methods fall where the processing time is not known. Method 2 however 
can be adapted to include logic which calculates the processing time instead of just 
referencing the data source. 
 
Real Process Characteristics 
Entities 
Entities are those objects in the modelling environment which represent people or 
items in the real system. The most common entities, other than the primary items, are 
labour and there are various ways of modelling labour in Extend and the choice 
should depend on the nature of model metrics and the scope of the case study. For 
example 
Method 1: If labour is a constraint or utilisation is a metric then a labour block can be 
used. This is an inbuilt Extend function which allows for the allocation of attributes 
and costs based on labour usage. Furthermore, as in the case of a resource pallet, this 
block is an ‘item through’ block which means that labour is modelled as actual items. 
Any constraints can be represented physically by stoppage in the model due to 
unavailable labour.  
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Method 2: Labour can also be modelled in resource pools whereby they are not 
items, simply units of resources with attributes and utilisation figures attached, the 
main difference being that allocation can be based on difference conditions set within 
the resource pool block.  
Due to the fact that labour does not usually have associated with it activities 
independent of the primary items there would be little added benefits to modelling 
them as physical items within the model. Therefore it is best to use method 2. The 
constraints due to labour shortage are modelled much in the same way as method 1 
i.e. if the labour is not available the item requesting it will simply sit in a queue. 
However in addition the resource pool gives the extra option of labour allocation 
based on first come first served or given priority.   
 
Ancillary Activities (CIP/SIP) 
Cleaning procedures only correspond to equipment used either within the main 
process stream or for ancillary activities such as buffer preparation and waste 
disposal. There are two ways in which CIP/SIP can be modelled and a number of 
reasons for choosing one method over the other.  
Method 1: As part of the main process chain logic. This means that a block(s) 
representing CIP/SIP is placed wherever the activity is required. For example in 
hierarchical block A representing fermentation there may be 3 further sub-functional 
blocks in the child diagram. These may represent filling, fermentation and 
harvesting. The latter will be directly followed by a clean and a CIP/SIP block will 
be placed there accordingly. This method means that there may be multiple 
(depending on the number of clean occurrences) CIP/SIP blocks and is used when 
the equipment are modelled as the main block constructs (role decomposition). 
Method 2: The CIP/SIP will be represented by one single block which will be 
externalised from the main process chain. This method is used when there is 
functional decomposition and the equipment are modelled as item resources. When 
cleaning is required the equipment is sent to the clean block and returned to its 
pool/pallet or back to the process stream. In order to model multiple equipment being 
cleaned at the same time there are two scenarios to be considered. The first is if all 
equipment share the same CIP/SIP rig. Here a queue should be used to represent the 
wait time. In the second scenario, more than one rig is available, in which case the 
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same CIP/SIP process stream can be used by the different rig/equipment items, 
representing the overlap of the cleaning procedures.  
This method means that the requirement specifications are more fully met for various 
reasons. Firstly it reduces the number of building blocks (visible complexity) and 
thus allows for a degree of reduction in the model run time. Secondly it creates a 
more intuitive model in the case where there is a CIP/SIP equipment or material 
constraint as it allows for visual tracking of item movement through clean. Finally if 
a generic CIP/SIP is built, it will contribute greatly to the maximisation of model 
reusability and sustainability.  
 
Resources 
Resources such as materials, equipment, utilities and labour can be modelled in a 
number of ways.  
Method 1: modelled as an item. This is beneficial when it is necessary to visually 
track the resource’s movements, when the resource and primary item need to be 
paired for a section of the model, and/or the resource carries its own attributes. The 
resource item can either be generated then discarded or be managed via a “pallet 
block”.  
Method 2: modelled in a resource pool where the aspect of the resource is the 
number available at any specific time. One pool may be used to hold all similar 
resources if individual utilisation data is not required or it is calculated elsewhere 
and/or usage is based on the same shift/rule or this is determined elsewhere. This 
method is to be used where the conditions described under method 1 do not exist 
such as in the case of labour. Furthermore, consumable resources such as water or 
buffer materials should be held in resource pools as they do not loop back to be used 
again (unless recycling of such materials is part of the system being modelled). 
 
ISA-88 describes the way in which resources should be allocated and arbitrated. For 
the purpose of model construction resource allocation and arbitration is an important 
factor. Extend allows the use of blocks such as Select Output which makes path 
decisions (and therefore resource decisions depending on model setup) based on 
toggle or input values. A selection criteria such as ‘select equipment based on input 
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volume’ can also be achieved however this requires some slightly more complex 
configuring of the inbuilt blocks.  
In terms of arbitration there are ways of dealing with resource demand in Extend, for 
example, prioritising resource demand. Also the left to right logic of the program 
means that in the process path, the farthest left will use that resource first.  
An algorithm such as "first come/first served" might be used as a basis for 
arbitration’ and can be seen in Extend in the form of FIFO (first in, first out) queues.   
 
Data 
Data Transfer 
As stated under the overall requirement specification there must be sufficient 
complexity and data input to be relevant and useful to the user.  It is only necessary 
to have user defined inputs where they will fall within the scope of the model. In 
other words the inputs required are those which allow the model to calculate/output 
parameters such as cost, time, yield/throughput and resource utilisation. Input 
parameters should also be accessible without going deep into the model.  There are 
two ways of achieving this  
Method 1: input parameters can be entered into the database, either in Excel or 
Extend. The problem with the latter is that the user will be introduced to the 
underlying data source of the model.  
Method 2: by creating a notebook level where all input locations are cloned from 
block dialog boxes. The user will only see the notebook containing a list of inputs 
and their meanings. Outputs can be cloned onto the notebook in the same way. This 
method is simple and user friendly, and does not require the opening of additional 
files, thus making it the better option.  
 
Database 
The Extend platform uses an interface between Excel to transfer data to and from its 
inbuilt database. The best way to enter and manipulate the data is to first work in 
Excel. As a data handler the Excel software is much more equipped and user 
friendly. Furthermore it is more or less a universal software and therefore almost all 
users will have access to and knowledge of it (for purposes of future model changes). 
The data can then be imported into Extend and used for the running of the model. 
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However difficulties arise when changes are made to the database in both Excel and 
Extend. It is important that the two be synchronised, or better still, for all changes to 
be made in Excel. 
 
Tracking 
There are two ways to track items or values as they change within the dynamic 
system (model).  
Method 1:  Global Arrays. These are basically matrices which hold real or integer 
values and can be built to specifications in terms of columns and rows. Values 
corresponding to item, resources etc can be held in global arrays, updated 
periodically and accessed either by replicating the array block itself and connecting it 
to the block reading the value or by using code to look up the matrix address (array 
index, row index and column index). The latter helps in reducing the number of 
blocks needed if more than one address is required for decision logic.  
Method 2:  by using physical items much in the same way as using item resources. 
Visual tracking of items is often useful in cases of debugging and can contribute to 
the intuitiveness of the model by allowing the user to see exactly where items are at 
any one time. The two methods of tracking are not mutually exclusive and a 
combination of both is necessary to build models representing complex systems with 
many interactions.   
3.5 Evolution of Standard Framework 
This section will discuss the standard framework in its final version and how it 
evolved over time, looking at the shortcomings of each of the earlier versions and 
how they were highlighted through application to biopharmaceutical manufacturing 
case studies.  
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3.5.1 Overall Structure 
3.5.1.1 The Evolutionary Process 
Three versions of the framework were developed. Figures 3.3, 3.5 and 3.8 show the 
overall structures of the different versions while figures 3.4, 3.6 and 3.7 show the 
timelines for the corresponding modelling case studies to which they were applied. 
As figure 3.3 shows, Version 1 of the framework consisted of scope definition, 
model characterisation and model construction. As the timeline in Figure 3.4 shows, 
the model took 7 months to build at the end of which a rebuild was necessary, thus 
extending the timeline even further. In fact the overall duration of the BioSynT case 
study was approximately 9 months. Section 3.5.1.3discusses the reasons for this. 
Figure 3.5 shows Version 2 of the framework which expanded on the Problem 
Structuring phase of Version 1 by adding a non-coded description of the system. It 
also added a Design Phase, a model specific description of the system, mapping the 
system or process elements to the model elements. As the timeline in Figure 3.6 
shows, the overall mAb case study took just under 5 months, with the actual model 
construction phase significantly reducing from 5.5 months to only 1 month. 
However, the debugging stage did take longer than expected with a duration of 3 
months. Section 3.5.1.3discusses the reasons for this. 
Figure 3.8 shows Version 3 (final version) of the framework, which is very similar to 
Version 2 with the only difference being the addition of the templates. The library of 
templates were created to reduce not only the model build time but also the 
debugging time, by providing building blocks which could easily be used and 
debugged due to their standard nature. Figure 3.7 shows the projected timeline if the 
mAb case study were to be carried out again using the framework Version 3, 
showing that the overall duration would significantly reduce by 65%. 
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Figure 3.3 Proposed methodology for the different stages of model design and 
construct as part of the Standard Framework Version 1 
 
 
 
Figure 3.4 Stages of BioSynT model build (Case study for Standard Framework 
Version 1). 
 
Where 
1. Given remit with a series of Gantt charts. No direct contact with client 
2. Independent review of possible capacity management questions that could be 
asked  
3. Began design of model based on predetermined standards and guidelines such as 
decomposition, resource modelling and data management 
4. Began model construct based on standards and limited information given with 
remit. 
5. Structure of model put into place. Initial elements added such as activities, 
database for data management, resources and cycle times.  
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6. First contact with client. Scope increased but no further information given.  
7. Increased levels of complexity added to account for increased scope, largely based 
on assumptions. A few rules on resource usage added based on discussions 
8. Second meeting with client. Some data provided - new information suggests that 
model contains too much unnecessary/redundant complexity based on previous 
assumptions. Decision point on how to proceed: revisions will mean more code, 
more rules and more data to manage, resulting in high levels of hidden and visual 
complexity. Model rebuild will mean more time dedicated to model construct 
however expected increase in model efficiency with new knowledge. 
9. Model REBUILD 
 
 
Figure 3.5 Proposed methodology for the different stages of model design and 
construct as part of the Standard Framework Version 2 
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Figure 3.6 Stages of mAb model build (Case study for Standard Framework Version 
2) 
 
Where 
1. Problem Structuring Phase I (2 days) 
2. Problem Structuring Phase II (14 days) 
3. Design (4 days) 
4. Build (30 days) – including early version templates construct 
5. Debugging (90 days) 
 (Validation occurred throughput the project with the help of system experts) 
 
 
Figure 3.7 Projected Stages of mAb model build (Standard Framework Version 3) 
 
Where 
1. Problem Structuring Phase I (2 days) 
2. Problem Structuring Phase II (14 days) 
3. Design (4 days) 
4. Build (15 days) 
5. Debugging (15 days) 
 (Validation occurred throughput the project with the help of system experts) 
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+ Templates   
What are the questions that need answering / the remit
What are the desired results/outputs?
What data is available?
Metrics to measure against e.g. throughput, completion 
time
Model Characterisation
Scope
Process Elements
Non-coded description of process using process terminology
Text based
Diagrams
Spreadsheets
Using the predefined list of questions based on Standard Version 1 
Model Elements 
Build Model 
Problem Structuring I
Problem Structuring II
Design
Construct
Model specific description of process using model terminology
Coded description of process 
Extend Model
 
Figure 3.8 Proposed methodology for the different stages of model design and construct as part of the Standard Framework Version 3 
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3.5.1.2 The Standard Framework Final Version 
Since developed as part of an evolutionary process, Version 3 bares a similar 
resemblance to the first two versions, but with additional features such a more 
comprehensive methodology and a library of template blocks. Furthermore, a 
significant finding of this work is that in order to minimise the degree of 
customisation required the standard, and in particular the templates, should be 
created with a certain degree of inbuilt customisation. This move away from a 
completely generic framework inherently limits the number of systems for which the 
templates can be applied. As such, although the modelling methodology is a 
universal one and can be applied to any modelling activity of any system, the 
majority of the templates will be limited to the specific domain of biopharmaceutical 
manufacture. The following describes the key features of the standard framework 
Version 3. 
The final version of the standard framework consists of three major parts: 
(1) Methodology for model development 
(2) Standard templates for model construct  
(3) Standard set of questions to ask the client 
3.5.2 The Methodology 
There are two possible approaches to the development of a model 1) begin construct 
immediately, or 2) design on paper before even approaching the modelling platform. 
It is believed that the latter method of approach – design before build – will increase 
the efficiency in terms of block usage and will importantly reduce the amount of 
model construction time (Robinson 2008). 
The methodology proposed here is a series of steps defined to provide a more 
structured and disciplined approach to model development by clearly defining the 
problem formulation and model design stages. Its aim is to reduce the time taken for 
model development by  
- speeding up the data gathering process 
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- ensuring a clear and well defined scope which will lead to a more relevant model 
- providing a way for the developer to more easily and quickly verify their 
understanding of the process before construction 
Brooks and Robinson (2001) define two stages prior to the construction of a 
simulation model, the ‘Problem Structuring’ stage where the problem and system are 
clearly defined, and the ‘Conceptual Modelling’ stage, defined as a software 
independent description of the model that is to be constructed. Here these two stages 
have been combined under Problem Structuring Phases I and II.  
 
Problem Structuring I 
Scope 
This is given by the client or the user and describes the questions that they would like 
answered in the model. For example, in the BioSynT model, the scope was to 
determine how fast the process could be run in series mode given a series of 
constraints.  
The scope will also cover the inputs or the data available and the desired results or 
outputs that the client would like to see. For example, in BioSynT, they were 
interested in seeing the number of tickets generated during the process and were able 
to provide a spreadsheet of the ticket generating tasks.  
Finally, the scope will cover the metrics that the client would like to measure against, 
for example, production costs, throughput or completion time.  
 
Model Characterisation 
The scope will lead to the definition of the type of model required to answer the 
questions. This definition or characterisation will describe the platform and the 
system. For example the BioSynT case study considered a scheduling problem, 
looking at the dynamic utilisation of resources for the production of a product with 
no consideration of any mass balancing. Therefore the model required was 
characterised as an ‘Extend Manufacturing’ model, based on the selection criteria 
described in Chapter 2. 
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Problem Structuring II 
Process Elements 
These are used to create a text-based description of the process and are the elements 
which were defined under Section 3.2. Used as a form of questionnaire, giving a 
more structured approach to the developer/client interaction and providing a means 
of obtaining the relevant information needed to create an accurate picture of the 
system. The terminology used here is process terminology so that both developer and 
client have a clear understanding of the outcome. 
Furthermore it is also useful at this stage to identify those parameters which are 
variable so that this variability can be added to the model and controlled by the user. 
 
Design 
Model Elements 
Here the process elements are used to design the model, considering the various 
modelling options to map them. The terminology used here is model terminology, 
translating those used under process elements. For example, tasks become activities. 
 
Construct 
Build Model 
This is where the process elements are actually mapped onto the modelling platform 
using templates.  
 
There are four types of template as shown in Figure 3.9. 
 
 
 
 
 
 
 
Figure 3.9 The different types of model template as part of the Standard Framework 
Version 3 
 
Model Template 
Main Activity Template 
Sub-Activity 
Template 
 
Database 
Template 
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The database template provides a predefined set of tables which the developer can 
fill in. Its structure follows closely that of the questionnaire given in Table 3.4 with 
all the common system elements incorporated.  
The model template is a generic structure template which acts as a guide, telling the 
developer where elements should be placed by containing hierarchical top level 
blocks. 
A combination of the Main Activity Template and the Sub-Activity Template has 
been used to create a standard template with a certain degree of customisation, with 
those elements specific to the system later added by the model developer. So this 
means a main activity template contains various built in elements as found to be 
common amongst the different systems such as the gates, equipment and also the 
sub-activities.  
The sub-activity blocks themselves have been given a standard structure; all sub-
activity blocks are identical and are given identity by entering a single number in a 
clearly defined box. The first sub-activity is number 1, the second number 2 and so 
on. Therefore the nature of the actual sub-activity e.g. wash, need not be known. The 
identifying number is used by the block to reference the correct tables in the database 
for all required parameters.  
Figure 3.10 shows the different types of template which can be used at different 
hierarchical levels to build a model. 
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Figure 3.10 Different templates created under Standard Framework Version 3 
3.5.2.1 Support for the Standard Framework Version 3 
The following sections describe in greater detail why the framework evolved as it 
did, giving the reasons behind the additions made.  
 
Problem Structuring and Design 
The two phases, Problem Structuring II and Design, were omitted from the first 
version of the standard framework. As a result, when the standard was applied to the 
BioSynT case study, the project took far longer than expected and required a 
complete rebuild because it simply did not meet the requirement specifications and 
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failed to fully cover the given scope (albeit a rather unclear scope). This is shown by 
the timeline in Figure 3.4.  
The first problem was that the model was built too quickly based on too many 
assumptions where the information required was not available. In fact an initial 
meeting with the client did not take place until the majority of the model was already 
in place, having been built based entirely on a process Gantt Chart. The problem 
faced here regarding the data for modelling is not a new one. Sadowski and Grabau 
(2000) suggest that the problems regarding data are that it can be insufficient or at 
times excessive such that the modeller has difficulty in identifying the relevant parts 
and furthermore there can be the danger of misinterpretation of the data especially 
where the modeller is unfamiliar with the system.  
Secondly, many important system elements which greatly affect the scheduling and 
resource management were omitted such as probe failures, additional rules like 
storage allowances and wait thresholds on columns. One could argue that these are 
not added upon initial model construct anyway and only come about after 
discussions with the client. However this did not happen. Such elements may not be 
discussed on the first or even second meeting with the client for two reasons, (1) the 
client is usually unaware of the capabilities of the model and the significance of these 
elements to its running (2) the modeller is more often than not unfamiliar with the 
system and therefore does not know the right questions to ask or data to seek. 
What these reflections on the initial model construct suggest is that the approach to 
the process may have been wrong and that greater or, more importantly, ‘better’ 
communication with the client would have shortened the construct phase and would 
most likely have negated the need for an entire rebuild. Here is posed a dilemma: a 
hasty model construct can result in a model largely based on assumptions and not 
truly representative of the system. But too much time spent on the design and waiting 
for data can delay construct indefinitely. The solution here is to have a set of 
standard questions which are common to similar systems. For example perhaps with 
a biotechnology manufacturing system the questions must always be regarding Cycle 
Times, Activities, Resources, Rules for resource usage and Labour. This would help 
in the case of a model where the remit is to look at scheduling. But what about in the 
case where the model needs to answer the question of flow, taking into consideration 
utilities availability and flow constraints in the same biotech facility?  In which case 
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information such as Vessel Volume, Flowrates and Utility requirements would be 
more useful than labour and perhaps resources such as buffers (unless these too share 
the same utilities). Therefore it is not only the system being modelled which must be 
considered when asking for the relevant information but also the question being 
asked or the remit.  
 
Templates 
These observations made above were tested during the mAb case study, which as 
Figure 3.5 shows, took significantly less time than the BioSynT study. This can not 
only be attributed to the existence of a far more comprehensive problem structuring 
and design stage but also the existence of the early version templates which aided in 
the construction process by acting as basic building blocks, reducing the variability 
in structure and narrowing down the possibilities amongst the myriad of ways to 
model a particular system element or feature. However, the mAb case also showed 
that there are shortfalls to the framework. Firstly, although the construction phase 
was accelerated, the debugging stage took far too long. It can be argued that better 
model outputs or built in indicators could have helped. Secondly, the degree of 
customisation later made to each of the template blocks was quite significant, with 
many features such as lot cycles added to the chromatography columns. Perhaps the 
templates could be taken a step further by creating different blocks for the different 
functions such as fermenters and columns. This would subsequently reduce the 
degree of customisation and thus reduce the construction time, possibly impacting 
the debugging phase also.  
The database template was initially designed and built within Extend, using the SDI 
link to externalise it to Excel for user input. However a major flaw with the SDI tool 
is that in order for Extend to be able to read the external database, its structure must 
follow certain rules, which do not lend themselves to a necessarily user friendly 
input. In this case, upon review with the end user of the model, it was decided that 
bypassing the SDI tool would create a far more intuitive database, with structures 
familiar to the system users. Subsequently the database was externalised, making the 
Excel end of the data link the front end of the database construct, with all table 
structures designed to maximise user intuitiveness. The data from this database 
would then feed into the internal database automatically upon model initialisation, 
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taking the form required for global reference within the model. Section 3.5.3 will 
describe this template in far greater detail. 
Due to the fact that the templates library very much evolved during the construction 
of the mAb model, additional template blocks were created to meet requirements of 
system features as they arose during the project validation meetings. Upon review, it 
wasseen that many of the blocks could be combined. For example, there were three 
different blocks, the Makeup, Primary and Secondary activity blocks, which were 
practically identical in structure but which looked different and had different names. 
Combining these would simplify the library significantly. 
Conversely, the level of standardisation created by building a single activity block 
for all system functions is perhaps too great. For example, the single main product 
handling activity template block was used to build all unit operations from 
fermentation to chromatography. The difference between the operations was then 
built in by tailoring the blocks to represent the system elements. It can be rather 
difficult to strike the correct balance between standardisation and customisation, with 
general consensus stating a 80/20 rule appropriate. That is, 80% of the functionality 
is provided by the template and 20% is customised by the modeller to achieve 100% 
system representation. However the degree to which these blocks were changed or 
added to far exceeded 20% in this case and therefore it can be argued that the level of 
standardisation was too great. For example, perhaps it would be more efficient to 
create separate blocks for the different unit operations allowing for their different 
system features to be incorporated into the template rather than later added in.   
This increased specificity of each functional block poses a potential problem as it 
could limit the use of these blocks across different types of biopharmaceutical 
system. For example, could the library blocks be used to rebuild the fill/finish 
model? The answer is most likely no, as the level of customised functionality added 
means that the relevance of each block to a different system will be diminished. In 
order to be representative, each block would have to be further customised, 
exceeding the 20% desired customisation threshold, thus making model construct 
inefficient. Therefore, it is proposed that there be a different library of blocks for the 
different systems i.e. one for biopharmaceutical manufacturing and one for fill/finish. 
This grouping of manufacturing systems is made possible by the commonalities 
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between the systems, for example the existence of chromatography columns in both 
the BioSynT case and mAb. Furthermore, the different types of activities found are 
also common, for example, all biopharmaceutical manufacturing processes will have 
ancillary activities and buffer/media makeup of some sort. Whether these elements 
fall within the scope of the model is at the discretion of the modeller however they 
will be present in the library if needed.  
3.5.3 Detailed Structure 
This section describes, in detail, the features of the proposed framework. The 
methodology which forms the premise of the framework consists of problem 
structuring, design and construction phases along with the use of generic building 
blocks. These are all based on certain inputs and outputs found to be common among 
biopharmaceutical manufacturing systems, in particular, within the scope of capacity 
management. Figure 3.11 shows these input and outputs. 
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Inputs Outputs 
 
 
 
 
 
 
 
Manufacturing 
Model 
 
 
 
 
Throughput 
Overall cycle time 
Facility utilisation 
Equipment utilisation 
Labour utilisation 
Resource utilisation 
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Figure 3.11 Inputs and Outputs of a manufacturing model 
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3.5.3.1 Questionnaire 
It was stated under the proposed methodology that a questionnaire should be used by 
the modeller to guide the problem structuring phase, allowing them to retrieve the 
relevant information more efficiently. Table 3.4 is a list of process elements which 
form the basis of this questionnaire. 
3.5.3.2 Templates 
All templates library blocks can be found in A.1 and have been built using existing 
Extend version 7 blocks, in other words, no new blocks were coded in order to 
maintain a low level of hidden complexity and to allow a modeller ease of 
understanding.  
An important note which must be reiterated here is that, upon review of various 
different systems and the application of the standards to the various manufacturing 
ones, while the modelling methodology can be applied to any system, the templates 
developed here are specific to biotechnology manufacturing capacity management. 
The reasons for this are simple. Firstly, in order to keep to the 80/20 rule of 
modelling it was necessary to create templates which were generic only to the degree 
that up to 80% of the work had already been incorporated into them, thus reducing 
model development time. Secondly, different systems have so many inherent 
elements and features that the scope for template development is vast. It was decided 
that, instead of creating a less comprehensive standard to meet the requirements of 
all systems, one system would be concentrated on thus maximising usefulness and 
relevance. Finally, although the templates here have been developed specific to 
biotechnology manufacturing capacity management, they can be used as a starting 
framework to take the standard much further, with commonalities across systems 
being used to adapt many of the template features to cover a far wider range such as 
Fill/Finish and QC systems. This will be further discussed in the Future Work 
section.
‐92- 
Table 3.4 Process Elements 
Activities Entities Resources Scheduling 
Main Product Handling Product Labour Shift Patterns 
What are they? Single or multiple? Types Labour set associated with each 
Order Demand Skills/capabilities  
Parallel? Available inventory  Scheduled Outages 
Sub-activities: Pre, run, Post, CTs Batch size Equipment - TBF 
Synchronisation rules Batch campaigning? i.e. splitting batch Number available - TTR 
Priorities Stability Failures  
Mutually Exclusive activities?  - Time before failure, TBF Production schedule 
Cycles?  - Time to repair, TTR - Historical? 
Labour requirements  Operating shifts - Random? 
Resource requirements  Volume - Constant? 
Clean  Efficiency  
  Flowrates  
Buffer   Area  
What are they?    
Order  Chemicals   
Type  - simple delay  Amount available  
           - sub-activity level  Allocation rules  
Resource/Labour requirements  Costs (if relevant)  
Clean    
Expiry times for buffer makeup  Utilities  
Holding requirements  Amount available  
  Allocation rules  
Ancillary  Costs (if relevant)  
Type of clean  - simple delay or    
                - sub-activity level  Areas  
Resources  Conditions  
Expiry  Allocation rules  
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3.5.3.3 Data Input 
Database template 
The database template, as with the library block templates, should require minimised 
customisation by the modeller and therefore should incorporate all of the 
commonalities of the systems and models for which it will be used.  As stated, the 
focus of this work has been mainly on biopharmaceutical manufacture and as such, 
the templates created will cater to these systems. However they can be taken much 
further and adapted for other systems, building a far more comprehensive library of 
templates. For example, work flow, fill/finish, QA/QC laboratories and so on. This is 
discussed further under the Future Work section.   
The database template is an Excel file called Input Data (see Appendix A.1) which is 
used to automatically populate the internal Extend database upon model 
initialisation. The structure of the tables therefore cannot be changed without these 
changes also made within the Extend database however with this in mind, the 
external file has been created in such a way that allows for additional information to 
be added without any necessary structural changes. For example, the parameter 
tables for all of the activities have 15 sub-activity rows available, a number chosen 
based on previously built and analysed models. Furthermore, there are 25 of these 
activity tables, a number deemed as sufficient for the number of activities usually 
seen in a biopharmaceutical process chain which is most cases will fall far short of 
twenty-five. 
The tabs in the external database categorise the different data sets required to run a 
typical biopharmaceutical model. These are listed below: 
• Run model – containing the macro to run the model 
• General Parameters – with various user defined parameters such as cycle 
limit for columns 
• Activities – a list of all main and makeup activities used a reference point by 
the database 
• Products – this tab contains two very important tables. The first lists the 
product(s) along with user defined titre(s). The second holds the user defined 
campaigning schedule which calculates the required number of batches 
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needed based on the titre and the set demand in kg. The model uses this table 
to generate items. 
• Scheduling – containing shift calculations based on a user defined operating 
shift and the main facility shutdown which can be used for various 
scheduling features such as shutting down utilities supply during scheduled 
shutdown periods. 
• Process Areas – containing information on the rooms or process areas in the 
facility and the shutdown/turnaround procedures surrounding them.  
• Equipment information – here the user can define the parameters such as 
volume, yield, stability and reliability. As with most parameters in the 
database, the different equipment or activities can have different parameters 
by varying product. 
• Column info –for processes where chromatography takes place and defines 
the parameters such as column dimensions and dynamic binding capacity. 
• SplitCombine – Many calculation surrounding batch cycles are contained 
here. The primary purpose of this sheet is to calculate ratios in 
chromatography column cycling based on titre and process yield. However, 
using a switch in the General Parameters tab, the user can overwrite this 
functionality and use the tables here to simply split or combine items at 
different points in the process.  
• PSD Data – containing CIP and SIP parameters if relevant to scope 
• Utilities – here is a list of the utilities to be modelled and their relevant 
parameters such as maximum capacity and fill factor. These parameters are 
useful in line with the flow method of modelling, used in the utilities 
template which is described in a later section. 
• Main/Makeup Activities – these tabs contain the user defined cycle times and 
labour requirement for all activities, broken down to the sub-activity level.  
• Calcs for Lookahead – using the information entered in to the previous 
sheets, this calculates the run time, and preparation time for each activity and 
subsequently the estimated start time for each activity based on all those 
preceding it in the process stream, assuming no constraints. The Lookahead 
block template uses these calculated values to trigger future events based on 
what will happen. 
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3.5.3.4 Data Output 
The data output template is an Excel file which is automatically populated with 
model data once the simulation run has ended. Using data capture blocks placed 
within each main activity block template, it generates an actual time based analysis 
of each activity including Gantt charts and utilisation figures.  The premise behind 
this output file is to provide a basic framework for data manipulation with most 
analysis being based on cycle times. However as the majority of capacity 
management questions focus largely on scheduling outcomes, it is believed that the 
output here is sufficient as a starting point for any capacity management model. 
3.5.3.5 Extend Template Libraries 
Activities Library 
The Standards Version 2 resulted in a set of six template blocks dedicated to 
different activities: Main Primary, Main Secondary, Makeup up, Sub-Activity, Sub-
Activity with Failure, Sub-Activity Run. As stated earlier these offered little existing 
structure and had to be greatly altered in order to meet the requirements of the 
elements being modelled. As such, the activity block templates have been combined 
and reclassified and are now as follows: Main activity with cycles, Main activity 
without cycles, Sub-Activity with failure and Sub-Activity without failure. The 
rationale behind this new classification is that the blocks required for cycling 
activities such as chromatography can be incorporated into the main template as 
default, thus minimising the amount of customisation needed to build these features 
in, as was done during the mAb case study. 
In addition to this library is the CIP/Rinse w/Flow block with can be used to model 
CIP or rinse only when there is flow from a utilities source, such as the template 
Utilities block. A separate CIP/Rinse without flow has not been added to the library 
as one of the existing main activity template structures could be used for that. 
 
Labour Library 
There are essentially two ways to model labour. The first is where labour requests 
are made and processed internal to the process stream. This method is used when the 
cycle time of the activity making the labour request equals the amount of time that 
the labour is required. In other words, the labour will be present for the duration of 
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the activity. Thus the labour is batched with the item before entering the sub-activity 
or group of sub-activities and then released at the end. This means that all labour 
blocks are placed internal to the model and are subsequently greater in number.  
The second method is used where the duration for which labour is required does not 
equal the cycle time of the activity. The most common example of this is 
fermentation, where a growth period may last several weeks however labour will 
only be needed for a few hours a day. Since labour must be pulled and released 
during the activity, the processing of the request is externalised. This method uses far 
fewer executing blocks however, since the labour requests are actual generated items 
which are thrown to the externalised processing block, the actual number of blocks is 
actually similar to the first method. Furthermore, since the labour request is 
processed in a different location to the actual request, debugging is potentially more 
complex. However, this has been deemed as the best solution to the dilemma of 
having a labour requirement duration which is not equal to the activity cycle time.  
Consequently, there are five labour template blocks: 1) Labour pull (Hrs=CT), 2) 
Labour release (Hrs = CT), 3) LabourRequest (Hrs<>CT), 4) LabourRequestProcess 
(Hrs<>CT), and 5) Shift check. The latter block can be used when there is a 
constraint in place which states that an sub-activity or group of sub-activities can 
only be started if there is enough time remaining of the current shift.  
 
Resource Library 
This library contains three blocks, two of which are based on flow. The first is the 
Utilities block which is used to model the supply of utilities to the system. The 
Model Template itself contains this block as default, where it has been externalised 
placed in the Buffers/Utilities external storage block. However, as the block only 
accommodates for three utilities or resources, the option of additional ones has been 
given by placing this block in the library. It works using a very simple concept, 
linking to the utilities table in the database to retrieve data such as maximum 
capacity of the supply vessel and fill factor. A sensor  is used to control the flow of 
the utility from supply to facility storage vessel before demand from the system (in 
the shape of an item entering a pull flow block and requesting flow) pulls the 
resource. The routing block uses a demand priority system and can flow to more than 
one place in the system at any one time, allowing the set user parameters and the self 
scheduling of the model to determine the overall flow in and out of the facility 
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storage vessel. This allows for a generation rate to be determined based on how fast 
it has been necessary to supply the facility with the utility, an output parameter 
which is captured and sent to the output excel file. 
The second flow block is the Receive Flow and can be used to either link to the 
Utilities block, for example to receive steam when modelling SIP, or can be used 
with any other flow resource, capturing its user defined parameters such as flowrate 
and fill quantity from the database. One particularly useful instance for this block is 
where one resource such as an acid used in equipment preparation is made up in one 
batch however that batch is used in more than one place, i.e. for example three 
equipment need it at different stages of the process. Realistically, the makeup tank or 
storage tank is not freed until the entire acid resource has been used by the process. 
Using items to simulate this hold time can become complex with the use of gates, 
sensor blocks and database tracking. However using flow allows for the simulation 
of a tank still holding a certain quantity of resource and only when it becomes empty 
is the tank released. Therefore the use of flow in this instance reduces the visible, 
and the hidden complexity of the model and also makes it far more intuitive to the 
user as they can track the status of resource flow far more easily. 
The third block in this library is the Receive Resource block and it is a very basic 
item receive block which catches a resource and batches it with the primary item in 
this case, which would be the equipment or batch. This block can be used wherever 
the rationale applied to the use of the Resource Flow block does not apply, i.e. the 
resource either does not have associated flow or the modelling of flow is not 
necessary as the timing of resource allocation is not an issue and can be assumed to 
be an instance. 
 
Logic Library 
This is the most comprehensive of the libraries and contains many of the important 
function blocks which allow many modelling elements to be modelled in a far 
quicker and intuitive way. The first block is the most basic one and is the Timer 
block. Although already placed by default within the Main Activity blocks in the 
template library it is also present here and can be used to capture any activity time. 
There are six time elements which can be captured, these are the Pre-Run start and 
finish, Run start and finish and the Post-Run start and finish. The data can then sent 
to the output excel file for cycle time analysis.  
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The second block is the Gate block which is linked to the database and can be used 
anywhere in the model to control item flow. It simply needs to be linked to the 
appropriate data tracking table to allow it to know when an item can be allowed 
through. The conditions surrounding this event are entirely user defined and can be 
for example, when a batch has finished processing and the next one can be allowed 
through, or the next campaign must be delayed in entering the system until all 
turnaround procedures have been completed.  
The third block is the Lookahead which uses the before mentioned Calcs for 
Lookahead Excel calculations sheet to automate the triggering of any activity based 
on future events. For example, if a buffer is needed at a certain time x, within the 
process, and it is necessary to follow a ‘just-in-time’ procedure then that buffer must 
be prepared based on the current time, the cycle time of all activities between now 
and x, and the preparation time for the buffer.  
The fourth block is the CIP Check which can be used where it is necessary to model 
CIP expiry based on ‘dirty’ equipment or limited clean hold time. The block links to 
the database for user defined parameters such as expiry time and can be used in 
conjunction with any CIP modelling method, whether externalised or internal, 
simple or complex. 
The fifth block is the Mass Balance block and can be used in models where the scope 
requires tracking product yield throughout the process. Linked to equipment 
information defined by the user, it calculates the mass of product throughput based 
on activity yield and product stability. This block can be placed after each relevant 
activity enabling the tracking of product throughput across the process without 
further modeller input. 
The final block is the Area Shutdown/Turnaround block which is actually a rather 
complex structure and can be used for either area shutdown, turnaround or both, 
where turnaround is the procedures necessary following a product changeover in a 
multi-product scenario. The block contains many useful functionalities, for example, 
it can decide whether to synchronise shutdown or turnaround of different process 
areas or allow a rolling effect (where the procedures begin as soon as the area is 
ready) or whether to synchronise shutdown and turnaround if they are due to occur 
within a user defined window, thus reducing area shutdown. This functionality 
features heavily in Chapter 6 and will therefore be discussed further. 
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3.6 Conclusion 
The standard framework developed in this thesis provides the methodology and 
modelling tools to allow modellers to construct models which satisfy the six 
requirement specifications: 
-  Intuitive to user 
-  Relevant 
-  Ease of data input/output 
-  Short run time 
-  Maximised reusability and sustainability 
-  Minimised development time 
 
During the data gathering stages, the framework acts as a guide to improve the 
efficiency of relevant data retrieval and validation, reducing the construction time by 
ensuring that a realistic and accurate understanding of the system is first achieved.  
The standard templates developed as part of the framework have been designed to 
speed up the model development process by providing the fundamental building 
blocks for any biopharmaceutical manufacturing capacity management model. These 
templates have been designed with a degree of customisation which will allow 
different process elements to be realistically and more easily captured, but with 
sufficient generality built in to allow them to be used across different system models.  
The development of the standard framework has been an evolutionary process using 
different biotechnology case studies as a means of evaluating the ability of the 
standard in aiding the construction of models which meet the proposed requirement 
specifications. Furthermore, these case studies have been used for analyses such as 
debottlenecking, dealing with uncertainty and cost analysis, using techniques such as 
Monte Carlo simulations to test the ability of the standard to create models capable 
of answering more complex questions. These case studies are described in Chapters 
4, 5 and 6. 
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4 CHAPTER 4 
Application of Standard Framework 
to a Biotechnology Capacity 
Management Case I 
 
4.1 Introduction 
In biopharmaceutical manufacture there are significantly high costs associated with 
the running of a production facility, attributable to resources such as labour, utilities, 
energy and opportunity cost. The latter can be considered an intangible cost and is 
the cost of using the facility for only one product when it can in theory be used for 
multiple products. There are therefore two possible reasons for speeding up the 
production process. The first is to reduce the running costs whilst maintaining 
production output; if 50kg are produced over a period of 6 months, the cost of 
resources will be considerably less than if the same amount were produced over a 
period of 12 months. The second is to free up the facility in order to schedule 
production of other product(s). This use of the facility in comparison to leaving it 
idle can reduce further costs such as facility mothballing and labour re-training 
which can be the result of long shutdown periods.  
Speeding up a manufacturing process is not an easy task. It requires the identification 
of bottlenecks, whether they are resources such as equipment or labour, and the 
optimisation of activities scheduling such as buffer makeup in time for process 
demand.  
The aim of this thesis section is to illustrate the use of the developed standard 
framework version 1 in constructing a model capable of being used for this purpose, 
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looking at capacity management in the large scale production of a biosynthetic 
therapeutic, henceforth known as BioSynT, in order to maximise facility efficiency.     
In section 4.2 a brief description is given of the areas where uncertainty can be found 
in biopharmaceutical manufacture, particularly in biologics production. Section 4.3 
will go on to provide a brief background to the BioSynT case study, describing the 
model scope and elements. Section 4.4 will discuss the stages of the model construct. 
In Section 4.5 a deterministic analysis of the model parameters is presented, using 
process completion time as the objective function. In Section 4.6, a scenario analysis 
is described, using Monte Carlo analysis to determine possible strategies for process 
acceleration. Finally, Section 4.7 will evaluate the use of the standard framework 
version 1 to construct the model.  
4.2 Uncertainty in Biopharmaceutical Manufacture 
Although manufacturers endeavour to reduce the amount of uncertainty present in 
their processes, not all elements can be fully controlled even with the most state of 
the art equipment and automation systems. For example, equipment failure is one 
element which can be reduced by putting in place regular maintenance checks in 
order to prevent breakdowns. However one could argue that failure can never truly 
be eradicated and thus should be taken into consideration when modelling any 
production process, especially a newly built one.  
Also cycle times can vary for many reasons. For example, manual operations such as 
tray loading/unloading can vary according to labour availability or human error.  
In addition to the uncertainties internal to the process, external factors can also play a 
part. For example, utilities supply across a site can affect the CIP capability of a 
process if for example, required purified water is made unavailable to it.   
4.3 Case study Background 
The remit for the BioSynT case study is as follows. The entire production process 
consists of two streams known as FrontEnd and BackEnd. Both streams have up to 
now been housed in one facility however a new BackEnd facility was recently 
commissioned and built, separating the two parts. 
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The scope of the case study is to determine how fast a certain number of batches (the 
demand) can be run through this BackEnd facility which contains three major 
process stages, one of which is the BackEnd process. Figure 4.1 shows these stages 
where the shaded area containing the three chromatography stages is the Backend 
process.  
A model is required which will generate x batches to represent output from the 
FrontEnd process which will itself not be modelled. These batches will then run 
through the model elements, all representing an element of the BackEnd facility or 
system. The model will then output the ‘real’ time in which all x batches were 
processed given the constraints relevant to the real system. For example, a specific 
constraint is the mode of operation for the process which will be series, that is, only 
one batch will be processed in the BackEnd part of the facility at any one time thus 
when one batch finishes, the next will begin. 
In order to determine how fast the process can run it will be necessary to develop 
activity and resource utilisation profiles as well as determining the process 
bottlenecks which may be slowing the process down. Furthermore once these 
bottlenecks have been determined the next logical step will be to investigate the 
effect, on the overall cycle time, of removing them i.e. to run scenarios. In order to 
do this it will be necessary to run the model both under deterministic and stochastic 
conditions. 
Figure 4.2 gives an outline of the steps involved in the determination of these 
bottlenecks using the deterministic and stochastic approaches and the selection of 
scenarios based on the outcome of the former. It is based on the assumption that the 
scenarios chosen are directly linked to the primary bottlenecks. This is believed to be 
a fair assumption as the selection of these scenarios is based on discussion with a 
pharmaceutical manufacturer of a biosynthetic therapeutic, modeller experience and 
the outcomes of the deterministic analysis, all of which put together can give a fair 
indication of where the bottlenecks may lie.  Figure 4.3 shows these steps specific to 
the BioSynT case study, illustrating the results of the study which will be discussed 
in further detail in following sections.  
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Figure 4.1 Flowchart illustrating process housed in Backend facility including storage vessels (S) and buffer/utilities vessels (T) 
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Figure 4.2 Diagram showing the 10 steps involved in determination of process 
bottlenecks using a deterministic and stochastic analyses 
 
 
Application of Standard Framework to a Biotechnology Capacity management Case I 
- 105 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Diagram showing steps involved in determination of BioSynT process 
bottlenecks using deterministic and stochastic analyses 
 
 
Step 1+2: Deterministic Analysis 
- Col Run CT 
- FD Run CT 
- Equipment Breakdown 
- CIP Rig Breakdown 
- FD Shelf Misalignment 
- FD Leak Test Failure 
- PWEC Alarm  
 
(those underlined had greatest impact) 
Step 3: Stochastic Scenarios 1 
- Additional FD 
- Additional Water Tank 
- Additional Buffer Makeup Tank 
- Additional Buffer Hold Tank 
- Additional Operator 
- Product Storage Before FD 
- FD Unload During Night Shift 
- Buffer Makeup Start Point 
 
Step 4: Determination of Primary 
Bottlenecks 
- Freeze Dryer 
- Insufficient Operators 
 
Step 5: Stochastic Scenarios 2 
- Additional FD + Water Tank 
- Additional FD + Operator 
- Additional Water Tank + 
Operator 
- Additional FD + Water Tank + 
Operator 
Step 6: Review of high impact 
scenarios  
- Additional FD + Operator 
- Additional FD + Water Tank + 
Operator 
Step 9: Determination of Secondary 
Bottleneck 
- Buffer Makeup Start Point 
Step 7: Deterministic Analysis 2 
- Additional FD + Operator 
Step 8: Changes to Key Parameters? 
- Col CT is now the most 
significant parameter to affect 
the completion CT 
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4.4 Method 
This section will describe the construction of the BioSynT model using the Standard 
Framework Version 1, first describing the project scope and process of platform 
selection and finally the actual constructs seen in the model. Appendix B.1 describes 
the rationale behind these constructs. 
4.4.1 Model Characterisation 
Single or Multiple unit operations within problem scope? 
In the BackEnd purification process alone there are four chromatography stages and 
therefore multiple unit operations, in addition to the Reverse Phase step and the 
Freeze Dryer.  
 
Continuous or Discrete Event? 
The primary items which enter the BackEnd purification stream are containers of 
frozen intermediate from the FrontEnd purification process. Each container enters the 
first step individually as a batch. Each batch is processed at each unit operation, 
pooled and then sent to the next unit. Law and Kelton describe discrete event 
modelling as the ‘modelling of a system as it evolves over time by a representation in 
which the state variables change instantaneously at separate points in time’. Events, 
defined as ‘instantaneous occurrences that may change the state of the system, occur 
at these points in time’. 
The analysis of resource usage according to batch ‘generation’ in the BioSynT 
process is a discrete event system and not a continuous one.  
 
Dynamic simulation 
The system consists of a series of both sequential and parallel steps, with batches 
moving from one step to the other. Each step also has a cycle time associated with it. 
Therefore the time dimension must be modelled. 
 
System Elements which must be Modelled? 
The case study will examine the scheduling of the BackEnd BioSynT process, taking 
into consideration the effects of the various system constraints and rules, such as 
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labour allocation, on the schedule. Therefore the system elements which must be 
captured are the, activities (both main and ancillary), resources (labour, equipment. 
buffers) and entities (batches). The numbers/amounts of the resources along with the 
time attributes of the activities will require tracking in order to ascertain the effects 
on the schedule. 
 
Metrics 
Since the remit is to find out how fast the required number of batches can be 
processed, the two main metrics of the model should be the number of batches gone 
through and the time taken to process or the overall completion cycle time. Also 
there are certain constraints on the system, mainly in the form of resource 
availability, the effects of which should be measured. Therefore resource utilisation 
should be an output of the model, with visual aids such as Gantt charts and single 
figures such as percentage utilisation to give a clear indication of resource usage over 
time as well as overall. Finally, one element of the system, of interest to the BioSynT 
client, is the rate of ticket generation during the running of the process. These tickets 
are documents which are generated when an activity starts and closed when the 
activity has ended and the responsible labour has signed off on it. The number and 
location of ticket generation must therefore also be tracked.  
For the purposes of this case study, due to the fact that it is more of a scheduling 
problem, it will not be necessary to model the biochemistry across the purification 
steps, therefore mass balancing will not be required. 
 
Constraints 
The constraints on the system are mainly resource availability and time constraints in 
terms of limits for product holding in storage. A list of the given constraints under 
the scope can be found in Table 4.1. 
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Table 4.1 Summary of BioSynT case study scope 
Single or multiple activities / 
unit operations? 
Multiple 
Continuous or discrete? Discrete 
Static or Dynamic? Dynamic 
System elements • Entities:         
- Batches 
• Activities:   
- Main activities e.g. chromatography 
- Sub-activities e.g. equilibrate 
- Ancillary e.g. CIP 
• Resources:  
- Buffers 
- Equipment 
- Labour 
Metrics • Throughput 
• Cycle times 
• Resource Utilisation 
• Ticket generation 
Constraints • Series mode of operation 
• Labour allocation for sub-activities 
• Synchronisation of equipment preparation 
with resource availability 
• Storage hold time limit 
• Labour availability 
• Share buffer makeup and hold tanks 
 
4.4.2 Platform Selection 
In order to meet the requirement specifications of a simulation model it is important 
to choose the right platform to construct the model on. There are various types of 
simulation software on the market; the following will describe the main platform 
types, specific to examples given for each platform type. 
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There are four major types of simulation platform which can be used for simulation 
of such systems. These are Spreadsheets (Excel), Mass balance (Batch+), Discrete 
Event (Extend) and Equation Oriented Modelling Packages (MathCAD). In order to 
choose a suitable platform for this particular model construct it is necessary to 
perform an analysis of the capacity management problem.  
Spreadsheets such as Excel are suited to less complex systems where modelling of 
the dynamic evolution of system objects is not required. In effect spreadsheets are 
good for creating snapshots of the system at certain points in time, where simple 
(relatively) calculations are sufficient for system analysis.  
Engineering calculation or mathematical modelling platforms such as MathCAD are 
similar to spreadsheets in that they are better suited to less complex systems where 
dynamic evolution is not required. They allow for stochastic modelling with tools 
such as Monte Carlo. They are suited to the creating and documenting of calculations 
and can be used for such things as mass balancing and chemical calculations.  
Mass Balancing platforms such as Batch Plus or SuperPro Designer are suited to 
detailed analysis of the chemistry behind unit operations, allowing for analysis of the 
component makeup as a result of reactions/binding and so on. These packages have 
graphical user interfaces (GUIs) which help to represent the system. 
Discrete Event simulation platforms such as Extend are suited to more complex, 
discrete, dynamic systems where detailed mass balancing is not required, but rather a 
more overall system analysis, with entities, resources and control systems; for 
example, looking at scheduling and resource utilisation. These also have GUIs. 
Table 4.2 compares the four major types of the simulation tool, against the 
requirements of the BioSynT case study as defined under the project scope. The 
comparison has been carried out using a scoring system where relevant, representing 
the extent to which each platform is able to model each requirement.  
Ultimately, as the system being modelled is a dynamic, discrete event one, this 
eliminates spreadsheets and engineering/mathematical platforms.  
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Table 4.2 Showing the different types of modelling platforms and their modelling capabilities in terms of model scope requirements. 
Scores given out of 5, 0=not at all, 5=fully meets requirement 
 Spreadsheets 
(Excel) 
Mass Balancing 
(Batch Plus) 
Discrete Event 
(Extend) 
Equation Oriented 
(MathCAD) 
Single or Multiple 
Activities 
Single 
(too complex at multi) 
Multiple Multiple Single 
Continuous or Discrete -  Discrete capabilities (see below) Discrete with continuous 
capabilities 
- 
Static or Dynamic? Static Static (Aspen Plus Dynamics can 
extend static models to dynamic) 
Dynamic Static 
Stochastic capability? 3 4 5 3 
Mass balancing? - statically 5 - basic - statically 
System Elements 3 
Not dynamically 
4 5 2 
Not dynamically 
Metrics 0 
Outputs required are based 
on dynamic calculations 
3 
Better for platform defined 
metrics e.g. biochemistry 
5 
 
0 
Outputs required are based 
on dynamic calculations 
Constraints 1 3 5 1 
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This leaves mass balancing and discrete event tools. Since the scope does not require 
mass balancing, rather more user defined outputs, Batch Plus would not be a good 
candidate in this case. 
It is believed that Extend would be more suitable as it meets all of the requirements. 
4.4.3 Model Construct 
SYSTEM ELEMENTS (REAL PROCESS FEATURES) 
Activities (Product Handling) 
These are the four chromatography stages followed by the freeze drying step. The 
intermediate storage steps are also considered product handling. Hierarchical blocks 
represent all these functions. As the project scope requires a more detailed analysis 
of resource utilisation and constraint modelling, it was decided that the sub-activities 
of each main product handling activity would also be modelled i.e. the preparation of 
the equipment, the running/processing of the product, the post run cleaning of the 
equipment.  Each of these sub-activities is a further hierarchical block containing 
Extend blocks which represent processing time. Modelling the further level of detail 
ensures that the model remains within the scope by answering the questions of 
scheduling and utilisation more fully and therefore contributes to its reliance and 
reusability.  
Activities (Ancillary) 
The only ancillary activity is CIP of the main product handling equipment. This 
activity has been externalised and sits on the top most level of the model. The 
externalisation of this activity means that equipment are ‘thrown’ here for their CIP 
processing rather than each containing their own CIP block. This reduces the visible 
complexity of the model by using far fewer blocks and concentrating this particular 
function in only one place. Also this block can be used to represent CIP for the other 
products under multi-product manufacture as it sits external to all process blocks. 
Activities (Preparation of Buffers) 
There are two types of buffer preparation related activities. The first is the actual 
preparation of all buffer materials. The second is holding of some buffers before use 
within the process. Like the Ancillary activities, these have been externalised. 
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Within each of the buffer blocks there are sub-activities representing the makeup of 
that buffer, again, to ensure enough level of detail to capture the correct utilisation of 
the equipment and consumables used in making the buffers i.e. water for cleaning the 
tanks. 
Entities 
The entities in the model are the primary items or batches. As inventory exists within 
the model some batches are held after the Reverse Phase in frozen state, and some 
before the Reverse Phase. The batches are numbered sequentially in order to track 
their progress and the process data associated with the processing of each, for 
example, cycle time through the freeze dryer. 
Resources 
Labour has been modelled in resource pools which are kept externally on the top 
most level of the model. Labour allocation is based on whichever activity block 
executes a request first. 
The equipment are held in ‘pallets’ which are in effect holding blocks where the 
labour sits. Gates control whether each equipment leaves its holding block to be 
prepared for processing. 
The consumable resources in this system are the buffers. In Appendix B.1.it is stated 
that these should be modelled in resource pools. However in this case there is a third 
method which must be considered to account for consumable resources which are 
used over a period of time when the equipment where they are dispensed from is held 
up during that period. This method is the use of Flow; for example one lot of acid is 
prepared once and used for three different washes in three different consecutive main 
activities. The tank in which the acid is prepared cannot be cleaned and used for the 
next lot until all required material has been drawn from it with the remainder sent to 
waste. In order to simulate the holding up of this tank, flow must be used because a) 
if the acid material is held in a resource pool then this externalises the contents of the 
vessel and makes it difficult to track its contents and b) if the acid material is 
unbatched and represented as an item then this creates a tracking nightmare. Flow 
internalises the resource, representing more truly the contents of the vessel. It also 
allows better control as the vessel is actually held up until the required contents have 
flowed out 
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LAYOUT 
Physical Layout and Decomposition 
Discrete event simulation modelling in Extend involves hierarchal levels containing 
blocks. Functional Decomposition has been used and therefore the hierarchical 
blocks represent the activities in the real system. The top level of the model looks 
like that in Figure 4.4 with all ‘storage’ blocks (blocks containing externalised 
elements, global arrays and resource pools) positioned at the very top of the 
workspace. 
 
 
Figure 4.4 Top most level structure of the BioSynT model 
 
 
Block Construct 
In addition to the higher level structures a standard structure has also been devised 
for the sub-activities and blocks below the main activity level. As stated under the 
Standard Framework, in situations where there are equipment (or indeed any entity) 
which have their own activities independent of the primary item, the following 
structure for the arrangement of sub-activities can be used.  
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Figure 4.5 Diagram showing the sub-activity structure within the BioSynT model 
 
Note that this structure can be used in part, that is, there may not necessarily be pre-
run or post-run activities before or after the primary item comes in.  
Item Transfer 
Item transfer occurs using the conventional IDEF0 block and connector method to 
create an intuitive model. The model also flows left to right within all hierarchical 
blocks. This is due to both model clarity and also the fact that Extend executes 
blocks in a left to right direction. 
Item Flow Control 
There are certain areas of item flow which must be controlled. This is done using a 
gating system whereby a series of gates are used to synchronise activities by doing 
checks such as ‘are all required buffers ready?’ and to control item flow based on 
equipment status. In order to create more generic blocks, the basic structures of these 
gates are identical; they only differ in the data arrays which they reference.                                         
 
MODEL INITIATION 
Primary Items Generated 
The main items generated in the model are batches. The required number is 
generated all at once and their path through the model is scheduled by the gating 
system. 
 
MODEL LOGIC 
Metrics 
Cycle Times: Although cycle times of individual activities are set in the database, the 
actual process times vary due to the constraints and delays inherent to the running of 
the process. A simple block has been used to record the time at various points in the 
PreRun Sub-Activities 
PostRunSub-Activities 
Run Primary Item Primary Item
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model. These times are stored under the appropriate attributes e.g. BatchStartTime 
and later sent to Excel where a Gantt chart is automatically generated.   
Throughput: This is quite simply the output of the model. The number of primary 
items which leaves the model is the number of batches that have been processed. 
Equipment Utilisation: As all cycle times for all activities are sent to Excel it is quite 
easy to calculate the equipment utilisation (Eq.Ut) using the following equation: 
 
Eq.Ut = Total Actual Processing Time x 100% 
 Time Finished Processing Last Batch -Time Started Processing First Batch  
(4.1) 
 
Total Actual Processing Time is the time that the equipment spent processing the 
batch minus all the gaps due to waiting for resources. This time however does 
include the downtime. 
Resource Utilisation (Labour): It is useful to track the usage of labour in order to 
determine exactly what number is required to run the process or to analyse the effects 
of varying availability.When constructing the model only two rules or constraints 
regarding the labour allocation existed, 1) each subtask must be started and 
completed by the same operator and 2) the unloading of the freeze dryer must be 
done during the day. The first is rather logical since every task must be signed off 
with most lasting only an hour, some only 10 minutes.  
In order to model the first rule it was initially considered that a logic be placed before 
every sub-activity in order to check that it could be completed during that shift. 
However there are in total 42 of these sub-activities which would mean a rather 
significant increase in visible and hidden complexity. Therefore it was decided that 
each main product handling activity be broken down into ‘sections’ of sub-activities 
which if started must be finished but which can have time gaps in between without 
‘expiry’. For example a column could be prepared and equilibrated and then wait for 
the next ‘section’ which would be the processing of the batch. Note that since each 
shift lasts 12 hours, this would be the maximum (and unlikely) time gap. It was 
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assumed that this would be allowed, for example, equilibration could be done and 
left without ‘expiring’ until the next shift.  
Each main activity was broken down into the following chunks or sections 
‐ RP   All sub-activities 
‐ Solvent Exchange 1 PreRun, Run, PostRun 
‐ Size Exclusion  PreRun, Run, PostRun 
‐ Solvent Exchange 1 PreRun, Run, PostRun 
‐ FD   PreRun, Load, Unload, PostRun    (no labour for run) 
 
At the beginning of each section where a worker is needed a shift rule block is placed 
which checks the following: 
- What is the current time and therefore current shift, night or day 
- How far into the shift is current time 
- What is the cycle time of the activity 
- Assuming that the section can begin as long as the current time is greater than 1 
hour before the end of the shift, an operator is pulled from the resource pool. 
However if it is in the last hour of the current shift, a delay is forced which waits 
until the end of the shift before an operator is pulled. 
For the freeze dryer the same block is used however only day shift worker is made 
available 
Ticket Generation: During the construction it was decided that the generation of 
work tickets should be tracked in order to see how long each is kept open before 
being signed off and more importantly how many are open at any one time. In order 
to tackle this, a ‘ticket’ block was created. This block is used for the opening and 
closing of a ticket. When a ticket is opened (for example when a column is going to 
be packed) the block is turned into an opening ticket place entering a 0 in the top left 
hand corner. The ticket number is then entered at the bottom. This number is set and 
can be referenced in the global arrays block. The block will then automatically write 
to the global array when that ticket was opened. Subsequently the contents of the 
global array are sent to Excel at the end of the simulation where a Gantt chart is 
created showing ticket generation. 
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Shift 
The facility runs on a 24hour basis with a current 12hour labour shift. There are two 
significant rules based on the labour shift which must be considered: 
- No activity can be started by a worker towards the end of a shift i.e. a worker 
must be able to start and finish an activity 
- Unloading of the freeze dryer can only occur during day shift 
 
DATA 
Data Transfer 
Data generated by the model is transferred to Excel for analysis from either global 
arrays or attributes. Current data is all time related and therefore the output charts are 
all Gantt.  
Database 
All data is entered into the excel database and transferred to Extend via the SDI link.  
4.4.4 Case Study 
The next section will focus on the results of the case study, looking at the 
deterministic and stochastic analyses carried out. This section will briefly discuss the 
key base assumptions used to form the basis of the study. 
4.4.4.1 Key Base Assumptions 
The model was run with the following parameters and assumptions. Those made 
variable have been marked as such. All others were hardwired into the model 
structure. 
General 
‐ Number of runs = 1 
‐ The process is only run in series mode, that is, only one batch can be in the 
BackEnd process at any one time however at the same time there may be one 
processing in Reverse Phase and also Freeze Drying.  
Application of Standard Framework to a Biotechnology Capacity management Case I 
 
- 118 - 
 
‐ The model time horizon is 1 year, based on a 310day year, 30day month. This is 
based on the assumption that the overall process will run at 85% efficiency 
‐ Shift: 12hour labour shift, 24hour process operating shift (Variable) 
‐ Assuming 40kg per annum required throughput, this equals 40 batches required; 
5 held in frozen inventory after RP and 35 before RP (Variable) 
‐ Assuming that product will remain viable in intermediate storage for 24hrs and 
48hrs depending on stage 
‐ The Reverse Phase operation will only run during running of the Freeze Dryer 
‐ No equipment is prepared for processing a batch until a check has been carried 
out to ensure all required buffers are available 
‐ The Freeze Dryer requires up to 4 people to load and unload. It has been 
assumed that 2 will need to be pulled from the regular shift and that the 
remainder will be available as and when and are therefore not a constraint 
(Variable) 
‐ Columns can be equilibrated and left for up to 12 hours 
‐ There is no storage between the last column, Col 4, and the Freeze Dryer. The 
batch must be eluted straight to the dryer. Therefore product is kept in S5 and S6 
but only for up to 24 hrs. Col 4 is then run just in time to elute to FD. 
- Reverse phase does not go to CIP. It is regenerated and re-equilibrated straight 
after elution and put into storage 
Failures 
‐ Buffer tank probes fail 1/10 or 1/20 (depending on tank) runs/make-ups 
(Variable) 
‐ PWEC tank supply stops 4 times in a 12hr shift for 30 minutes (Variable) 
‐ CIP rig breaks down once per 24hr operating shift for 6 hours (Variable) 
‐ FD leak test fails 1 out of every 3 runs. It takes 2 hours to investigate before 
repeating the test (Variable) 
‐ FD shelf misalignment occurs 1 out of every 4 runs. It then takes 8 hours to 
unload and fix before reloading. (Variable) 
- There is a breakdown in the Main Product Handling equipment (columns and 
FD) once a week with a different one every week. Since there are 5 pieces of 
equipment, time-before-failure for each will be five weeks. (Variable) 
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- Assuming that if equipment breaks down while processing product, that batch or 
cycle lot will not be discarded.  
Buffers 
‐ Buffers A and B together take 5 days to make up (20 batches worth) 
‐ The order of buffer makeup is fixed i.e.: 
Tris 20 Æ Caustic 100 ÆTris 5 Æ Caustic 10 Æ Caustic 100 Æ Buffer AÆ 
Buffer B 
‐ Buffers for RP (A and B) are made up once the level of buffer remaining 
reached below 5 batches (Variable) 
- Buffer makeup for each batch begins only when the final column, Col 4 has been 
cleaned and placed in storage 
Labour 
‐ 2 operators do everything. PT only helps with load and unload of FD (Variable) 
‐ The 2 operators can work simultaneously on all buffer makeup. They can do this 
during process operation spending a percentage of their time on each task 
- There is no unloading of the FD during the night shift 
Concerning Scenarios 
‐ When there are two T415 tanks (used for caustic, tris and RP buffers) the tanks 
do not make the same buffers, rather they share the burden. In other words one 
tank will only make caustic, the other will be dedicated to Tris and RP buffers. 
4.5 Results and Discussion 
4.5.1 Initial deterministic analysis 
In order to perform a worthwhile scenario analysis it is first necessary to determine 
which parameters will have the greatest impact on the measured output or process 
performance. This is where a deterministic sensitivity analysis must be used. 
However, when modelling a complex system there are a myriad of parameters which 
could be tested and it is important to be able to eliminate all but only those with 
potential impact in order to save time. The following section will discuss the setting 
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up of the deterministic case, including the selection of parameters for the study and 
the results of the analysis. 
4.5.1.1 Setting up the deterministic case 
In order to carry out a worthwhile deterministic analysis it is necessary to first 
ascertain which factors have the greatest impact so that only those may be looked at. 
The following examines the possible factors or parameters. 
Throughput 
Firstly based on the assumptions outlined in section 4.4.4.1 the throughput was 
calculated to be 100% i.e. 40 batches output. This is due to the fact that the allocated 
time horizon of 310 days is more time than required to process the required 
throughput considering that each new batch goes through on average every 6.46 
days, requiring a total of only 258 days for all 40 batches. However this cycle time 
which equates to 8.62 months is still rather high if the desired outcome is to reduce 
production time to 6 months or below, in order to shut down the facility for half the 
year or more importantly, use if for another product. Therefore it would be 
interesting to deterministically investigate possible ways in which this cycle time 
could be reduced. One obvious way would be to reduce the cycle times of the main 
product handling materials. 
Utilisation 
Three types of utilisation were tracked: equipment, facility and labour. Table 4.3 
shows the results for the base case. In order to show how these results differ for 
different scenarios later incorporated, the utilisation figures for the two main 
bottlenecks have also been included. The third column shows that when an additional 
operator is available taking the number of operators to 3, the labour utilisation drops 
from 70% to 47% which is expected as the burden of labour requirement is spread 
across a larger number of operators. This column also shows that the utilisation of 
the freeze dryer increases to 93% which is again, expected as later work shows that 
the FD is the second bottleneck in the process behind labour availability. The fourth 
column in the table shows that when both the bottlenecks are removed, the utilisation 
figures for the labour and freeze dryers decrease.  
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Table 4.3 Utilisation figures for base case scenario, addition of an operator and the 
addition of an operator plus a freeze dryer 
 Base 3 Operators 3Ops + FD 
Facility 84% 69% 64% 
RP (combined) 52% 84% 95% 
G15 19% 23% 24% 
Sephadex 26% 32% 35% 
G25 42% 52% 56% 
FD 1 78% 93% 51% 
FD 2 - - 50% 
Labour 70% 47% 43% 
 
One strange feature of the results is that the utilisation figures for the equipment 
increase as the bottlenecks are removed, particularly the labour bottleneck. The 
reason for this can be found by looking at equation 4.1. 
Using the first solvent exchange column, Col 2 as an example, when the elements of 
the equation are compared with the base case scenario and the addition of an operator 
the following results are seen: 
 
Table 4.4 Elements of equation 4.1 calculated for base case and 3 operators for Col 2 
 Base case 3 Operators % Change 
Total Actual Process Time 47.5 46.9 -1.3% 
Time Started 0.24 0.24 0.0 
Time Finished 253.2 205.5 -18.8% 
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When plugged into the equation the result is a greater value for equipment utilisation 
with application of the labour scenario:  
 
-1.3% Equipment Utilisation = -18.8% x 100%  (4.2)
 
In terms of what is actually happening in the model, when additional labour is 
available the times during which the equipment sits waiting for labour is reduced. 
This reduces the total actual processing time for the equipment (as this includes all 
the gaps due to labour unavailability). But this effect is local to Col 2 hence the 
relatively small decrease of 1.3%. However throughout the process the increase in 
labour availability also has an impact on every other equipment, meaning that 
batches can be processed faster. This global impact is what affects the ‘time finished’ 
element of the equation, hence the large decrease of 18.8%. Therefore although the 
overall impact of labour availability may be an overall reduction in cycle time, 
locally the equipment utilisation figures will increase due to the use of the above 
equation and the assumption incorporated. This also explains why the overall facility 
utilisation decreases with the removal of the bottlenecks, particularly labour.  
 
Cycle Times 
The cycle time of each batch through the BackEnd alone varies, averaging 4.6 days, 
with the overall cycle time for all batches through RP–BackEnd–FD being 258 days.  
Figure 4.6 shows all main product handling activities from Reverse Phase to Freeze 
Drying including all intermediate storage, for the production of one batch. Firstly, 
Reverse Phase is not the first activity to take place as there is inventory product held 
in freezers between RP and Backend. This means that the latter can begin processing 
immediately taking defrosted material from pool tank S3. From here it enters the first 
solvent exchange and then subsequently gets eluted into pool S4. From here a 
significant overlap can be seen within the BackEnd process due to the use of pooling 
vessels S5 and S6. Here the batch entering size exclusion is split into 6 lots where 
each is cycled through the column. As a batch is eluted it enters straight into a 
storage vessel. The first half of the 6 lots fill storage vessel S6 while the latter half 
fill vessel S5. This is the first overlap. The second occurs when, while storage vessel 
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S5 is being loaded with material from the size exclusion column, vessel S6 begins to 
unload its contents into the second solvent exchange. Finally the freeze drying stage 
begins on the 4th day. Therefore the BackEnd section of the process takes 
approximately 4 days. 
What the Gantt chart shows is that the pre- and post-run activities are not the factors 
with high impact on the overall process cycle time as these are done well in advance 
in the majority of cases, ruling them out as bottlenecks. It is the cycle times for actual 
product processing which should be investigated particularly in the case of the freeze 
dryer which takes 55 hours to run only one batch.   
Furthermore the fact that the pre- and post-run activities are not bottlenecks suggests 
that the buffer supply is adequate and not in itself a bottleneck. Therefore buffer 
supply will not be looked at under the deterministic sensitivity analysis. 
The vertical axis corresponds to different main product handling activities while the 
horizontal bars correspond to different sections of activities within the main product 
handling ones. These sections are PreRun, Run and PostRun. The darker shaded bars 
along each horizontal grid line represent the processing of batch material and the 
lighter shaded ones represent the pre-run and post-run activities associated with the 
equipment. 
 
 
Figure 4.6 Gantt chart showing the Backend facility process for 1 batch. Running 
conditions: (1) 2 operators available, (2) 40 batch demand - 5 of which come from 
frozen inventory post RP. 
Application of Standard Framework to a Biotechnology Capacity management Case I 
 
- 124 - 
 
Labour 
The labour used for each section is tracked using attributes. The top chart in Figure 
4.7 shows labour usage for a 31 day period. In order to see the effects of labour 
availability on the process it is useful to compare this chart with the process Gantt. 
The bottom chart in Figure 4.7 shows the main product handling activities for the 
same 31 day period.  
The labour chart shows that the labour usage fluctuates constantly with not all 
available labour being utilised all the time. This is unsurprising as the labour 
utilisation figure is 83%.  
 
 
 
Figure 4.7 Labour usage and main product handling activities for the same 30 day 
period 
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Table 4.5 Showing days during which labour is fully utilised and therefore 
unavailable along with times during which process sub-activities wait for labour 
availability 
0.5 - 
3.4
4.4 - 
8.5
8.6 - 
9.6
9.6 - 
10
11.8 - 
16.9
17.1 - 
17.3
17.6 - 
19
19.1 - 
20.7
21.7 - 
22.4
22.5 - 
23.8
24 - 
25.7
26 - 
31.4
1.1 4.5 9.3 11.2 19 19.1 22.1 22.8 25.7 26
2.2 7.3 11.8 22.3 23.1 29.5
3.1 8.2 14.8 30.2
3.2 16.9
3.4
Range of days during which labour is unavailable
Times 
where 
gaps in 
process
 
However although the utilisation may not be 100% the scheduling of events means 
that labour is required when unavailable; Table 4.5 shows more clearly the days 
during which labour availability is zero along with the corresponding gaps during the 
main production process when activities are waiting for labour to become available. 
It shows that all 23 gaps fall during the times when labour is being utilised 
elsewhere. Therefore labour is a factor which affects the overall cycle time. 
However, it will not be included under the deterministic analysis as a potential 
uncertainty but will rather be set as a scenario. The reason for this is that the process 
simply will not work with less than 2 available workers and therefore a distribution 
for uncertainty would be heavily biased towards the positive. 
4.5.1.2 Deterministic analysis parameters 
Below are those parameters to be included in the deterministic study. 
Equipment Breakdown Frequency and Time to Repair: The frequency of breakdowns 
in the process equipment is on average once per week with repair time being, again, 
on average 6 hours. It seems that both these numbers fluctuate, particularly due to the 
fact that the process is new and that the modular nature of the facility has meant 
more difficulty in gaining access to areas and instruments for repairs.  
CIP Rig Breakdown: According to the process team, the new CIP rig is rather 
temperamental and can break down with high frequency. Unlike the equipment 
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breakdown however, only the breakdown frequency will be changed, keeping the 
time to repair constant. 
Freeze Dryer Manual Operation Cycle Time: The Loading, Sampling and Unloading 
of the freeze dryer are carried out manually and take several hours. Factors such as 
illness, labour shortage or time of day can contribute to slower labour input. On the 
other hand, extra labour, or good moods could mean an increase in efficiency.  
Column Cycle Times: Changes in product potency can lead to changes in the charge 
volume resulting in different cycle times. These would typically be in the region of 
plus/minus 10%. Furthermore, variations in flow rate can also affect this.  
FD Leak Test Failure: The failure of the freeze dryer leak test is a common 
occurrence and can cause several hours delay for investigation and repair. The test 
must then be repeated.  
FD Shelf Misalignment Frequency: Shelf misalignment occurs during loading of the 
freeze dryer and is a common occurrence. The delay caused is significant as the FD 
must be unloaded and reloaded before continuing. 
PWEC alarm: the alarm on the cold PWEC supply tank sounds rather frequently 
during every shift. Since the makeup of all buffers relies on PWEC supply, 30 
minute stoppages may have an effect on the speed of availability of the buffer. 
However since buffer supply is unlikely to be a bottleneck, it is believed that this will 
be one of the lowest impacting factors. 
4.5.1.3 Deterministic analysis results 
Figure 4.8 is a tornado diagram showing the parameters tested and the impact on the 
process completion time for all 40 batches. It shows that the biggest impact is seen 
when the frequency of the freeze dryer shelf misalignment is changed, particularly 
when it is increased. It is this negative impact on the overall cycle time which puts 
this parameter higher on the diagram than the chromatography column cycle times 
which show a bigger range of percentage change in comparison. There is a similar 
pattern observed with the equipment breakdown and freeze dryer cycle time. The 
lowest impacting parameters are the FD leak test failure frequency and the PWEC 
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alarm frequency. These will consequently not be considered in the stochastic 
analysis. 
 
Figure 4.8 Impact of key uncertainties on completion cycle time for 40 batches 
4.5.2 Scenarios Analysis 
4.5.2.1 Scenario analysis setup 
The setup of the scenario analysis comprised of two parts. Firstly, the scenarios were 
selected based on the results of deterministic analyses. Secondly, taking those 
parameters with the greatest impact on the completion cycle time from the 
deterministic analysis, randomness was added to the model during each scenario 
run.These parameters are shown in Table 4.6. The chosen scenarios are discussed 
below. 
 
The scenarios chosen were as follows: 
- Additional operator 
- Additional freeze dryer  
- Additional water tank 
- Change to start of buffer makeup 
 
The addition of the operator was chosen as a scenario due to the findings discussed 
under section 4.5.1.1 which showed that labour was a constraint on the process, 
causing activities delay as labour became unavailable at various points during the 
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process. The findings also showed the impact, on the process utilisation, of adding 
just one additional operator.  
 
With regards to the addition freeze dryer, the unit operation could only process one 
batch at a time with no storage between the final purification stage and the dryer, 
meaning that the product would not load onto the final column until the dryer was 
ready. This of course placed a significant constraint on the scheduling of the process 
and, as Gantt outputs of the process showed, gaps appeared in the process schedule 
where batches could not be fed through due to unavailability of the freeze dryer 
suggesting that itwas a major bottleneck. This could only be solved by significantly 
reducing the cycle time of the step (rather unlikely) or by increasing the number of 
freeze dryers. 
 
In order to understand further bottlenecks in the process, the series mode of operation 
was removed, allowing overlap of batches in the Backend Process. The purpose of 
this exercise was to determine what would be a major constraint if the process were 
allowed to run as fast as possible, with only the resources acting as constraints i.e. in 
parallel mode. As expected, the series mode output Gantt chart showed no overlaps 
in the start-finish of each batch. Although it was expected that there would be 
overlaps in the parallelmode Gantt chart, it was in fact identical to that of series 
mode. This anomalous result in parallel mode however was not due to the freeze 
dryer as that would not stop the second batch from starting before the first had 
finished. It would instead show an overlap in start-finish followed by a waiting time 
represented by a gap between the preparation of the final column and its running 
(similar to the series case). Since the process was being pushed into series mode 
there must be another earlier constraint causing it to do so. Review of the model 
outputs showed that the first column was delayed in preparation because it was 
waiting for Water, classified as one of the BackEnd buffers. Only one tank was used 
to makeup the water supply, with six make-ups necessary to process one batch. In 
series mode the low makeup cycle time meant that it did not act as a constraint, with 
enough time to meet the water requirements of the one batch before the next came 
through. However in parallel mode the second batch required water while the tank 
was still being used elsewhere, hence the delay in preparation of the first column. 
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Therefore the water (PWEC) make-up tank was a bottleneck and therefore a chosen 
scenario. 
 
Finally, under Section 4.4.4.1 it was stated that buffer makeup for each batch would 
only begin when the final column (col 4) had been cleaned and placed in storage. 
This rule was put in place following discussions with the BioSynT process engineers. 
In order to understand the impact of this rule however, the controlling gate was 
removed, thus allowing buffer makeup to be a continuous loop process. The simple 
analysis showed that the earlier availability of buffers had a positive effect on the 
process cycle time due to the fact that equipment preparation was impacted to a 
lesser degree with regards to waiting for buffer availability. Therefore the change in 
buffer makeup start time was chosen as the final scenario. 
 
Table 4.6 Showing the uncertainties incorporated in the model and distributions used 
where TBF = Time Before Failure, TTR = Time to Repair 
Parameter Distribution 
Equipment Breakdown Triangular distribution    TBF(3,7,14) days 
                                         TTR(1,6,10) hrs 
CIP Rig Breakdown Triangular distribution    TBF(0.5,1,2) days 
FD Shelf Misalignment Probability of Success through   
Triangular distribution    TBF(0.1,0.25,0.5)days 
FD Run CT Triangular distribution    TBF(-10%,base,+10%) hrs 
Columns Run CT Triangular distribution    TBF(-10%,base,+10%) hrs 
 
The stochastic simulations were run for 1000 iterations each in order to achieve 
reasonable convergences. 
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4.5.2.2 Scenario analysis results 
A frequency distribution was then generated for each scenario. Figure 4.9 shows that 
generated for the base case. Here the distribution is as would be expected with the 
peak value corresponding with the base case cycle time of 8.62 months, since this 
base case was obtained using the most likely values. The distribution also shows the 
range of possible completion cycle times to be between 8.45 and 9 with the best and 
worst case combinations of uncertainty values. This means that although the 
probability is relatively low (as indicated by the area under the peak) the cycle time 
could be increased by 4.4% which is an undesirable event. 
Figure 4.10 shows the frequency curves derived from these distributions along one 
axis in order to compare their positions relative to each other as well as the base case. 
Only those which had an impact on the completion cycle time have been included. 
 
 
Figure 4.9 Frequency distribution of completion CT for 40 batches of BioSynT in 
the base case scenario. 1000 iterations were used with a convergence of 0.0001 in the 
Monte Carlo simulation to account for equipment failures and cycle time 
uncertainties. The darker shaded column represents the deterministic value of 
completion CT. 
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Figure 4.10 Combined frequency distributions of completion cycle times for 40 
batches showing the scenarios with greatest impact on completion CT.  Each 
scenario run for 1000 iterations with a convergence of 0.0001. These scenarios are 
(a) base case (  ), (b) additional freeze dryer (  ), (c) additional operator ( ), 
(d) additional freeze dryer and water makeup tank ( ), (e) additional freeze dryer 
and an operator ( ), (f) additional freeze dryer, water makeup tank and an 
operator ( ) and (g) additional freeze dryer, an operator and change to start of 
buffer makeup ( ). 
 
The stochastic results clearly show the lower cycle times which can be achieved if 
any of those scenarios shown in Figure 4.10 are implemented. The resolution of the 
primary and secondary bottlenecks together, that is, the freeze dryer, operator and 
buffer makeup, result in a reduction of several months for the processing of the 40 
batches, bringing the cycle time to below six months. In fact most of the peak range 
lies below the 6 month point meaning that even with the uncertainties in place the 
likelihood of achieving a 6 month process time is high.  
This chart also supports the ranking of the bottlenecks, that is, the labour availability 
as the biggest, the freeze dryer cycle time as the second and the buffer makeup 
trigger as the third. This sequence is shown by the position of the peaks relative to 
each other; the more significant the bottleneck the further away from the base peak. 
To take this analysis one step further it would be interesting to quantify the findings 
in terms of the investment that would be required if the changes highlighted by the 
bottleneck analysis were made. Figure 4.11 is a bubble diagram illustrating this. 
Application of Standard Framework to a Biotechnology Capacity management Case I 
 
- 132 - 
 
Taking the standard deviation to be the risk involved, the preferable place to be on 
the bubble chart would be in the bottom left hand corner, that is, low risk and low 
completion cycle time. According to the chart the scenario with FD+Water+3Ops 
would therefore be the better choice. However what little is gained in terms of cycle 
time reduction relative to the next scenario, FD+3Ops, does not really justify the 
extra £30k pa investment. Therefore of these two scenarios, the latter would be 
preferable. But then the scenario with FD+3Ops+Buffer Makeup although has a 
higher risk, has the lowest completion cycle time. This is highly beneficial if the 
company want to close the facility down for half the year or dedicate it half the time 
to another product. If however the minimum investment is desired for reasonable 
gain in cycle time reduction, then perhaps the best scenario would be to appoint the 
one additional operator. This would reduce the completion cycle time to just below 7 
months, allowing for facility shutdown (or use for another product) for almost 3 
months out of the 10 month time horizon.   
 
 
Figure 4.11 Bubble Diagram showing mean completion CT v. standard deviation for 
different scenarios: (a) base case ( ), (b) additional freeze dryer (    ), (c) additional 
operator (    ), (d) additional water makeup tank and an operator (     ), (e) additional 
freeze dryer and an operator (         ), (f) additional freeze dryer, water makeup tank 
and an operator (    ) and (g) additional freeze dryer, an operator and change in 
trigger of buffer makeup (            ). The bubble size is proportional to the investment 
required for each scenario. Input costs: (1) Freeze Dryer £500,000 (capital), (2) 
Water tank £15,000(capital), (3) Additional Operator £45,000pa (£30k plus 50% 
overhead costs (Coulson & Richardson 2005)). 
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4.5.3 Evaluation of use of the Standard Framework in Construction 
of the BiosynTModel 
The BioSynT model was built to answer the specific capacity management question 
of how fast could the process be made to go and also to test the Standards Version 1 
framework its ability to guide the construction of a model that meets the set 
requirement specifications. In order to understand and evaluate the value of using the 
framework to construct the BioSynT model a qualitative analysis must take place. In 
an ideal world, a quantitative analysis would also be performed however it is 
exceedingly difficult to quantify the comparison between the process of two 
construction methods. What can be offered is the feedback from the end users and 
the validation outcomes of data/trend verification, using the requirement 
specifications as a guide. 
 
Intuitive to user 
According to the guidelines outlined by Valentin and Verbraceck (2002), a model 
can be made intuitive to the end user if it is constructed in such a way that the 
‘Interactions between model parts...should represent interactions in the real system’, 
‘Use concepts that represent functionalities as found in reality and that can be used 
for visualisation purposes’ and ‘Visualise a system in such a way that complexity is 
reduced but the essential processes are still shown’. These statements simply mean 
that in order for the end user to fully understand the model within a short space of 
time, the system elements should be easily identifiable within the model and that any 
model elements which are non system specific should be hidden and ideally 
minimised so that the level of complexity is reduced. Following these guidelines, the 
BioSynT model was constructed using functional decomposition and therefore the 
main block constructs visible to the user are the main system operations. 
Furthermore, the hierarchical nature of the Extend platform allows for model 
elements to be hidden away within blocks, helping to reduce visible complexity. This 
feature was heavily utilised in the BioSynT model. 
 
Relevance and Ease of Data Input/Output 
The BioSynT model uses the SDI link offered by the Extend platform whereby the 
database source sits within Excel. All of the parameters needed to run the model have 
been pre set into the database meaning that the user need not access the input Excel 
Application of Standard Framework to a Biotechnology Capacity management Case I 
 
- 134 - 
 
file. The reason for limiting the access requirement is due to the fact that the Excel 
database would have to be manually exported and imported in order for any changes 
to be applied in the model database, no matter how small those changes. 
Furthermore, the SDI link is designed with a rigid structure meaning that in order for 
Extend to be able to read the tables correctly any structural changes such as an extra 
row or field in any table would have to be manually noted within the Excel file 
before exporting. These features are deemed as shortfalls because they increase the 
necessity of user input where knowledge of the model and database is required. As 
such the major variable parameters have been placed within the model using the 
intuitive notebook feature so that the user can easily access them. However, the 
nature of the database and the limitations of the notebook function mean that the 
degree of variability is reduced, with parameters such as cycle time only being 
changeable within the relatively complex database structure.  
 
Maximised reusability and sustainability 
Table 4.7 shows those parameters easily accessible to the user. The model inputs 
clearly shows the limited number of parameters made truly variable, with all other 
parameters accessible only through the database. As stated earlier, these latter ones 
can be changed by the user but only if they have knowledge of the SDI function. 
Although the model has been set up in such a way that the user can easily change the 
number of equipment and labour, further scenarios analysis would need access to this 
database and possible structural changes to the model. For example, a change in the 
process sequence would need alterations to both model and database. Although 
rather difficult to quantitatively score the BioSynT model in terms of reusability and 
sustainability, it is possible to qualitatively state that these requirements are limited. 
 
Table 4.7 Summary of inputs and outputs to BioSynT model 
Model Inputs (Notebook)  Model Outputs (Excel)  
Resources 
 
- Number of labour available
- Number of equipment 
Throughput 
Durations 
Utilisation  
Other 
Graphical 
representations 
- Batches 
- Activities 
- Equipment, Labour
- Ticket generation 
- Excel Gantt charts 
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Short Run-time 
The run time of a model is important particularly when the number of runs required 
increases. For example, if a model were to be run only once, then even a ten minute 
run would not be too significant. However if 1000 runs were required (during a 
Monte Carlo analysis for example), even a two minute run time would result in two 
thousand minutes or 33 hours of simulation time. If only four scenarios were then run 
(as in the case of the BioSynT case) then this would mean 5.5 days of simulation run 
time. This would not only be draining on CPU capacity but would make the use of 
the model as a decisional tool somewhat inefficient. Therefore a short a run time as 
possible, preferably less than a minute, would be ideal. Without an equivalent 
BioSynT model to perform a direct comparison with, it is rather difficult to quantify 
any improvement in run-time. However, during the review of existing models it was 
found that most took several minutes to run only once. The BioSynT model takes 
approximately a minute and therefore it can be deemed to meet this particular 
requirement to a certain degree. It is important to note here that discrete event 
models, due to their nature, take longer to run than purely algorithmic based models 
and therefore, although run-times of only seconds would be preferable, the 
complexity of discrete event makes it more unlikely if larger systems are being 
modelled. 
 
Minimised development time 
The major shortfall in the construction of the BioSynT model was the development 
time; although in theory it should have taken a matter of months in total, the design 
to final documentation stage took over a year to complete. One major factor was the 
model rebuild which took place months into project commencement due to the 
realisation that the model did not quite meet the scope. Section 3.5.2.1 explored this 
in greater detail.  
4.6 Conclusion 
The BioSynT case was used to demonstrate the ability of a model, built using the 
standard, of being used as a decisional tool. A deterministic study was first carried 
out in order to determine those parameters whose variability would significantly 
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impact the output metric, completion time for the processing of forty batches, thus 
identifying the primary bottlenecks within the process. It showed that the biggest 
impact was seen with the frequency of freeze dryer misalignment, lengthening the 
process completion time when increased. 
A stochastic study was then carried out using the results of the deterministic analysis, 
looking at the impact of different scenarios combined with process uncertainties to 
determine how these would affect the running of the process and to highlight any 
shifts in bottlenecks. A cost analysis of the scenarios was also carried out to add a 
further dimension to the study. The outcome of this was that in order to reasonably 
reduce facility operation time whilst injecting minimum investment the best scenario 
would be to increase the number of operators by one, giving a reduction in overall 
completion time of almost 3 months.  
Finally the BioSynT case study was used to implement the Standard Framework 1, 
testing its ability to guide the construction of a manufacturing capacity management 
model capable of meeting the requirement specifications stated under the standard. A 
qualitative analysis showed that these were not sufficiently met, with rigidity in the 
method of model construction and the approach used, leading to a less than adequate 
reusability and sustainability, a relatively long run time and a far greater 
development time than desired (with time and cost efficiency as measures).  
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5 CHAPTER 5 
Application of Standard Framework 
to a Biotechnology Capacity 
Management Case II 
 
 
5.1 Introduction 
As illustrated in Chapters 3 and 4, version 1 of the Standard Framework for building 
capacity management models required improvements to optimise development time, 
model reusability and extensibility. This chapter illustrates a case study, the large 
scale production of a monoclonal antibody, used to test the ease of use and 
limitations of version 2 of the Standard Framework when addressing industrially 
relevant questions.  The case study focuses on how a biotechnology facility built for 
the commercial production of monoclonal antibodies will cope with future cell 
culture titres and searches several strategies to identify the optimal set of process 
changes to make in order to overcome expected capacity bottlenecks.  
The reason for selecting this particular case study (known as mAb) was three fold; 
firstly, having based the standards amendments on a biotechnology process (Chapter 
4) it made sense to illustrate the new version on another biotechnology case in order 
to truly test its applicability in biopharmaceutical capacity management. Secondly, 
the case offers new dimensions to those examined in the Chapter 4; particular 
modelling challenges include capturing split batches occurring in parallel across 
multiple unit operations, enabling brute force combinatorial optimisation and 
capturing the consequences of failure rates and including costs. These modelling 
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challenges are expanded on in greater detail in Section 5.3. Thirdly, to provide an 
immediate data source which would speed up the data gathering process for any new 
model, two models, one at the facility level and one at the process level, existed. 
However having been built without the aid of a standard framework these models 
were deemed to fall short of the requirement specifications. Furthermore the original 
scopes had developed and therefore a new model would be needed to cover the new 
scope.  
Section 5.2 provides a brief background to the mAb case study, outlining the reasons 
for selecting this particular process in demonstrating the use of the framework tool. 
Section 5.3 will discuss the method behind the case study, looking at the stages of 
the model design and construct. In Section 5.4, the results and discussions section, a 
deterministic analysis of model parameters is presented, using process throughput as 
the objective function. In this section, Monte Carlo simulations are also used to 
mimic the randomness of one particular parameter highlighted as high impacting. 
This section also discusses the scenario analyses used to determine the best strategy 
to deal with process variability and uncertainty while minimising the downstream 
cost of column repack and maximising process throughput.  
5.2 Case Study Background 
A case study examining the implementation of version 2 of the standard framework 
to a biotechnology process will now be presented. The case is based on a new facility 
built for the large scale manufacture of mAbs. The main drivers for a capacity 
management model are: 
- The process has been designed to cope with a certain titre range of 1.5g/L ±10%, 
however it is expected that titres up to 10g/L could be seen. This means that there are 
concerns over downstream bottlenecks since the main constraint to process 
throughput is the binding capacities of the downstream chromatography units, in 
particular the initial Capture column step. Possible solutions include greater numbers 
of cycles (splits) in these units or upgrades in equipment size or resin type. However 
there are associated tradeoffs between upfront investments costs, running costs and 
efficiencies which must be investigated.   
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- Due to the downstream capacity limitations, it is necessary for the harvest stream to 
be split into cycles once it has existed the recovery area. This is so that both the 
volumetric and binding capacities of the chromatography units can cope with the 
product stream. A question posed here is what number of splits will reduce the 
downstream bottleneck while remaining feasible and cost effective; the tradeoffs 
being greater step efficiency but greater costs associated with resin replacement (the 
greater number of cycles means more repacks required). 
- Equipment failure, both mechanical and contamination, is a concern both in terms 
of subsequent shutdown periods and the discarding of valuable batches or batch lots. 
An understanding of the impact of variable failure and discard rates on process 
throughput will highlight a threshold beyond which process efficiency drops below 
an acceptable value.  
- The facility is due to begin producing a single mAb product however it has been 
built with the intention of introducing more mAb products as they emerge from the 
clinical trials pipeline which will use the same platform process. The impact of this 
is that although the case study will focus on a single product scenario, the model 
constructed should have multiproduct capabilities in order for reusability and 
sustainability, 
Initially, the existing models were reviewed and, comparing the new scope with 
those of the old models, it was deemed that only one model would be required, 
providing a sufficient level of detail necessary to fully answer the capacity 
management questions being asked.  With a finalised scope in place, the model was 
constructed using the standards framework as a guide to ensure that it met the model 
requirement specifications, proposed in Chapter 2. The output parameters were then 
validated with the mAb team at Eli Lilly to ensure that the model had realistically 
captured the elements of the system such as scheduling constraints and operating 
parameters.  A deterministic sensitivity analysis was then performed to identify the 
key factors influencing the process throughput. Sensitivity scenarios were then 
carried out to examine the effects of higher titres on the process throughput and to 
determine the strategies which could be adopted to deal with any bottlenecks 
identified. These scenarios also serve as a demonstration of the capabilities of the 
model in answering biopharmaceutical manufacturing capacity management 
questions and therefore, also demonstrate the effectiveness of the standard 
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framework in constructing models with such capabilities. The following will 
describe the stages of model construct and the setup and results of all the analyses. 
5.3 Method 
5.3.1 Model Development 
The following sections describe the construction of the mAb model using the 
Standard Framework Version 2, with the main stages: Problem Structuring I, 
Problem Structuring II, Design and Construct. 
5.3.1.1 Problem Structuring I - Scope 
The first part of the problem structuring phase is where the project scope is defined 
and the model is characterised. In the mAb case study, two levels of questions and 
requirements were identified under the project scope, at the facility level and at the 
process level. These are listed in Table 5.1. Table 5.2 gives the required model 
outputs. 
The scope of the case study combines and expands on the scope of the two existing 
models. Although these models were originally built based on different scopes, they 
converged to capture similar elements. However they failed to meet key 
requirements identified in the Standard Framework, namely, ‘intuitive to the user’ 
and ‘reusability and sustainability’ thus making them difficult to navigate and 
extend.  Hence the need for a new model, built with the aid of the standard 
framework which could meet these requirements while addressing the new extended 
model scope.  
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Table 5.1  Scope given for mAb model 
Category Question 
Scheduling - Single product campaigning based on scheduled preventative 
maintenance shutdowns 
- Trigger points for buffer and media makeup 
- Downstream split/combine ratios 
- Implications of cell culture contamination on the schedule 
- Understanding of the material holding times 
- Implications of staggered formation of 5000L fermenters  
Resources - Equipment sizing 
- Utilisation of various resources (equipment, utilities, buffers) 
- Required WFI generation rate 
- CIP skids utilisation and utilities requirement of CIP and SIP 
- Variability in resource/utility requirements 
- Volume of media required for each growth step 
- Labour usage and number needed 
Debottlenecking - Location of bottlenecks 
Future 
capabilities 
- Multi-product campaigning based on constraints and influencing 
factors such as different turnaround procedures 
- Implications of different trigger points for new campaigns in 
multi-product campaigning 
 
 
Table 5.2  Required outputs of mAb model 
Category Outputs  
Throughput indicators - Batch throughput 
- Base grams throughput 
- Completion cycle times 
Resource Utilisation - Minimum number of labour required to run 
process 
- Utilities utilisation profiles 
- Sizes and number of equipment  
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5.3.1.2 Problem Structuring I – Model Characterisation 
There are two parts to the characterisation of the model. The first considers the type 
of system and the second defines the modelling platform. Firstly, the system being 
looked at is a production process for monoclonal antibodies therefore it is quite 
clearly a manufacturing system. Secondly, in order to determine the modelling 
platform it is necessary to summarise the scope according to the criteria for platform 
selection. Table 5.3 shows this summary. 
 
Table 5.3  Summary of new mAb model scope 
Feature mAb 
Single or multiple activities Multiple 
Continuous or discrete? Discrete 
Static or Dynamic? Dynamic 
Stochastic? Yes 
Mass balancing? Yes  basic 
System elements Entities, Activities, Resources  
Metrics Overall CT, Throughput (batch, base grams) 
Constraints?  Yes 
 
Table 5.4 compares the four major types of the simulation tool, against the 
requirements of the mAb case study as defined under the project scope. The 
comparison has been carried out using a scoring system where relevant, representing 
the extent to which each platform is able to model each requirement.  
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Table 5.4 Showing the different types of modelling platforms and their modelling capabilities in terms of model scope requirements. 
Scores given out of 5, 0=not at all, 5=fully meets requirement 
 Spreadsheets 
(Excel) 
Mass Balancing 
(Batch Plus) 
Discrete Event 
(Extend) 
Equation Oriented 
(MathCAD) 
Single or Multiple 
Activities 
Single 
(too complex at multiple) 
Multiple Multiple Single 
Continuous or 
Discrete 
-  Discrete capabilities (see 
below) 
Discrete with continuous 
capabilities 
- 
Static or Dynamic? Static Static (Aspen Plus Dynamics 
can extend static models into 
dynamic) 
Dynamic Static 
Stochastic capability? 3 4 5 3 
Mass balancing? 4 - statically 5 3- basic 4 - statically 
System Elements 3 - Not dynamically 4 5 2 - Not dynamically 
Metrics 0 - Outputs required are based 
on dynamic calculations 
3 - Better for platform defined 
metrics e.g. biochemistry 
5 
 
0 - Outputs required are 
based on dynamic calcs 
Constraints 1 3 5 1 
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Since the mAb case is a discrete event one, this immediately eliminates spreadsheets 
and engineering/mathematical platforms. This leaves mass balancing and discrete 
event tools. The scope requires basic mass balancing which would make both Batch 
Plus and Extend viable candidates. However the mass balancing is only basic and 
more emphasis is placed on user defined metrics and the capturing of all system 
elements and constraints.  Therefore it is believed that Extend would be more 
suitable as it meets all of the requirements.  
In conclusion the model can be characterised as a Manufacturing Extend model. 
5.3.1.3 Problem Structuring II 
The second part of problem structuring builds a non-coded description of the 
process. This means that text, diagrams and spreadsheets are used to create a 
comprehensive picture of the process using only process (and not model) 
terminology. Problem structuring is largely platform independent and uses the 
predefined list of questions from the standards framework as a basis. This stage of 
the construction process was particularly emphasised in the mAb case study in order 
to understand and validate the process and data before actually building the model. 
This greatly helped to avoid a rebuild. Figure 5.1 shows a flowsheet diagram of the 
mAb process followed by Table 5.4 which shows the general system parameters 
identified as important to the running of the model. It is important to emphasise the 
importance of this table as it forms the basis of all calculations carried out within the 
input database and provides a global reference for scenario selection within the 
model.  
It must be noted that this table does not show all of the data required for the running 
of the model, only the important parameters used for global referencing. Each 
process step has its own data table detailing its specific resource and CIP 
requirements, sub tasks and cycle tines.  
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Figure 5.1Flowsheet diagram of mAb process comprising fermentation train, recovery and chromatography based purification operations. Key 
media, buffer and utilities resources are also shown. An indication of suites for each operation is illustrated. 
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Table 5.4  General parameters used as inputs to mAb model 
Parameter Description  
Number of operators available Number  available per shift defined under Scheduling 2 
TPrep for Media Window in which to prepare media before it is needed (hrs) 96 
Cycles Col-CAPTURE Number of cycles after which column needs repacking 80 
Cycles Col-AEX Number of cycles after which column needs repacking 80 
Cycles Col-CHT Number of cycles after which column needs repacking 80 
Recovery Yield Calculated during initiation 90% 
Purification Yield Calculated during initiation 75% 
SD/Turnaround window Time between current Turnaround requirement and next scheduled Shutdown where 
synchronisation is allowed (months) 
0.5 
Split Ratio Calculation Method Based on titre, not limited = 1, Based on titre, limited = 2, Based on user input = 3 2 
Rolling shutdown Rolling shutdown = 1, Synchronised shutdown = 2 2 
Height Calculation Fixed = 1, Based on Titre = 2 1 
Titre entry Fixed = 1, Random based on triangular distribution = 2 1 
Cycle Limit Cycle limit or split ratio limit for CAPTURE column 8 
Split Occurrence  Equipment ID before which split occurs 13 
Combine Occurrence  Equipment ID before which batch combine occurs 17 
Shift Duration per 24 hrs Hours during the day that are covered by shifts 18 
Number of Bellco 1 
Number of 5K Bioreactors Enter 1-4 3 
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5.3.1.4 Design 
The design of the model was very much in adherence to the guidelines laid out in 
Standards Version 1. That is, with the IDEF0 defined left-to-right flow structure, the 
functional decomposition of the main block constructs whereby blocks represent 
activities (rather than equipment) and the use of templates where possible. This has 
resulted in main block constructs which all look very similar, apart from small 
variations due to the nature of the activity. For example, chromatography columns 
have cycles whereas fermenters do not. These cycles are represented by the splitting 
of the process stream into the equivalent number of cycles in order to process the 
batch. This feature is explained in further detail in the next section. The majority of 
the template blocks have been constructed so that they may be extracted and used for 
any process with similar attributes such as cycle times and equipment. These 
templates and their role in the standard guidelines is discussed in greater detail in 
Chapter 3.   
Table 5.5 gives a more comprehensive mapping of the system and model elements. 
The detail behind the model design, for example the block constructs, the templates 
used and the features captured in discussed in the next section.  
5.3.1.5 Construct 
The construct phase is very much linked to the design phase and in fact the two occur 
simultaneously, with the design of the model guiding its construct. During this phase 
of the mAb case study, the templates were placed in their appropriate positions and 
tailored to various degrees in order to truly represent the process elements as in the 
case of the cycles within the chromatography blocks. During the construct phase it 
was a key aim to reduce the visibility of Extend blocks. In other words, the first four 
hierarchical levels down would only show hierarchical blocks, rather than actual 
Extend blocks, representing either logic or process elements, thus helping user 
intuitiveness, should the user ever need to access the actual model.  
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Table 5.5  List of the system and model elements for the new mAb model 
  Element Mapping 
Activities  Process steps USP & DSP 
 Buffer/Media makeup 
 Pre, Run, Post  
Entities  Batches / Multi-product 
Resources Labour 
  Equipment 
  Ancillary: CIP, Utilities 
System 
Elements 
   Rooms 
Physical Layout Functional decomposition 
Logical Layout Process flow 
Parallel Activities Combined functions 
Main Block Construct Process steps 
Item Transfer Blocks and arrows  
Layout 
Item Flow Control Gating 
As fast as process is capable.  Initiation Items Generated / Primary 
Item Not scheduled 
Mass balancing 
All Resource Utilisation 
Hold times 
Failures –stochastic 
Load Volumes  
Equipment sizing  
Metrics 
Split ratios 
Clean of previous tank 
Prep of next tank 
Look ahead 
Buffer / media makeup 
Model Logic 
Shifts Different shift patterns  
Data transfer To Excel via Extend database 
Database Template based Data 
Tracking Global arrays and database 
 
Layout 
Functional Decomposition was used and therefore the hierarchical blocks represented 
the activities in the real system. The top level of the model looked like that in Figure 
5.2 with all ‘storage’ blocks (blocks containing externalised elements, global arrays 
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and resource pools) positioned at the very top of the workspace. Figure 5.3 shows the 
next hierarchical level and the main activity blocks. 
 
Figure 5.2 Top most hierarchical level of mAb model 
 
 
Figure 5.3 Second hierarchical level showing main activity blocks 
 
Main Block Constructs 
Inoc, CIC and MCC 
With the exception of Inoculum growth, all of the fermenter blocks were identical in 
structure with five pre-run sub- activities before the actual run. The selection of the 
5000L vessel occurred before the professing of the 1000L fermenter within the 
1000L main activity block and was based on the availability of the each of the 5K 
fermenters. Based on selection, that fermenter’s preparation was triggered using the 
standard Look Ahead block, placed here rather than in the Initiation block due to the 
fact that it was not known which 5k fermenter would be used until this point.  
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Recovery 
As the preparation of the diafiltration system was carried out along with the 
preparation of the centrifuge the preparatory sub-activities were only present within 
the Centrifugation activity block. Furthermore, unlike the other main activities, the 
diafilter went through CIP before its last sub-activity which was the removal of the 
filters. 
 
Purification 
The three chromatography columns, Capture, AeX and CHT, were very similar in 
structure and had the same cycle feature. Each column also had a repack check block 
which checked if repack was required based on whether it had exceeded the 
maximum number of cycles allowed or whether there would be a product 
changeover. If repack was required the equipment was sent to the Repack block 
which is described below. 
 
Repack 
Repack of a column was an activity which occurred externally under the Purification 
hierarchical block. When the repack check determined that a column required 
repacking it was thrown to this block and once the column had been repacked, it was 
sent back to its own hierarchical block where the repack time was reset. 
 
Buffer/Utility Blocks 
Buffer Makeup 
There were 3 buffer makeup vessels of different size, 1000L, 5000L and 15000L. 
The makeup activities in each were identical, they were simply chosen based on 
volume of buffer to be made up and the availability of the vessel. The logic used to 
select also ensured that of the possible vessels available and able to make up the 
volume, the smaller of the two was always selected unless not available.  
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Figure 5.4 Buffer makeup hierarchical block showing the receiving of the trigger item, determination of the buffer sets, creation of buffer 
lots, allocation of makeup tank based on volume and buffer makeup before storage in totes prior to routing to process.
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Upon opening the Buffer hierarchical block (Figure 5.3) there were several sections 
immediately visible. The first, at the top of the page, created buffer sets where the 
number of sets equalled the split ratio or the number of cycles through each column. 
The next section was where buffer lots were created based on the fact that each cycle 
through a column required a buffer set made up of buffer lots so that 
 
buffer set = ∑ [buffer lots]                                       (5.1) 
 
Each buffer lot had a different volume depending on the product and the column (the 
volume which determined the choice of makeup vessel). The different volumes could 
be found in the database and were variable.  
So, for example, for the product being modelled in this particular case, the capture 
column required 8 buffer lots for every cycle. If the split ratio was 6 then there were 
six cycles through the column. Multiplying the numbers gave the total number of 
buffer lots for that batch i.e. 54. The ‘Route’ block then sent the buffer item to a 
vessel request block based on the volume and the vessels capable of handling that 
volume. Once the vessel had been pulled from the resource pool, two items were 
thrown to the buffer activity block; the first triggering preparation of the vessel, the 
second representing material processed. Once buffer was made up, it was held in 
disposable totes and then routed to the process main stream.  
 
Media Makeup 
There was only one makeup vessel for media, 4000L which was used to make up 
both 1000L and 4000L media volumes, made up in that order. When 1000L was 
made up it was stored in disposable totes to free up the tank for the next volume. 
When 4000L was made up it was held in the tank until required by a fermenter.  
 
Utilities 
Three utilities were modelled: (1) CSTM for SIP, (2) WFI Ambient for buffer 
makeup and (3) WFI Hot for CIP. The source supply had infinite capacity however 
the valve controlled the filling up of the holding tank, only allowing it to be filled 
when its contents dropped to 25%. The capacity of this tank was set in the database 
and was variable.  The diverge block then routed the flow to whichever area requests 
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that utility and therefore flow was determined by demand. This allowed for the 
required generation rate to be determined. 
 
Ancillary Activities Blocks 
There were two CIP skids: 
- Skid 1 used for Upstream and Recovery 
- Skid 2 used for Purification and Makeup 
 
Based on the allocation of the skids to the various process equipment and the CIP 
requirements, the CIP block had four main streams. The CIP requirements were as 
follows: 
- USP:  after each harvest there was a sequence: Rinse Only Æ SIP Æ CIP 
- Recovery: CIP only 
- Purification: CIP only 
- Makeup: the makeup tanks went through Rinse Only by default unless the CIP 
expiry was exceeded or the maximum number of rinse cycles had been exceeded 
(variable)   
All CIP/Rinse blocks were identical. Each block could be set to Rinse Only, CIP 
only or either of the two by entering a 1,2 or 0 respectively into the top left hand 
corner dialog box.  
 
Other Blocks 
Split/Combine 
The splitting or combining of batches and lots was a highly variable process as the 
number of splits and the location of both split and combine were user defined (the 
number of splits could also be set to calculate based on titre). This meant that all 
activities where they could occur must contain the appropriate blocks i.e. all 
downstream activities. The modelling method used comprised of a check which 
looked up the database split/combine table. This table gave both the ratio and the 
location given as activity ID. If the lookup logic recognised that for example a split 
was to occur, the batch was split into the correct number of cycles for processing. A 
similar procedure for combine occurred where the correct number of lots 
wererebatched. A particular challenge faced here was the combining of lots within a 
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batch where one or more lots had been discarded. In order to deal with this, a global 
array was set up to track the number of batches and lots being processed at any point 
in the process at any time. Thus if a discard occurred in an activity, the number of 
lots being processed there and in all downstream steps would be decremented by one. 
The activity where combine would then occur would be able to reference this array 
and know that a fewer number of lots than expected (according to the combine ratio) 
would have to be rebatched. 
 
Area Shutdown/Turnaround 
Turnaround occurs between product changeovers and this is therefore more relevant 
to multi-product scenarios. However as it is an important feature of the model’s 
capabilities, it is discussed here. The last main activity of each process area or room 
contained an Area Shutdown/Turnaround block. Shutdown is simply scheduled 
shutdown which was set to every 6 months although this was variable. These two 
activities were entirely separate but could occur together if scheduled that way; 
within the initial Route block several blocks could be found which decided this. 
Firstly the equation block decided if turnaround was required based on whether there 
was going to be a product changeover. The second equation block then made the 
following decision. 
- If turnaround was required 
If the next scheduled shutdown was due within the next 2 weeks (variable), 
then shutdown was moved forward to coincide with turnaround 
- If turnaround was not required 
Shutdown would occur now only if the scheduled period of 6 months had 
been reached  
 
Once the decision had been made, whether shutdown, turnaround or both, the item 
was routed to the Shutdown/Turnaround block where the associated activities would 
take place. Note that shutdown of an area could be synchronised with other areas in 
which case it would not occur until all rooms were ready for shutdown. This was 
achieved by placing gates ahead of the shutdown area, all referencing a global array 
where the activity status of the rooms was stored. Once all rooms to be shutdown had 
been marked with ‘ready’, the procedure would go ahead by opening the gate for the 
item to enter.  
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Once the process area had gone through the necessary shutdown/turnaround 
activities the room and equipment were freed up for the next batch. 
 
Equipment Failure 
Each equipment within the main process stream had a run sub-activity which models 
variable equipment failure. The probability of failure and the subsequence 
probability of forward processing (whether the batch/lot was discarded or not) were 
set in the database table and referenced here. If a discard did occur, then the global 
array tracking the batch/lot throughput would decrement the appropriate array 
address (based on activity) by one. Figure 5.5 shows a representation of the 
modelling methods used.  
 
 
Figure 5.5  Representation of modelling sequence in failure block 
 
Mass Balance 
Every main activity block in the process chain contained a Mass Balance block. 
These blocks calculated the kg throughput of each batch based on the step yield and 
also the stability of the product, affected by how long the product had been made to 
wait before moving on to the next step. The Mass Balance block within the Capture 
column differed from the rest in that it offered the choice of calculating throughput 
according to stability or number of cycles based on a linear equation, a feature 
implemented as a ‘nice to have’ following discussions with the client. Furthermore 
any lot discards were accounted for here by calculating the mass equivalent of the 
lost lot or lots within the batch. 
 
Labour Request Process 
This block could be found within the Resource Pools storage block and externally 
processed every labour request made within the model.  As a labour request item 
entered, it waited for the required number of labour. Once it picked up the labour it 
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then went to the activity block which simulated the labour hours associated with the 
Sub-activity which made the request.  
A challenge posed here was that for the fermentation activities labour was not 
required for the duration of the fermentation period. Instead the required labour had 
to be pulled every 24 hours and held for the correct labour hours. This was modelled 
by using the unbatch block to create the number of labour items which was equal to 
the number of days. The pulse block then opened the gate every 24 hours to allow 
one through to process a labour request. 
Note that for the 5000L this was taken a step further as different numbers of 
operators were required each day.  
 
Model Parameters 
All model parameters such as cycle times, flow rates, titre, campaign schedule, shift 
duration, and column dimensions were entered into the external reference file called 
MAb Input Data.xlsm. This was an Excel file which upon initialisation of the model, 
was accessed by Extend and used to populate the relevant database tables, in the 
internal database. The model was set to run for a time horizon of 365 days based on 
100% plant efficiency. Any shutdowns were modelled as part of this time. 
 
Primary Items Generated 
The main items generated in the model were batches. The required number was 
generated all at once according to the user defined product demand and their path 
through the model was scheduled by the gating system and the Look-Ahead logic. 
Firstly, the Create block was linked to the Production Schedule database table which 
defined the campaigns generated and the product identity for each campaign. Note 
that only one item was generated per campaign at this point. The number of batches 
required per campaign was calculated in Excel according to the demand (kg) and the 
variable titre using the following equation: 
 
Num of Batches = Demand (kg) 
 
(Titre x Fermenter Volume x Purification Yield)/1000 
(5.2) 
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The result of this equation was then used to generate the required number of batches 
for that campaign using the Unbatch block.  
The BatchNum attribute was then set along with the flagging attributes for the last 
and first batches of each campaign (although more relevant when modelling multiple 
campaigns). 
 
Batching and Scheduling 
Although a Production Schedule table was used, this only defined the campaign sizes 
and their start dates and not the exact sequencing of batches. Therefore the model 
was not based on a production schedule; rather batches were generated to run as fast 
as possible through the process and their flow self regulated by the rules and 
constraints modelled mainly via the gating system. The work schedule was based on 
a 7 day week with 24 hour operation starting Monday 9am. 
 
Metrics 
‐ Cycle Times: Although cycle times of individual activities were set in the 
database, the actual times varied due to various delays. A simple Timer block 
was used to record the time at various points in the model. These times were 
stored under the appropriate attributes e.g. ‘BatchStartTime’ and later sent to 
Excel where a Gantt chart was automatically generated.  
‐ Throughput: This was the number of batches within each campaign which were 
processed and the equivalent base kilograms. This latter value took into account 
any kg losses due to batch/lot discard.  
‐ Base Grams: This was the kg throughput for each batch. Calculations were 
carried out at the end of each step and based on the step yield and product 
stability in storage, the output was determined and stored under the Base_Grams 
attribute. In the END block, the total kg throughput for the campaign was 
determined and sent to Excel where it could be compared to the initially 
calculated required throughput in order to determine the % processed metric, 
which will be discussed further in Section 5.4.2.4. 
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Lookahead 
Lookahead was a particularly challenging feature as it meant creating a modelling 
method to decide when to trigger activities based on events which hadn’t happened 
yet and whose occurrence was based on the self-scheduling of the model. The 
approach adopted was to create Look Ahead blocks which were placed in the 
initiation section of the model.  which were largely identical and were differentiated 
between by entering the ActivityID of the activity which they triggered preparation 
of. A table was also created and placed in the database which calculated the 
cumulative run time of all sequential activities and the preparation time of each based 
on their pre-run sub-activities. Each block automatically accessed these cycle times 
to determine the time at which an equipment needed to be prepared in time for the 
next batch.  This time was calculated as a delay which was then used in the Activity 
block to delay the item before it went on to send a Trigger Item to the appropriate 
activity equipment hold in the main activity block ahead of all the preparatory sub-
activities. Essentially, what this did was to prevent the equipment item from going 
ahead and performing the pre-run activities before it was needed by having to wait 
for the trigger item to batch with it. The equation used to calculate the delay time for 
this trigger delay was as follows: 
 
TriggerDelay = CumRunCT – PrepCT                                (5.3) 
 
Where 
CumRunCT = Cumulative Run Cycle Times for all Preceding Activities 
PrepCT = Preparation Cycle Time for that activity 
 
Data Transfer 
Data generated by the model was transferred to Excel using the Data Import/Export 
blocks.  
 
Database 
All data was entered into the built in database within Extend by the appropriate data 
access blocks which populate it using the external MAb Data Input.xlsm file.   
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5.3.2 Key Base Assumptions in Case Study 
The following are the key base assumptions built into the model.  
• The facility adopted a platform process approach and hence the process 
sequence was fixed for all products entering the facility.  
• The base case titre was 1.5g/L, chosen as it represents a typical but relatively 
low mAb production titre  
• The number of available 5000L production fermenters was limited to four. 
This was based on a facility with the capacity to currently house three of 
these fermenters with the possibility for expansion to accommodate the 
fourth.  
• Any failure modelled was based on the assignment of the failure rate to all 
main non-disposable process equipment. Although the base case assumed a 
failure rate of zero due to the random nature of the parameter, any specific 
studies assumed a base case value of 4% based on discussions with the 
process team. 
• The calculation of the split ratio (the number of cycles through the 
chromatography units) was based on the upper range of the titre fluctuation 
i.e. +20%, assumed and accounted for when specifying the operating strategy 
of DSP operations (personal communication, Guillermo Miroquesada, Eli 
Lilly, Indianapolis). 
• Split would occur prior to the Capture step and combine would occur prior to 
the CHT step (final chromatography step) due to volume capacities 
• The base case split ratio limit was 8 meaning that no greater than 8 cycles 
would be passed through the chromatography units per batch.  
• Cycle 1 from the Capture step would move straight on to the next 
chromatography step while cycle 2 was being processed in the Capture 
column. 
• Holding times were not limited as storage availability was an issue being 
reviewed under the scope.  
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5.4 Results and Discussion 
5.4.1 Sensitivity analysis 
5.4.1.1 Setting up the deterministic case 
Having constructed the model with certain key base assumptions, described under 
section 5.3.2., it was decided that these would form the base case scenario against 
which the sensitivity can be measured. It was also decided that the analysis would be 
performed at three different titres 1.5g/L, 4.5g/L and 10g/L. The reason for this being 
that 4.5g/L represents a value that current processes are achieving (Aldridge, 2009) 
and 10g/L serves to test the sensitivity of the system to products in the future, thus 
giving a more longer term impact of system variability.  
Ultimately, a sensitivity analysis is used to test the robustness of a system to 
variability. As such, it is important to know which parameters to test, in order to gain 
a true understanding of their impact. For the mAb process one of the key variable of 
interest was the split ratio, that is, the number of cycle per batch through the 
chromatography columns. The reason for this is that the split ratio or the number of 
cycles is based on the following equation: 
 
       Split Ratio = (Titre x Production Fermenter Volume x Recovery Yield)       (5.4)  
  (DBC of Capture Column x Capture Column Volume) 
 
where DBC = dynamic binding capacity. As the titre increases the number of cycles 
or the split ratio must also increase if the column parameters remain constant. 
However if that ratio is limited, in this case to a maximum of eight, then the capacity 
of the column becomes limiting with the percentage of product binding with every 
column volume decreasing as the titre increases i.e. with increase in titre, a greater 
percentage of product cannot bind and flows through. This affects the overall process 
throughput.  
According to Equation 5.4, there are further parameters which could also show 
impact on the % processed value: yield, column dynamic binding capacity and 
column volume which is determined by height and diameter. Also, the resin lifetime 
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should also be investigated as it is affected by the number of cycles through a 
column. If the lifetime is varied then the number of repacks also varies, thus 
affecting the process cycle time and possibly having visible impact on the % 
processed due to time availability.  
Further to this the failure rate or the contamination rate must not be ignored. The 
base case scenario assumes that there is no failure within the process however this is 
actually inaccurate. A certain percentage of failure is present in any new process and 
therefore must be captured. It can be assumed that the failure rate of a new facility 
will be in the order of around 4% for each equipment with a corresponding 
probability of material discard or forward process (material not discarded). Setting 
the probability of failure to greater than zero means that as the batches(or lots) enter 
the Run subactivity of each activity, that block will process a failure based on the 
probability. These blocks have been specifically designed to deal with failure and are 
called ‘Subactivity w/Failure’ blocks which means that the failure rate is always 
present. Entering a zero simply switches it off and therefore the control for this 
parameter is within the Excel input file.  
In order to run the sensitivity analysis a number of assumptions were made, as listed 
below. The input parameter values used can be found in Table 5.6. 
 
- Single product/campaign 
- Batch demand set to 55 
- Column parameters only of Capture/Protein A 
- Split ratio limit of 8 
- Fixed downstream batch split/combine locations 
- Failure rate of zero unless being tested 
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Table 5.6  Summary conditions set for sensitivity analysis for all titres 
Parameter Base Value Change 
Titre   1.5g/L, 4.5g/L or 10g/L ±20% 
Resin Lifetime  80 cycles ±20% 
Yield  Equipment dependent ±5% 
Capture DBC  20g/L ±50% 
Failure Rate  4% ±50% 
Column Height  25cm ±8% 
Column Diameter  60cm ±20 
Split Ratio Limit  8 ±20% 
 
As stated earlier, the model was already set up to deal with any probability of failure 
or failure rate. Similarly, the other parameters could easily be changed by different 
inputs in the Excel input file. For example, if the resin lifetime was changed from 80 
to 90 cycles, the ‘Repack Check’ block would read this value and send the column to 
be repacked every 90 cycles instead. Similarly the yield input would be automatically 
read by the ‘Mass Balancing’ block and accounted for in the calculations. Column 
dimensions, DBC and the split ratio limit were used for the calculation of the 
split/combine ratios which occurred within the Excel input file. The model would not 
be aware of any changes to these parameters other than the number of cycles through 
the columns which may have differed. Similarly, titre was used for the calculation of 
the split ratio and also to determine the number of batches required to meet a kg 
demand. Within the model the number of batches created for each campaign would 
be based on this titre, however again, the calculations would have all been carried out 
in the Excel input file.   
5.4.1.2 Deterministic analysis results 
Using the parameters stated under Table 5.6, the model was run deterministically and 
the kg throughput of each run was recorded. Using the base case (0% variability for 
all parameters) the impact of each parameter change could then be recorded as a % 
change in kg throughput against the base i.e. against 0%. Figure 5.6 shows the results 
of the analysis for all three titres using Tornado diagrams.  
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Figure 5.6a shows that at the lowest titre the biggest impacts are due to the step 
yields, failure rate and titre. The column height, split ratio limit and resin lifetime, 
have no impact and the column diameter and DBC only have negative impact. This is 
due to the fact that at low titres, the number of splits or cycles required through the 
Protein A column is 6 and therefore well below the limit. Increasing the column 
dimensions or the split ratio limit will not make a difference to the amount of product 
able to bind as it is already maximised. Likewise, decreasing the split ratio limit by 
20% sets it to 6 and therefore still allows for the required cycles. Decreasing the 
column diameter and DBC however raises the required cycles to 10 and 12 
respectively thus resulting in a decrease in the amount of product actually binding. 
The overall kg throughput is therefore reduced. 
Conversely, at the higher titre of 4.5 g/L, the base split ratio limit is exceeded with 18 
cycles required to process all of the product. Therefore the changes in yield and titre 
become less and less significant and the factors affecting the column capacity begin 
to dominate i.e. DBC, Diameter, and Split ratio limit as illustrated in Figure 5.6b. 
A similar trend can be seen in Figure 5.6c  at the 10g/L titre. This suggests the 
existence of a downstream bottleneck at higher titres, most likely the capacity of the 
capture column. It must be noted that the resin lifetime does not have an impact on 
kg throughput at any of the titres. This is due to the fact that the number of cycles is 
limited to 8 regardless of split ratio requirements. The maximum number of cycles 
that the capture column performs is therefore never greater than eight times the 
number of batches. If the split ratio limit were removed this parameter would have 
far greater impact as repack would be needed more often. 
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Figure 5.6 Tornado diagrams showing the sensitivity of the kg throughput to 
keyinput variables at difference titres: for (a) 1.5 g/L, (b) 4.5g/L, (c) 10g/L 
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5.4.2 Scenarios Analysis 
As a result of the sensitivity analysis a methodology has been formulated for 
scenarios analysis, looking at different possible strategies to deal with the identified 
downstream bottleneck. Figure 5.7 is a flowchart illustrating this methodology. 
5.4.2.1 Scenario 1 analysis setup 
The deterministic analysis showed that the process is sensitive to the capture column 
parameters, particularly as the titre increases. Since the capacity of the downstream 
columns, in particular the capture column, is the limiting factor, then changes in 
column parameters should be considered as a strategy for debottlenecking. Scenario 
1 therefore asks the following question: 
Given fluctuations in current and future titres, what strategy should be adopted in 
order to minimise resin costs while maximising % process throughput (kg) and 
achieving a reasonable split ratio. The strategies are as follows: 
a) Buy a new capture  column (diameter change) 
b) Buy a new Protein A resin (DBC) 
c) Increase capture column height (height change) 
d) Improve process efficiency (failure rate) 
e) A combination of the above 
 
These strategies were chosen as the options because the parameters corresponding to 
them were found during the deterministic analysis to be highly impacting on the 
process throughout. 
 
Table 5.7 Summary of input parameter values for scenario1 
Titre (g/L) DBC (g/L) Diameter (cm) Height (cm) 
1.5 ±20% 20 60 25 
4.5 ±20% 30 70 27 
10 ±20% 50 80  
  90  
  100  
  
166 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 Flowchart showing methodology for scenarios analysis 
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Titre:The manufacturing company have stipulated that their process has been 
validated for ±20% fluctuations in titre. It is therefore assumed that this is the general 
trend which they have observed and can be used here for each of the main titre inputs 
as a typical trend.  
DBC: Taking the GE Healthcare ProteinA resin MAbSelect as an example of a 
typical resin used, it can be assumed that there is a range of dynamic binding 
capacity achievable  between 20-30g product/L. The model uses a DBC value of 20g 
product/L a value typical for current ProteinA resins and the lower DBC achieved 
with MAbSelect. The upper range of 30g/L is set as a value achievable without any 
changes to the resin. Furthermore, any split ratios determined for this resin take the 
upper range value for their calculation, a technique adopted to maximise load 
efficiency. There is also a newer GE resin called MAbSelectXtra which has a 
binding capacity of 50g /L. 
Height: The recommended mobile phase velocity for the MAbSelect resin is 
500cm/hr however most common velocities are stated to be around 300cm/hr for 
most resins (and therefore the assumed base case value). Although the higher the 
height, the lower the velocity (and higher the residence time), it is assumed that a 
2cm increase in height to 27cm is allowable within the operating range of the resin. 
Diameter: Any change in diameter from the base case will mean purchasing a new 
column. MAbSelect and MAbSelectXtra have available for them variable size 
columns which reach 120-150cm in diameter. 
There are thirty different combinations of parameters as shown in Table 5.8. Given 
the ±20% fluctuations there are 90 combinations for each titre value, giving a total of 
270 simulations run.  
 
Table 5.8 Different combinations of parameters used in scenario 1 
Combination Capture DBC Capture Diameter Capture Height 
1-30 20 60, 70, 80, 90, 100 25, 27 
31-60 30 60, 70, 80, 90, 100 25, 27 
61-90 50 60, 70, 80, 90, 100 25, 27 
Application of Standard Framework to a Biotechnology Capacity management Case II 
 
 
 
5.4.2.2 Scenario 1 analysis results 
For each combination the kg throughput has been recorded and given as a % 
processed based on the required to actual throughput ratio. This is plotted against the 
‘cost of repack’, the cost incurred every time a column is repacked with a particular 
resin. It must be noted that the initial purchase cost for the resin has not been taken 
into account due to the fact that these costs are used for comparison analyses and 
therefore only relative numbers are necessary. Figure 5.7 shows these plots.  
As figure 5.8a  shows, at the titre of 1.5g/L the number of cycles required to fully 
bind 100% of the product is 6, below the set maximum split ratio limit of 8. This 
means that the % processed at the base case is already above 100% (greater than 
100% is possible because the batch demand overcompensates for step losses). Any 
changes in column dimensions will have an effect on the cost of repack as the 
volume changes however the % processed will remain constant. Therefore optimal 
combination selection at this titre will not be based on meeting the split ratio limit or 
the greatest % processed achieved but any reductions in cost of repack.  
Figure 5.8b shows that as the titre increases to 4.5g/L it can be seen that the base case 
lies just below 50% processed. The reason for this is that 18 cycles are required to 
fully bind the product and therefore the split ratio limit of 8 is simply not sufficient. 
In fact, when compared to the previous graph for 1.5g/L a definite shift can be seen 
as fewer combinations result in 100% processed. Those which fail to meet this value, 
unsurprisingly, also exceed the split ratio limit in terms of split requirements. 
Figure 5.8cfor 10g/L shows a dramatic shift along the x axis with very few 
combinations actually resulting in 100% processed. This shift is expected; at this titre 
40 cycles are required for fully bound product. Only extreme process changes will 
compensate for this high cycle requirement such as a large increase in binding 
capacity and column diameter.  
From these graphs, combinations for all titres can be found which are deemed to be 
preliminary ‘optimal’ based on the following criteria: 
– Meeting the split ratio limit 
– Achieving greatest % process throughput 
– Greatest negative % change in cost of repack against the base case 
(taking only the top 10 percentile) 
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Figure 5.8  % Change in cost of repack against % processed for different 
combinations of Capture column DBC, diameter and height at (a) 1.5g/L, (b) 4.5g/L, 
(c) 10g/L titre. Where (▲) is the base case, (◊) is below split ratio limit and (x) is 
above split ratio limit. 
Application of Standard Framework to a Biotechnology Capacity management Case II 
 
 
 
These combinations are deemed ‘preliminary optimal’ because they do not take into 
account the investment costs which will be incurred if the process changes are made. 
It must be noted that these investment costs only account for the bare cost of 
purchasing a new column and not the cost of purchasing a new resin, nor the costs 
associated with personnel training or validation. Thus, taking these preliminary 
combinations the investments costs have been factored in, using a combination of the 
Cost of Repack and the amortized cost of investment to give an annual cost for each 
combination. Ordinarily amortization is applied to intangible assets such as patents 
and loans and depreciation is used for tangible assets such as equipment. However it 
is being assumed here that the columns have zero scrap value which is the only 
element differentiating depreciation and amortization. Thus the latter can be used. 
Furthermore, it is also being assumed that the equipment lifetime is 10 years, which 
is the estimated lifetime of a bio facility. 
Based on the annual costs which combine the cost of repack and the amortized cost 
of investment, the secondary optimal combinations can be found (these are in fact the 
final optimal combinations). Thus, looking at the combination with the lowest annual 
cost, the optimal combinations give the following strategic solutions for each titre. 
At 1.5g/L, 100% process throughput is achievable without any process changes. 
However, in order to save on cost of consumables (around 30% reduction in annual 
cost of resin), the following change can be made:  resin change from MAbSelect to 
MABSelectXtra to achieve the higher DBC of 50g product/L resin  and capture 
column diameter increased to 70cm (new column purchase) 
At 4.5g/L, process changes will have to be made in order to achieve 100% process 
throughput. These are: resin change from MAbSelect to MABSelectXtra to achieve 
the higher DBC of 50g product/L resin, capture column diameter increased to 80cm 
(new column purchase).  
At 10g/L, in order to achieve 100% process throughput, the process changes are: 
resin change from MAbSelect to MABSelectXtra to achieve the higher DBC of 50g 
product/L resin and capture column diameter increased to 100cm (new column 
purchase) 
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Figure 5.9 Annual cost for preliminary optimal combinations factoring in amortized 
cost of investment based on equipment lifetime of 10 years and cost of repack found 
at (a) 1.5g/L (b) 4.5g/L (c) 10g/L 
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5.4.2.3 Failure Rate 
The deterministic analysis found that the failure rate is a significant parameter in the 
mAb process and that a variation of only a few percent has a large impact on the 
process throughput.  
Since failure rate is based on probability it was not included in the combinations 
analysis, simply because the failure would differ with each run. The stochastic nature 
of the parameter calls for a stochastic analysis, in this case Monte Carlo simulations, 
in order to obtain a figure for process throughput with a great enough convergence to 
deem it accurate. Using four different failure rates: 1%, 2%, 3% and 4% the Monte 
Carlo simulations were run with a demand of 50 batches. The number of batches 
processed were recorded with the following results as shown in Figure 5.10. 
 
 
 
 
Figure 5.10 Distributions for % batches failed for  (a) 1% (b) 2% (c) 3% (d) 4% 
failure rates 
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According to the highest peaks the % of batches failed out of the possible 50 is 6%. 
8%, 16% and 18% for the different failure rates respectively. These figures however 
need validating and this was done by doing simple statistical calculations.  
Taking a simple statistical approach, the probability of failure here can be calculated 
by taking the unit operations in series which are affected by failure rate and 
multiplying their corresponding probabilities of failure to get the overall impact. In 
order to ascertain the number of batches out of the possible 50 which are successfully 
processed, it is necessary to consider the probability of success rather than failure, 
where P(Success) is the probability of success. For example, for a failure rate of 1%, 
the probability of success is 99% (100%-1%). Since there are four units in series 
which a batch must successfully pass through, the probability of success is powered 
to the number 4. This gives a figure of 0.96 or 96% success rate. Multiplied by a 
possible 50 batches, this gives a 48 batch throughput. As shown below, the same 
calculation can be applied to the different failure (or success rates) to determine the 
expected batch throughput. 
 
 
P(success) for a batch = P(success)1 x P(success)2 x P(success)3 x P(success)4 
          
1% Failure Rate: P(success) = 0.99^4 = 48 Batches or 2 fail (4%) 96% 
2% Failure Rate: P(success) = 0.98^4 = 46 Batches or 3 fail (8%) 92% 
3% Failure Rate: P(success) = 0.97^4 = 44 Batches or 6 fail (11%) 89% 
4% Failure Rate: P(success) = 0.96^4 = 42 Batches or 8 fail (15%) 85%  
 
The calculated figures are a few % lower than those obtained through the Monte 
Carlo analysis. This discrepancy however is expected due to the fact that if 5 out of 
50 batches fail, this does not mean that remaining 45 will be processed. Each failure 
has a TTR or Time to Repair associated with it which reduces the overall time 
available to process the batches. This consequently drives up the % of batches failed 
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because it also accounts for the batches that did not have time to get through but did 
not actually fail. But as the calculated values don't take this into account, the % failed 
is lower. 
As the figures are only a few percent different, the results of the Monte Carlo 
analysis can be used, taking the % batches failed to adjust the outputs from the 
combination analysis. Taking only those combinations deemed optimal at the 
preliminary stage the % processed has been plotted for all four failure rates by 
adjusting the kg throughput (assuming that % failure of batches can also be applied 
to kg throughput). Figure 5.11 shows the plot for 1.5g/L.  
 
Figure 5.11 Adjusted % process throughput, for different failure rates, for 
combinations with high relative % decrease in repack costs for 1.5g/L. Arrow 
illustrates failure rate target to achieve 95% process throughput 
 
Although not shown, the plots for the 4.5g/L and 10g/L titres showed identical 
trends. Assuming that it is desirable to achieve a minimum of 95% processed, the 
plot shows that the failure rate must be below 3% for all titres.  
5.4.2.4 Scenario 2 analysis setup 
In order to understand the extent to which the downstream bottleneck is linked to the 
split ratio limit a quick analysis has been performed which measures the amount of 
product processed at each of the titres, relative to the amount of product which 
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should have been processed. If it is assumed that the facility is used to full capacity 
and therefore the number of batches required remains constant, then a certain kg 
demand/required is set based on titre, production fermenter volume and process 
yield. This means that if a percentage of product fails to bind, the overall process 
throughput drops as a percentage of the kg demand. Thus, the percentage actually 
processed can be determined using the following ratio: 
 
% Processed =Kg Throughput                                         (5.4) 
Kg Required 
 
Plotting the % processed and the split ratio required against the different titres, 
Figure 5.12 shows the % processed decreases dramatically with each titre. This is 
explained by the solid line representing the required split ratio which far exceeds the 
split ratio limit as titre increases. With constant column dimensions the capacity of 
the column to bind the product remains the same while demand for binding capacity 
increases. A large amount of product therefore simply flows through. 
 
 
Figure 5.12 Split Ratio required and % processed for each titre assuming constant 
batch demand and removal of the split ratio limit of 8. 
 
Split Ratio Limit (8) 
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This suggests that if the split ratio limit is increased, the % processed should also 
increase. In order to examine this theory, the process will be run for the three 
different titres, with different split ratio limits ranging from 10 to 18. 
5.4.2.5 Scenario 2 analysis results 
Figure 5.13 shows the % processed for the three different titres, with the different 
lines corresponding to different imposed split ratio limits. 
 
Figure 5.13 % Processed with different split ratio limits for different titres, assuming 
constant batch demand. Where (       ) is split ratio limit of 8, (       ) is split ratio limit 
of 10, (      ) is split ratio limit of 12, (       ) is split ratio limit of 14, (       ) is split 
ratio limit of 16 and, (       ) is split ratio limit of 18. 
 
As the number of cycles allowed increases, the % processed increases also. When the 
limit equals the required split, % processed jumps to 100%. At 4.5g/L, this is 18. At 
10g/L this would be 40.  
Therefore, an alternative to adopting the strategy proposed in Scenario1 is to increase 
the split ratio limit. However it is not really feasible at higher titres due to the sheer 
number of cycles required. 
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5.4.3 Evaluation of use of the Standard Framework in Construction 
of mAb 
The mAb model was based on two previous models built during the design stages of 
the process. The functionality of the new model compliments the new scope which 
has various overlaps with the scopes of the original models. In order to understand 
and evaluate the value of using the Standards Version 2 framework to construct the 
mAb model a qualitative analysis must take place. In an ideal world, a quantitative 
analysis would also be performed however it is exceedingly difficult to quantify the 
comparison between the process of two construction methods. What can be offered is 
the feedback from the end users and the validation outcomes of data/trend 
verification, using the requirement specifications as a guide. 
 
Intuitive to user 
Under Chapter 3 it was discussed that in order for a model to be intuitive to the user, 
certain guidelines can be followed, as given by Valentin and Verbraceck (2002). 
These are that the ‘Interactions between model parts...should represent interactions in 
the real system’, ‘Use concepts that represent functionalities as found in reality and 
that can be used for visualisation purposes’ and ‘Visualise a system in such a way 
that complexity is reduced but the essential processes are still shown’. The latter 
point simply ensures that the level of detail built into the model, both in terms of 
coding and blocks, is sufficient to meet the immediate scope and likely additions in 
the future (in order to maximise reusability)  but no more. This works on two levels; 
firstly, limiting the level of detail to the necessary amount limits the resulting model 
run time and secondly, the risk of confusing the user is minimised if they can 
associate the level of detail with the well defined model scope. The first two points 
ensure that the visual parts of the model represent the real system so that the user can 
easily associate model elements to the system elements. In the case of mAb the user 
does not see the actual model itself (unless structural changes are being made) and 
only the input/output Excel files are seen. These however, as stated under the next 
section, have been designed to maximise user intuitiveness.  
 
Relevance and Ease of Data Input/Output 
In order to enter data into the database, the original models used the SDI link offered 
by the Extend platform. This meant that: the database source within Excel had to 
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have the SDI structure, the Excel database would have to be manually exported and 
imported in order for any changes to be applied in the model and the Extend file 
would have to be accessed in order to achieve this. 
The new model however has been built such that the Extend file need never be seen 
by the end user unless they need to make structural changes to the model. The input 
file or the source database has a user-friendly structure which industrialists have 
indicated is  in the format that they are used to seeing. Using a macro the Extend 
model automatically imports the data it needs, runs and then outputs the results into a 
different Excel file where the data is already set up to be in a user friendly format, 
with Gantt charts and tables of data summarising the process output. This method of 
construction means that an end user can easily vary any input parameter (all 
parameters have been set to be variable) and needs not have any Extend experience.  
 
Maximised reusability and sustainability 
The inputs and outputs to the mAb model are quite extensive, covering 
labour/operating shifts, utilities usage, multiproduct changeover and mass balancing. 
The number of fermenters can also be changed by inputting the number desired, 
although greater than four 5k fermenters will require a structural change.  Currently 
the facility is set to be used for one product only however a number of monoclonal 
antibody products could be manufactured using the same platform process. The set 
up of the model accommodates for the introduction of these new products, but with a 
maximum of three different products produced in the facility during any one year or 
model time horizon. This limit reflects the typical number of products expected in a 
commercial facility (personal communication, Roger L Scott, Eli Lilly, Indianapolis)  
Also, the use of the mAb model to perform the deterministic and scenarios analysis is 
a further testament to its capabilities. In this chapter is has been shown that the 
robustness of the system can be tested through a deterministic analysis, very simply 
carried out by changing the input parameters made readily available to the user. The 
scenarios analyses have also shown that more in-depth analysis can be made, making 
the model a useful decisional tool in strategic analysis based on future uncertainties. 
The following chapter will go on to illustrate the models capabilities in a 
multiproduct setting.  
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5.5 Conclusion 
Much like the BioSynT case, the mAb case study was used to demonstrate the ability 
of a model, built using the standard version 2, of being used as a decisional tool. A 
deterministic study was first carried out in order to determine those parameters 
whose variability would significantly impact the output metric, kg throughput. It 
showed that at different titres, different parameters had impact, with the capture 
column parameters becoming more significant as the titre increased.  
A stochastic study was then carried out using the results of the deterministic analysis, 
looking at the impact of different scenarios combined with process uncertainties to 
determine how these would affect the running of the process. Combining these with a 
cost analysis of various process options it was found that at all titres it would be 
beneficial to upgrade the resin used for the capture step in order to gain a higher 
dynamic binding capacity and that a new column (for increased height) would give 
greater process binding efficiency. 
Furthermore, in order to achieve a % process throughput of greater than 95%, the 
failure rate would have to remain below 3% for all titres. 
The study also found that as the number of cycles allowed increases, the % processed 
increases also. When the limit equals the required split, % Processed jumps to 100%. 
At 4.5g/L, this is 18. At 10g/L this would be 40. Therefore, an alternative to making 
expensive column changes would be to increase the split ratio limit.  
Finally the mAb case study was used to implement the Standard Framework 2, 
testing its ability to guide the construction of a manufacturing capacity management 
model capable of meeting the requirement specifications stated under the standard. A 
qualitative analysis showed that these were met to a far greater degree than illustrated 
with the BioSynT model, with significant improvements in model development time, 
user intuitiveness, reusability and sustainability, and ease of data input/output. Some 
shortcomings were also identified however (as discussed in Chapter 3) which 
necessitate further development of the standard framework. 
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6 CHAPTER 6 
Multi-Product Campaigning: 
Schedule Optimisation  
 
6.1 Introduction 
The increase in the number of drugs in manufacture and their large volumes has 
meant an increase in the number of multi-product facilities of which, one may 
consider, there being two kinds. The first being whereby different products are made 
in parallel, simultaneously and in different production suites, and the other whereby 
different products are made on a campaign basis in the same part of the production 
facility. 
An example of the former is the Bayer Multipurpose Biotechnology Plant, a 
pharmaceutical manufacturing facility in the US, which currently produces three 
recombinant protein technologies. Over half of the plant is dedicated to the 
manufacturing suites with each suite producing a separate product without 
interrupting other processes. Not all pharmaceutical companies however are able to 
have such large in-house production capacity and currently 35% of biomanufacturers 
outsource at least some of their biologics with these manufacturers projecting that by 
2008 47% will outsource at least some production (Langer 2004). As more and more 
companies are employing this strategy, contractors are having to cope with the 
varying operations due to the variations in product demands and requirements. Some 
plants may use dozens of equipment to produce several different types of products 
leading to a myriad of ways in which a plant can be operated and finding the best 
operating plan and schedule has become a challenge. In order to optimise 
productivity in multi-product, contract-manufacturing facilities where processes are 
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run in parallel requires a large degree of overlap between batches and effective 
utilisation of shared resources and equipment (Gosling 2003). The correct scheduling 
of such processes is therefore vital to the production optimisation of such facilities. 
There are certain cost implications associated with scheduling and unit utilisation. 
Multiproduct facilities are faced with the problem of having to maximise 
productivity and the effective utilisation of resources while reducing the costs 
associated with such production activities. As with all projects, more often than not, 
the optimisation of performance will mean a compromise between time and cost. If 
you want to fulfil full production capacity in the shortest and most optimal amount of 
time then that will more than likely mean spending more money. 
As manufacturers shift from a production driven focus to a demand driven one, 
manufacturing performance becomes increasingly important. Effective planning and 
scheduling is one of the keys of meeting manufacturing goals (Taylor). In 
biopharmaceuticals it is vital that product demands are met with sufficient supplies 
with certain products given priority over others depending on the circumstances. 
Therefore firstly manufacturers will be looking to optimise the scheduling and 
secondly at reducing the costs of running such multi-product facilities.  
6.2 Operating Strategies in Biopharmaceutical Multi-
product Manufacture 
If the production of monoclonal antibodies occurs in various clean rooms then when 
a product changeover occurs in the facility, as part of a multiproduct campaign 
sequence, these rooms must be shutdown and cleaned before the next product may 
enter. The procedure is known as ‘turnaround’. This ensures that cross contamination 
is minimised between the products and can also serve as a maintenance downtime. 
Since these rooms are sealed it is possible to validate the process such that different 
products can be processing in different rooms at the same time. This opens the way 
for two different types of product changeover. The first, called Synchronised, means 
that each campaign/product must finish processing in the facility i.e. across all rooms 
before the next campaign can enter. This means that if the first room has finished the 
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last batch of a campaign, it will not start its turnaround procedures until the last room 
has also processed that batch. Only then will all rooms be turned around at the same 
time. There are disadvantages to adopting this procedure, for example, if all rooms 
are to be turned around at the same time, the labour may become a constraint. Also 
the process throughput may be affected because the cycle time of each campaign 
increases. The second method of turnaround is called ‘Rolling’ where rooms need 
not wait for the entire process to finish with a campaign i.e. as soon as a campaign 
has left the first room, the turnaround procedures may begin. The implications of this 
method are that if labour requests for room turnaround are one after the other, labour 
may not be a constraint. Also, the cycle time of each campaign is reduced meaning 
that theoretically the process throughput could be increased.  
In addition to the procedures surrounding multi-production manufacture, a common 
variability among different manufacturing systems is the operating shift adopted. 
That is, the start time and duration of the labour shift. Depending on the degree of 
automation in a process, the labour shift will have an impact on the process 
scheduling. Below are some examples of rules which have an effect on how a 
process is run and which therefore must be captured in a model for true system 
representation. 
• An activity can only begin if it will finish running during the current shift 
• An activity can only occur during day/night shift 
• Certain sub-activity sequences must be processed in one go 
 
A shift pattern, as used in the context of this case study, is defined as the hours 
during which labour is available and can comprise of more than one labour shift. For 
example, if there are two labour shifts, one can run from 6am to 6pm, the other from 
4pm to 12am. There is a period of overlap between the shifts but ultimately there is 
labour coverage from 6am to 12am, making it an 18hour shift pattern.  
If a shift pattern associated with a process is 24hrs 7day this means that theoretically 
the process can continue non-stop until a scheduled shutdown or product changeover. 
The only delays will be due to various other constraints such as resource availability 
and such rules as those outlined above which are associated with the shifts that make 
up the shift pattern. If however, the shift pattern is 18hrs 7day, and assuming that the 
process does not continue without labour shift coverage, these constraints have an 
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effect as well as the forced stoppage of 6 hours. The cascading effect of these 
stoppages on the overall schedule and the achievable process throughput can be quite 
significant.  
6.3 Case study background 
Chapter 5 illustrated an example of using the standard framework to create a 
biotechnology manufacturing model capable of single product capacity management 
scenario analysis. It demonstrated such features in the model as parameter variability, 
split and combine ratios and batch failure. The constructed model however contains 
various other interesting features which have not yet been explored such as, 
multiproduct campaigning, product changeover procedures and operating shifts. 
A case study examining the use of these features will now be presented, looking at 
the optimal campaigning schedule of multiple products, given a set of constraints, 
according to three quantitative measures.  
6.4 Method 
Section 6.2 discussed how the process elements, Turnaround strategy and Shift 
Pattern can affect the scheduling of a process and thus the achievable throughput. 
This section will discuss how these elements have been captured in the mAb tool. 
6.4.1 Turnaround 
There were many challenges faced with regards to turnaround. Firstly the 
synchronised approach would mean that all process areas would have to be turned 
around at the same time however the flow of batches would have to be controlled 
vigorously so as to ensure that no activities were still ongoing when turnaround 
began. To tackle this, the model captured the turnaround procedure using a block 
which looked identical for all rooms. This block sat before all blocks within each 
room and every time a batch entered, it checked to see if it was the last batch of a 
campaign. If not then the batch simply went on to be processed. If however it was 
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recognised as the last batch then turnaround was triggered by splitting the batch 
iteminto two parts, the first representing the original full batch which went on to be 
processed, the second the turnaround item which would wait until that batch had 
been processed. If synchronised turnaround had been set, then the campaign gate 
would be shut, not allowing the next campaign through to begin processing. Once 
each room had finished processing the last batch of the current campaign, the global 
array holding the activity status of each process area would indicate a ‘ready’. Once 
all areas had been set to ready, the gate for turnaround would open and allow the 
procedure to go ahead. Since each room would have its own turnaround item 
generated as the batch went through, these items would go on to the turnaround 
activities which would call upon the required labour and would execute turnaround 
procedures with the predefined cycle times.  The second challenge faced was the 
possible synchronisation of turnaround with area shutdown which meant that if 
turnaround was needed and shutdown was required within the following two weeks, 
shutdown would be brought forward to occur at the same time, thus reducing the 
period of downtime. To capture this, the turnaround block contained logic to decide 
whether shutdown was required.If so, both a turnaround and a shutdown item would 
be generated to process both activities. The entire campaign changeover procedure 
was therefore automated meaning that the model could trigger turnaround according 
to whatever campaign schedule the user input.  
6.4.2 Operating Shifts 
This feature was modelled with the assumption that only two different shifts would 
be required. These shifts could be any length, start at any time, apply to any number 
of days per week, have any number of labourers allocated and could overlap. The 
user would put this information in the input file and the model would apply it to the 
labour resource pool by making labour available (or unavailable) according to the 
shift specified. The shift pattern specified had an effect on the process throughput 
because activities/sub-activities cannot process unless the required labour is 
available. For example a 24hr 7day shift would allow for continuous processing and 
would therefore most likely result in a higher process throughput capability than a 
18hr 5day shift pattern. 
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6.5 Results and Discussion 
The following section will describe the setup of a multi-product scenario looking at 
campaign scheduling, and the results achieved through basic method optimisation.  
6.5.1 Scenario Analysis Setup 
The scenario question was as follows: given three different products with the 
characteristics shown in table 6.1, if a certain number of batches of each product are 
required over a one year time horizon, what is the 'optimal' campaigning sequence 
given different turnaround strategies and operating shifts? Where the different 
turnaround strategies are Synchronised or Rolling and the different operating shifts 
are 18hr7day and 24hr7day.  
 
Table 6.1 Summary of product characteristics 
Product Description Titre (g/L) Demand 
(Batches) 
Demand 
(kg) 
A  Manufacture 1.5 40 203 
B Validation/consistency 2 5 34 
C Phase III Trials 3.5 2 24 
 
In order to model demand, the time horizon for the scenario will be one year, with 
the year split into four quarters. Demand is defined as the amount of product needed 
where the deadline is given as a quarter. 
 
Constraints 
• Validation and trial batches were  needed as early on as possible in order to speed 
up approval  
• A certain amount of the manufacture product A needed to be made first in order to 
meet demand while the facility was being used for products B & C.  
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Assumptions 
The following assumptions were made in the running of the scenario: 
• Validation batches were needed by the end of the first quarter 
• Trials batches were needed by the end of the second quarter 
• At least half of the manufacture batches must be made by end of second quarter 
• All batches for validation and trial products must be made in one campaign but 
production of the manufacture product could be split 
• Product A would be split into a maximum of two campaigns of even sizes 
• There were no constraints on the order of campaigns 
• There was no storage limit for the manufacture product  
• The ‘ideal’ campaign strategy would minimise plant downtime 
• Buffer and labour requirements of product A = product B = product C 
• The facility/process had a zero failure rate therefore no batches or lots were 
contaminated and/or discarded 
• In synchronised mode, enough teams were available for turning around all rooms 
 
Demand 
The following demand profile was used, constructed according to the assumptions 
and constraints outlined above. The deadlines were for end of quarter for example, if 
five batches of B were required in Q1 then the deadline would be  at the end of Q1. 
  
Table 6.2Product demand profile 
Product Q1 Q2 Q3 Q4 
A   20  20 
B 5    
C  2   
 
 
Metrics 
Customer service level: defined here as the (batches produced/batches demanded) for 
each time period. If all batches meet demand within a time period then the CSL value 
for that quarter would be 1. If none were produced in that quarter, then the CSL 
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value would be 0. If a product was not produced at all during the time horizon, then 
the CSL for that product would be -1. This ensured that there was a quantitative 
difference between a product being produced late and not being produced at all.  
Cost: defined as [cleaning cost per day after a campaign + start-up cost for a 
campaign]. The actual cost values to used were arbitrary as only relative costs were 
needed for campaign comparison. The desired outcome would be as low a cost of 
changeover as possible. 
 
OEE: This metric was used here to capture the downtime due to the campaign 
changeovers as well as the scheduled facility shutdowns. It was defined as:  
 
Quality x Availability x Performance                                 (6.1) 
 
where: 
Quality = ‘good’ batches produced/total batches produced including contaminations. 
Since it was being assumed that the process has 0% failure rate, the Quality 
parameter is 100% 
Availability = Operating time / Planned Production Time 
where: 
Planned Production Time = horizon length – scheduled shutdowns 
Operating Time = planned production time – downtime due to turnaround 
 
Performance = often called Product Rate, was defined as the average output from the 
process divided by the proven maximum output over the same time period. Usually a 
one week period is chosen as the timeframe. However, in this case, performance was 
taken to be the equivalent of the CSL value, as the latter effectively measured the 
performance of the campaigning sequence against the expected or demanded value.  
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Campaign combinations 
A B C  
A C B  
B A C  
B C A  
C A B  
C B A  
A B A C 
A B C A 
A C A B 
A C B A 
B A C A 
C A B A 
 
 
Model outputs 
In order to record the metrics the following outputs were needed: 
• Completion date of each campaign 
• Number of batches processed in each campaign 
• Number of turnarounds and durations 
6.5.2 Scenario analysis results 
In Appendix C the results of the different campaign sequences can be found. These 
tables show, for the different turnaround strategies and shift patterns, the throughput 
results of each simulation run for each sequence and the calculated Cost, OEE and 
CSL values based on the number of turnarounds and completion of required number 
of batches by the demand deadline. Figure 6.1 shows the plot for each of these 
values. 
Graphs 6.1a and 6.1b both illustrate the results for the synchronised turnaround 
method, showing that the spread of OEE and CSL is quite vast but with the majority 
of campaign sequences lying below the 50% level for both metrics. The difference in 
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cost between the two shift patterns is however apparent with the cost associated with 
turnarounds dropping quite dramatically across the spread of campaign sequences. 
These trends are rather unsurprising due to the nature of the turnaround procedure; 
when in synchronised mode, the process is forced into a longer delay between 
campaigns because each room must wait for all rooms to finish processing the final 
batch before beginning turnaround activities. This means that the start of every new 
campaign is delayed thus affecting the ability to meet demand. The resulting 
‘penalty’ is a decrease in the CSL value and since the performance part of OEE is 
based on the average CSL, there is a decrease in both metrics. Furthermore, when the 
shift pattern is 18hr7day the capacity of the facility diminishes relative to the 
24hr7day pattern simply because the process is operational for fewer hours per day.  
As the results in appendix C.1 and C.2 show the number of turnarounds are fewer 
because the number of campaigns processed reduces. Therefore the cost of 
changeover will show a decrease. This however is a trade-off; the cost of turnaround 
may decrease but this is because fewer campaigns have been processed thus showing 
a lower than desired OEE and CSL. 
Graphs 6.1c and 6.1d show the results for the rolling turnaround procedure and 
immediately it is seen that there is a significant shift in CSL and OEE values to 
above the 50% mark. Again, this trend is as expected due to the fact that the delay 
between campaigns is decreased as the rooms are turned around as soon as possible. 
This minimises the time between the end of the last campaign and the start of the 
next, meaning that there is greater possibility of meeting demand deadlines, thus 
increasing the OEE and CSL values. For rolling turnaround, due to increased facility 
capacity there is less difference between the two shift patterns. Finally, as the number 
of campaigns achieved during the time horizon does not show variability between the 
two shift patterns (see Appendix C.3 and C.4) in rolling mode it is unsurprising that 
the associated costs do not show great variance between the two shift patterns, again 
attributed to the already increased capacity due to the decreased delay between 
campaigns. 
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Figure 6.1 Cost of changeover, OEE and CSL for (a) Synch 18hr (b) Synch 24hr (c) 
Rolling 18hr (d) Rolling 24hr where     = Cost and  x = OEE.  Assuming no storage 
limit, zero failure rate and sufficient operators available to turn around all rooms in 
synchronised mode. 
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Extracting those campaign sequences from each of the four proposed strategies 
which show the highest CSL and OEE and the lowest cost (amongst the highest 
former values), it can be seen that the optimal sequence in each case is B-C-A. 
Figure 6.2 shows the metrics for this sequence under each turnaround strategy and 
shift pattern. Note that the metrics have been normalised in order to obtain 
comparable y-axis values. Furthermore, since the CSL and OEE values overlap the 
OEE values have been reduced by 10points so that they show on the graph. This does 
not affect the results as the graph is used for relative trends. 
 
 
Figure 6.2 CSL, OEE and Cost of Turnaround for the optimal campaign sequences 
for each proposed strategy where (♦) = CSL, (■) = Cost, × = OEE. Assuming no 
storage limit for product, zero failure rate and sufficient operators available to turn 
around all rooms in synchronised mode. 
 
As expected, the graph shows that the higher OEE and CSL values are attributed to 
the rolling turnaround mode. The associated costs are also higher because the number 
of campaigns achievable during the time horizon is higher. As the cost metric here is 
based solely on the cost of product changeover the two strategies show the same cost. 
However if the cost of labour were to be taken into account, the 24hr shift pattern 
would show greater cost, thus indicating another trade-off between process efficiency 
and cost.  
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6.6 Conclusion 
This chapter has illustrated the use of the mAb model to act as a decisional tool in 
multiproduct process optimisation focussing on different turnaround strategies and 
operating shifts. Using Overall Equipment Effectiveness (OEE) and Customer 
Service Level (CSL) as the objective functions, it was found that given the demand 
profile used here, it would be more viable to process shorter campaigns first in order 
to achieve higher CSL values. What must be noted is that although demand profiles 
will be different across different products and across years, what this study has 
illustrated is the capability of the constructed tool in multi-product scheduling and 
analysis. Thus it has demonstrated the ability of the standard framework in guiding 
the construction of a model which meets the requirement specifications of relevance, 
reusability and sustainability.  
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7 CHAPTER 7 
Commercial Considerations for the 
Development and Application of the 
Dynamic Standard Framework  
 
7.1 Introduction 
In this chapter, the potential commercialisation process is presented for the standard 
framework proposed in this thesis, focusing on its application in the area of 
biopharmaceutical manufacturing capacity management. Furthermore, it must be 
noted that while the market for commercialisation is mainly model developers, the 
end users of the models must also be taken into account when considering its 
commercialisation.  
7.2 Application of the Standard Framework 
The framework developed is primarily a methodology aimed to be used by modellers 
when approaching a modelling problem. The methodology consists of four major 
phases, Problem Structuring I, Problem Structuring II, Design and Construct, each of 
which guide the modeller in efficiently mapping the real system onto the chosen 
modelling platform in such a way as to meet the requirement specifications of a 
‘good’ model. The methodology in its very nature is not platform specific and can 
guide any modelling practice across all industries. Thus the scope for application is 
vast.  
Commercial Considerations for the Development and Application of the Dynamic Standard 
Framework 
 
 
 
However, the methodology has incorporated into it a set of templates which are 
designed to help in the construction phase of the modelling process and it is these 
templates which are platform specific, requiring a certain set of computer system 
requirements for their application. Figure 7.1 shows the infrastructure of the 
relationships within the application of the framework. Furthermore, these templates 
have been designed to be used for a specific scope, which the following section will 
discuss. 
7.2.1 Application Area of Templates 
Due to the extensive work carried out in building biotechnology based models, the 
templates have inevitably been developed for this application area. The parameters 
captured in the database, the output data generated and the template blocks 
themselves have been designed to deal with the complexities inherent to 
biopharmaceutical manufacturing capacity management. For example, production 
scheduling, single/multi-product procedures, ancillary activities and activities with 
associated cycle times. 
7.2.2 Requirements for Template Application 
The work carried out during the course of this research was specific to the Extend 
modelling environment, chosen due to the modelling preferences of the collaborative 
company, Eli Lilly and Corporation. The requirements for the use of these templates 
are as follows: 
- The templates were created in Extend Version 7.06 and therefore must be used 
in version equal to or more recent than this. The lack of backward compatibility 
with this platform means that while the templates can be used in future versions, 
they cannot be used in older ones.  
- Microsoft Excel must be available in order to use the database template. This 
input file as well as the output data file have been designed to automatically 
communicated with the Extend Platform and their presence is integral to the 
correct running of the model and block templates. 
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Similarly, if the model and its data capturing components are built in the Extend and 
Excel platforms, it is necessary for the end user to also hold a license for these 
platforms, following the specifications given above. 
 
 
Figure 7.1 Infrastructure of Framework Application 
7.3 Project Implementation 
An example is given of an implementation scenario which involves a modeller (e.g. 
within a large-scale biopharmaceutical manufacturing company) being approached 
by the client (e.g. team running a new in house facility for the production of a 
biosynthetic therapeutic).  
A chronological implementation plan is presented here of the key project phases as 
outlined in the proposed methodology. 
7.3.1 Problem Structuring Phase I 
- Client approaches modeller with capacity management issue 
- Modeller establishes the scope of the problem, gaining an understanding of the 
desired inputs and outputs, the data available and the desired metrics to measure 
against i.e. what is the client aiming to measure process performance against. 
The list given in Table 3.4 (in Chapter 3) can be used to aid this. 
- The model is then characterised based on the established requirements. For 
example, whether single or multiple activities, dynamic or static, metric etc. In 
this case, since the problem is associated with biopharmaceutical manufacturing 
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capacity management, it is assumed that the model can be classified as ‘Extend 
Manufacture’. 
7.3.2 Problem Structuring Phase II 
- Modeller builds a non-coded description of the system using process 
terminology 
- The system description is validated with client to ensure fully captured elements 
- Description is tweaked and revalidated if necessary 
7.3.3 Design 
- Modeller creates a process specific description of the system, using model 
terminology. For example, tasks become sub-activities.  
- Gaps highlighted here can be filled by returning to client. For example, 
constraints or cycle times which have not been captured. 
7.3.4 Construct 
- Modeller creates a coded description of the system, using the templates to map 
the system elements onto the modelling platform based on the model design. 
- Debugging follows first phase of construct completion 
- Using initial model outputs, validation can take place, comparing outputs with 
expected results from client 
7.3.5 Project Handover 
- Model is presented to client followed by training on how to use the model 
- Project is handed over to client along with documentation 
Commercial Considerations for the Development and Application of the Dynamic Standard 
Framework 
 
 
 
7.4 Project Costing 
The resource requirements and costs have been estimated based on a typical 
industrial project. The assumptions made are as follows: 
- Although both modeller and client are in-house, the modeller is assumed to be 
working on the project as a consultant, using an opportunity cost basis for 
determining costs associated with time spent on this project. The costs for the 
modeller have been assumed to be £20 per hour (lower than general consultancy 
rates due to in-house employment status), working a 40 hour week. 
- It is assumed that the modeller holds a license for the required modelling 
platforms. Therefore the client will incur the cost of a run-time license fee, 
which will not include maintenance or support fees. 
- Both the modeller and client own licenses for Microsoft Excel and therefore no 
costs are incurred 
- Table 7.1 shows the estimated project cost to total £8,080 with the project 
duration being approximately 50 days. 
 
 
Table 7.1 Project costing and task durations 
Task Duration Resource Cost (£GBP) 
Problem Structuring Phase I 
 2 days 
 
Modeller 
 
320 
 
Problem Structuring Phase II 10 days Modeller 1,600 
 
Design 5 days Modeller 
Microsoft Excel 
800 
- 
 
Construct inc debug 30 days Modeller 
Extend 
Microsoft Excel 
4,800 
- 
- 
 
Project Handover 3 days Modeller 
Extend 
Microsoft Excel 
480 
80 
- 
Total 50 days  8,080 
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7.5 Potential Benefit of Framework Application 
The benefits of the standard framework are two-fold. Firstly, the increased efficiency 
in model construct means that the modeller can move on to the next project in a far 
quicker time frame, thus increasing their productivity. More importantly the client 
will receive the answers to their capacity management problems far more efficiently, 
thus allowing for quicker implementation of any recommended changes to the 
process. Mallik et al (2002) estimate that for a typical new mammalian cell culture 
facility, even a 25% increase in capacity utilisation can result in an average of $280 
million increase in its net present value. Thus, the possible savings through the use of 
the standard framework are potentially very significant, highly beneficial to an 
industry somewhat struggling to maintain high profit margins.   
7.6 Dissemination of Standard Framework 
The potential benefit of the standard framework can only be realised if it is 
disseminated across the biopharmaceutical industry as a support tool. As with all 
standards, its adoption relies on widespread knowledge and user reviews. In 
industries such as the biopharmaceutical industry, the best means of reaching the 
target audience is through conference presentations, publications and release into the 
modelling community. Upon completion, the framework presented in this thesis was 
handed over to the sponsor company to be used in their current and future modelling 
projects. The positive feedback received acted as a key milestone indicating that 
dissemination to industry users had been achieved in the project. 
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8 CHAPTER 8 
Validation Issues 
 
8.1 Introduction 
The EMEA (The European Agency for the Evaluation of Medicinal Products) 
defines process validation as “the act of demonstrating and documenting that a 
procedure operates effectively....the means of ensuring and providing documentary 
evidence that processes (within their specified design parameters) are capable of 
consistently producing a finished product of the required quality”. Similarly, the 
FDA (Food and Drug Administration) defines validation as “Establishing 
documented evidence which provides a high degree of assurance that a specific 
process will consistently produce a product meeting its pre-determined specifications 
and quality attributes”. Both governing authorities therefore require that a process 
consistently meets a certain degree of quality. In order to ensure this, there are 
guidelines in place in the form of GMP or “Good manufacturing practice" which 
refers to the quality control of manufacturing for foods, pharmaceutical products, and 
medical devices. These guidelines are part of pharmaceutical legislature in many 
countries although the details of each guideline may differ from country to country. 
Process validation guidelines such as GMP primarily deal with critical aspects of a 
process, that is, those aspects which directly affect the quality of product.  
The work in this thesis outlines the process of model construct which can be 
considered an off-line process which can only affect the manufacturing process 
indirectly if changes are made as a result of the simulations. In such cases, the client 
must ensure that any process changes directly affecting the quality of the product are 
correctly tested and subsequently validated. Consistency lots will be required to test 
not only the product quality but also the overall efficiency of process; there are 
documentations which must verify that all aspects of the installation meet the 
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manufacturer’s specifications, that when assembled and in use all equipment within 
the process do perform as defined by the manufacturers specifications and that the 
performance of the equipment meet requirements. These documents are the 
Installation (IQ), Operation (OQ) and Performance Qualifications (PQ) and are vital 
in achieving equipment/process validation. 
 
Due to the nature of the work presented in this thesis, software validation must be 
considered and is the focus of the following section. 
8.2 Software Validation 
The standard framework presented in this thesis is based on the use of existing 
software. According to GMP guidelines as defined under the FDA, “Validation 
requirements apply to software used as components in medical devices, to software 
that is itself a medical device, and to software used in production of the device or in 
implementation of the device manufacturer's quality system”. Thus the framework 
does not fall under this validation category. 
8.3 Decision Support Systems 
Decision support systems are a class of information systems which support decision 
making activities. As stated in the previous section, the work presented in this thesis 
does not fall under the conventional category of software validation, as it is not 
designed to be used as an on-line process tool. However validation is required in the 
form of software testing which decision support systems generally go through, albeit 
in different forms. In the case of this thesis, the subject of tool validation was briefly 
discussed in the previous chapter and is an integral part of the methodology 
proposed, stating that at each stage of the modelling process, understanding of the 
system elements, model design and final construct must be validated with the client. 
This dynamic approach to the modelling process will: 
- Ensure that the initially determined scope is well understood and relevant 
Validation Issues 
 
 
 
- Ensure that all relevant systems elements such as constraints, rules, and 
parameters are sufficiently captured 
- Allow for debugging of the model 
8.4 Conclusion 
Due to the nature of the work carried out in this thesis, validation is not a legal 
requirement. However in order to ensure that the models created as a result of the 
application of the standard framework are useful in their capacity as decision support 
systems, it is necessary to follow the validation or testing protocols stipulated at each 
stage of the methodology.  
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9 CHAPTER 9 
Conclusions and Future Work 
 
9.1 Introduction 
Capacity management in the manufacture of biopharmaceuticals has changed over 
the years, with a clear shift towards creating more cost effective processes (Farid 
2009). As such some biopharmaceutical manufacturers are seeking to use simulation 
tools to experiment with various process alternatives at various stages of a facility’s 
life, from inception and design to ongoing process development. However in order 
for simulation techniques to add value as decisional support tools it is necessary to 
standardise the way in which the modelling process is approached. The aim of this 
thesis was to propose a dynamic standard framework to facilitate the practice of 
simulation modelling in biopharmaceutical capacity management. A methodology 
was developed including a set of standard templates as part of this framework. 
Section 9.2 highlights the significance of the work while Section 9.3 summarises the 
efforts made in this thesis to develop the framework and the overall conclusions 
made. Section 9.4 suggests directions for future research work. 
9.2 Significance of Work 
The platforms available for dynamic discrete event simulation provide an extensive 
library of blocks and coding languages to aid the modelling process, allowing for 
highly complex representations of the systems which they model. However the 
myriad of ways in which these tools can be used results in a complexity across the 
modelling portfolio of a company which makes them unintuitive and unsustainable. 
For example, the mAb case study presented in Chapter 5 was based on two pre-
existing models which were built during the design stages of the process. Although 
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these models were built by two colleagues sharing an office, they differed 
significantly in design, data input and output approaches, modelling techniques used 
and coding practices. Furthermore, upon reverse engineering these models it was 
discovered that they were modelling exactly the same system elements and 
answering almost identical questions. In other words they were performing the same 
functions with neither meeting the requirement specifications proposed in this work. 
If such differences can occur within an office, the problem is even greater across 
sites and geographical locations. Therefore a standard is required to streamline 
modelling activities. However, as found during an extensive literature review, the 
current standards for modelling practice are simply guidelines for the graphical 
representation of real systems and the annotations used. For example, how many 
hierarchical levels should be used, the connections between the system elements and 
their nomenclature. These guidelines aid the modelling process to a minimal degree, 
offering little help on the complexities such as how to capture rules, constraints, 
uncertainties and elements of biopharmaceutical systems such as batch cycling and 
buffer make-up scheduling. Therefore the non-existence of standards has increased 
the difficulties surrounding the simulation process, particularly in the 
biopharmaceutical industry which only recently adopted simulation techniques 
relative to other industries such as the semiconductor industry. Hence the 
significance of the work presented in this thesis is highlighted. 
9.3 Overall Conclusions 
The main focus of this thesis has been to develop a standard framework for the 
development of simulation models to effectively function as decisional tools. In 
order to understand the sorts of capacity management issues these decisional tools 
must tackle, Chapter 1 reviewed the challenges faced by biopharmaceutical 
manufacturers, in particular, process uncertainties, multi-product scheduling and 
capacity utilisation. A review of the different types of simulation environment was 
carried out in Chapter 2 along with a review of their application in the 
biopharmaceutical and other industries so that an understanding could be reached of 
the best environment or platform on which to focus the work in this thesis. It was 
concluded that discrete event simulators were the preferred platform for creating 
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dynamic models capable of representing uncertainties and constraints along with a 
more user friendly modelling environment. Furthermore the need for standardisation 
was recognised in order to aid the modelling process and as such the current 
standardisation approaches available were reviewed to assess whether an existing 
standard could be applied to the problem. It was concluded that only a few 
components of these standards could be applied as they did not take into account the 
many complexities of biopharmaceutical manufacture. 
The standardisation approach outlined in this thesis provides the methodology and 
modelling tools to allow modellers to build models which meet the requirement 
specifications of 1) Intuitive to user, 2) Relevance, 3) Ease of Data Input/Output, 4) 
Short Run Time, 5) Maximised Reusability and Sustainability, and 6) Minimised 
Development Time, thus creating valuable and cost effective decisional tools. The 
main premise of the methodology is to aid during the data gathering and model 
design stages in order to improve the efficiency of data retrieval and validation. 
Standard templates developed as part of the framework provide the fundamental 
building blocks, with a degree of customisation which will allow different process 
elements to be realistically and more easily captured, but with sufficient generality 
built in to allow them to be used across different system models. The domain 
focussed on in this work is the ‘Process’ level of the organisational hierarchy, more 
specifically biopharmaceutical batch processes, looking at the manufacture of bulk 
products, with the main system elements captured being resources (e.g. labour, 
buffer, equipment), entities (e.g. batches) and activities (e.g., product handling, CIP). 
The features of biopharmaceutical manufacture captured in the work will be 
discussed below and include upstream fermentation, downstream recovery and 
purification at the unit operation level, mass balancing based on step yield and 
equipment sizing based on upstream titre. Also resource scheduling such as ‘just-in-
time’ buffer makeup, equipment failure, batch splitting for purification and 
multiproduct scheduling. The platform chosen for the work is Extend (ImagineThat!, 
CA), a discrete event simulation software with a graphical user interface.   
The development of this standard framework was illustrated in Chapter 3 as part of 
an evolutionary process with reference to case studies carried out to test the various 
versions of the standard during its development.  
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The first of these case studies was presented in Chapter 4 where the first version of 
the standard was applied to the construction of a model for a biopharmaceutical 
manufacturing system, referred to as BioSynT, testing the ability of the standard to 
guide the construction of a manufacturing capacity management model capable of 
meeting the requirement specifications. The scope of the study was to determine how 
fast the downstream production process for a biosynthetic therapeutic could go, for a 
fixed batch demand, given certain constraints such as operating rules and 
uncertainties such as equipment failure. Firstly a deterministic sensitivity analysis 
was carried out to identify the key parameters that affect the overall process cycle 
time. Using these parameters Monte Carlo simulations were run to perform 
debottlenecking analyses and to understand the impact of different scenarios such as 
additional labour or process equipment, combined with process uncertainties to 
determine how these would affect the running of the process, and to highlight any 
shifts in bottlenecks. A comparison of scenario output distributions allowed for this. 
A cost analysis of the scenarios was also carried out to add a further dimension to the 
study and to understand the trade-offs  between operational improvements and the 
cost of process changes. Secondly a qualitative analysis showed that although the 
model was able to help perform useful analyses, the requirement specifications were 
not sufficiently met, with rigidity in the method of model construction and the 
approach used leading to a less than adequate reusability and sustainability, a 
relatively long run time and a far greater development time than desired (with time 
and cost efficiency as measures).  
Chapter 5 presented the second case study, that of a single product monoclonal 
antibody (mAb) manufacturing system, including both upstream and downstream 
processes, to test the second version of the standard framework. A similar study to 
that applied to the BioSynT case was carried out, combining deterministic, stochastic 
(Monte Carlo) and cost analyses to determine the impact of process uncertainties and 
different scenarios (such as new chromatography columns or resin upgrades) on the 
chosen output parameter, process throughput. To add another dimension to the 
application of the model and to take full advantage of the system complexities built 
into it, an addition to the mAb case study was introduced as presented in Chapter 6, 
looking at schedule optimisation for a multiproduct scenario focussing on different 
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turnaround strategies and operating shifts. Using Overall Equipment Effectiveness 
(OEE) and Customer Service Level (CSL) as the objective functions the model was 
used to run different scenario combinations to determine the best scheduling strategy.  
The studies presented in Chapters 5 and 6 demonstrated the ability of the standard 
framework in guiding the construction of a model which could be used for complex 
analyses, meeting the requirement specifications of relevance, reusability and 
sustainability. Furthermore, a qualitative analysis showed that these were met to a far 
greater degree than illustrated with the BioSynT model, with significant 
improvements in model development time, run-time, user intuitiveness, and ease of 
data input/output. However the need for a more comprehensive library of standard 
building blocks was also identified in order to help further accelerate the time spent 
on model development, to facilitate debugging through a more standardised block 
structure and to improve model intuitiveness. Thus the final version of the standard 
was developed.  
The work in this thesis highlights the benefits of adopting a standardised approach to 
simulation modelling in biopharmaceutical manufacturing capacity management. 
This finding has been illustrated through a series of capacity management case 
studies. The methodology developed can be used as a framework to guide the 
modelling process, allowing for a greater understanding of the system being 
modelled, a faster data validation process, and ultimately the construction of a model 
which meets the six requirement specifications. In doing so, the use of the standard 
framework tool can save a company time and money, adding value as a decisional 
tool at various stages from process design to full operation.  
9.4 Future Work 
The standard framework and tools presented in this thesis contribute to the growing 
field of simulation modelling in biopharmaceutical manufacture. It also provides a 
basis for future work as discussed next. 
The domain focussed on in this work has been the ‘Process’ domain, specifically 
looking at bulk manufacture. However as described in Chapter 3 there are a further 
six domains – Supply chain, Enterprise, Product, Site, Dept/Building and Equipment, 
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which could be considered. Although the methodology itself is a universal one, the 
templates have been specifically created for biopharmaceutical manufacturing 
capacity management models. An in-depth study of the commonalities and 
complexities across the different domains could lead to the expansion of the 
templates thus allowing for the framework to be used across an entire organisation 
for all systems. Furthermore, similar studies at the product and process level domains 
could allow for expansion into different areas of manufacturing, for example QC labs 
or Fill/Finish activities.  
Many different capacity management questions were considered in this work, 
ranging from equipment utilisation to process changes and operational rules. 
However, further case studies could be used to test the ability of the standard to help 
create decisional tools capable of answering more questions such as the impact of 
using disposables. To test the reusability and sustainability of the existing models, 
the scope of those case studies could also be expanded. Furthermore, the models built 
were created with some modelling constraints such as the ability of the mAb model 
to handle only three different products at a time in a multiple product scenario. The 
models could therefore be expanded on to be more versatile. For example, the 
database could be constructed to hold data for 10 different products, with all 
parameters such as specific step yield being highly variable according to the product 
mix. 
The reviews carried in this work have been very qualitative in nature. A more 
quantitative analysis to measure the exact value added could be carried out by 
embarking on a case study whereby the same system model would be built in two 
instances, one where the methodology and templates were implemented and one 
where they were not. This would give a direct comparison of the times attributed to 
design, development and validation, and the corresponding cost of developer hours 
and client consultations.  
The economic analyses carried out have been very basic, taking into account only the 
base costs of process alternatives such as membrane upgrades or labour increase. A 
more detailed process economics calculation would give a far greater understanding 
of the cost implications of the proposals and also increase the usefulness of the 
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models built. A way of doing this could be to attach the models to a cost database, 
either integrated into the main database template or in addition to it, providing a cost 
profile of all inputs to the model. Outputs such as process throughput could also be 
economically evaluated post simulation in order to provide an understanding of 
return on investment. 
The software used in this work, ExtendSim v7, was found to be appropriate for 
modelling biopharmaceutical manufacturing models. Although the templates were 
built specific to this platform, the methodology provides a universal approach and 
therefore its application to other modelling platforms and environments such as 
different discrete event simulators or optimisation tools could test its usefulness as a 
modelling standard. 
The modelling methods considered use a non-database driven approach whereby the 
database only provides the system parameters. This approach is aimed more at the 
developer as the model itself requires design and construction, albeit with the aid of 
the standard framework. Conversely, database driven modelling can be described as 
the modelling of a system whereby data input to the database determines the physical 
and logical structure of the model along with the system parameters. This approach is 
aimed more at the end user and the modelling constructs already exist but do not 
have identity or structure until the database is populated. Unlike non-database driven 
modelling where built-in commonality exists but any higher levels of detail can be 
supplied by the developer to tailor the model to the specific system, the level of 
standardisation required is far greater in the database driven approach as the 
constructs must be able to take the identity of any system element and every possible 
scope or question must be built in beforehand. However the latter approach does 
minimise interaction with the model and can potentially reduce development time 
significantly, eventually negating the need for a model developer at all once the 
constructs have been fully put into place. Studies of all biopharmaceutical domains, 
their possible scopes and an understanding of their commonalities can help move the 
standard framework towards a more database driven methodology. 
In conclusion, the future work outlined draws upon the framework and methods 
established in this thesis. The development of more sophisticated models and 
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expansion across different domains would enhance the standard framework’s 
capacity as a guide to create valuable decisional tools.  The lack of standardisation 
methods in the biopharmaceutical industry means that tools such as the framework 
described in this thesis are much needed and their use will be widely adopted across 
the industry in the future. 
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11 APPENDIX A 
Data for Chapter 3 
 
Appendix A.1 Standard Framework Version 3: Data Input Template 
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Appendix A2 Standard Framework Version 3: Library Templates 
 
Model Template Top Level 
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Activity with Cycles 
The block is identical to the Activity no Cycles block, but only at the top most level.  
At the next level however, it contains the following, ‘Split Equip’, ‘Combine Equip’ and ‘Split/Combine Batch’ 
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Appendix B.1Rationale behind construction of BioSynT model 
 
MODELLING THE ELEMENTS 
The following looks at the different system and model elements, describing the 
reasons for modelling them as they were modelled.  
Activities 
CIP 
CIP is an activity associated with the chromatography columns. Within the scope of 
this problem there is no requirement for the modelling of CIP component make-up. 
Cleaning procedures only correspond to equipment used either within the main 
process stream or for ancillary activities such as buffer preparation and waste 
disposal. There are two ways in which CIP can be modelled and a number of reasons 
for choosing one method over the other. ---+ 
+ 
 
Method 1: As part of the main process chain logic. This means that CIP is placed 
wherever the activity is required. This method means that there may be multiple 
(depending on the number of clean occurrences) CIP activities and is used when the 
equipment are modelled as the main block constructs (role decomposition). 
Method 2: The CIP is represented in one location within the model which is 
externalised from the main process chain. This method is used when there is 
functional decomposition. When cleaning is required the entity to be cleaned is sent 
to that clean location and then returned to the process stream.  This is the chosen 
method for this case study due to the following reasons. Firstly it reduces the number 
of building blocks (visible complexity) and thus allows for a degree of reduction in 
Appendix B 
 
- 242- 
 - 242 - 
 
the model run time. Secondly it creates a more intuitive model in the case as it allows 
for visual tracking of item movement through clean. Finally if a generic CIP is built, 
it will contribute greatly to the maximisation of model reusability and sustainability. 
Preparation of Buffers 
These activities are buffer preparation and each step of this preparation process will 
be modelled as an individual task. Preparation of buffers, similarly to CIP can be 
modelled as part of the product handling chain and therefore have multiple 
occurrences or can be modelled externally. The latter is the chosen method due to 
block use efficiency and clarity of model since there are a significant number of sub-
tasks associated with the preparation of each buffer. 
Entities 
Entities are those objects in the modelling environment which represent people or 
items (inc. batches and equipment) in the real system. The input items to this system 
are containers of frozen intermediate from the anion exchange chromatography in the 
front end process. These intermediates are simply batches and are the primary items. 
The generation of these items is not based on a schedule due to the fact that they do 
not directly come from the FrontEnd but are thawed as and when needed.   
Resources 
There are two types of resource in this system, consumable and non consumable. The 
former are the buffers prepared at various stages before use.  The non consumable 
resources are the equipment and labour. All these resources can be modelled in two 
different ways: 
Method 1: Modelled as items. This is beneficial when it is necessary to visually track 
the resource’s movements, when the resource and primary item need to be paired for 
a section of the model, and/or the resource carries its own attributes. Furthermore, 
importantly, it is necessary to use this method when the resource has activities 
associated with it which are independent of the primary item activities. The resource 
item can either be generated then discarded or be managed via a holding block where 
it sits until required.  The advantage of this method is that an item can be turned into 
a volume flow at any point. This is useful in situations where a transfer activity over 
a period of time must be represented, particularly when there are flow restrictions. 
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Method 2: Held in resource pools and pulled when needed. Resources held in pools 
are not actual items which can move through the model; instead the number available 
for that resource is changed every time it is pulled or released, telling the model its 
availability. This method should be used when the resource itself does not have any 
activities associated with it that are independent of the primary entities. Therefore as 
the primary item enters the activity it will pull the resource and carry it through the 
series of activities it must go through before releasing it back to the resource pool. 
One pool may be used to hold all similar resources if individual utilisation data is not 
required or it is calculated elsewhere and/or usage is based on the same shift/rule or 
this is determined elsewhere.  
Non-consumable resources such as equipment should be modelled using method 1 
because they have independent activities and should be tracked for debugging and 
general visibility purposes.  
Due to the fact that labour does not usually have associated with it activities 
independent of the primary item’s there would be little added benefit to modelling 
them as physical items within the model. Therefore it is best to use method 2. The 
constraints due to labour shortage are modelled much in the same way as method 1 
i.e. if the labour is not available the item requesting it will simply sit in a queue. 
However in addition the resource pool gives the extra option of labour allocation 
based on first come first served or a given priority. 
Consumable resources such as water or buffer chemicals should be held in resource 
pools using method 2 as they do not loop back to be used again (unless recycling of 
such materials is part of the system being modelled). 
Physical Layout and Decomposition 
The physical layout of a model is the position of blocks on the workspace and what 
they represent or the decomposition of the model. Discrete event simulation 
modelling in Extend involves hierarchal levels containing blocks. For an intuitive 
model it is necessary to reduce complexity at each level. The IDEF0 standard 
describes sub levels of a model as Child Diagrams (the top level being Parent 
Diagram), whereby functions are decomposed into their sub-functions. According to 
the standard, the number of child boxes on each child diagram should be limited to 3-
6.  The standard describes the following decomposition types: 
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Functional Decomposition – breaks down activities according to what is done. This 
is the most common decomposition strategy 
Role Decomposition – breaks down things according to who does what. This 
definition should be extended to also mean according to what does what (equipment 
based constructs) 
Lifecycle Decomposition – breaks down a system first by the phases of activity 
Functionalities found in reality should be represented in the model for both 
visualization purposes and for resource management by using the IDEF0 
decomposition criteria. 
The BioSynT process lends itself to Functional Decomposition and therefore the 
main hierarchical blocks will represent the major activities, in this case the 
purification, pooling and drying steps, which form the primary process stream.   
Main Block Construct and Parallel Activities 
As the main block construct will consist of chromatography columns and pooling 
tanks the second level of the model will have physical layout similar to that shown in 
Figure 4.1 in Chapter 4. For an intuitive model, functions should also ideally be 
hierarchically modelled together. E.g. if two equipments / activities perform the same 
function, there should only be one hierarchical block representing that function to 
contain them. In the real system the initial reverse phase chromatography activity 
consists of two columns whereas only one block is used to represent it. 
Item Transfer 
The IDEF0 standard considers the way in which boxes and arrows are used to 
represent objects and flow; That is, the sequence of events flow from left to right 
with arrows used to connect boxes which represent the object/activity being 
modelled. Since this convention is simple to understand and quite commonly used in 
flow diagrams, it will be adopted here, in order to create a more intuitive model.  
Item Flow Control 
The rules and constraints within a model make it necessary to control the flow of 
items until certain conditions are met. The main and possible best was of controlling 
flow is to use gates. The function of these is to check whether the required conditions 
have been met and to release the item accordingly. 
Appendix B 
 
- 245- 
 - 245 - 
 
 
Primary Items Generated 
The main items to be generated in the model are batches. Since one possible capacity 
management question considers multi-products, the database can be used to generate 
these based on a schedule. Then the products to be generated in each case (there can 
be combinations of products or only one as in this case study) can be chosen by the 
user and only those generated. 
Metrics 
Having described the possible capacity management scenarios, it is now necessary to 
determine what the model should be capable of measuring in order to be robust 
enough to be used for any one or combination of questions in addition to answering 
the question of ‘how fast can this process be run?’. Therefore the following describes 
the required measuring capabilities of the model. 
Cycle Times: In order to track the overall completion cycle time and the utilisation 
profiles of all the activities or equipment, it is necessary to record the times at which 
events occur. The data when compiled will then make it possible to create Gantt 
charts for activities.  
Throughput: This is both overall and for each step of the process and can be tracked 
by simply using looking at the number of items which exited the model. This is the 
case due to the fact that each item represents a batch; therefore the number of items 
which pass through a section of the model will represent the number of batches 
processed.  
Equipment utilisation: Tracking the utilisation of equipment is not simply the case of 
recording the percentage of time not held in its pallet. When a system is as complex 
as in this case with many sub activities, resources and constraints, it is far more 
useful to track the times which the equipment takes to complete these activities and 
also the how long it is sat waiting for a resource to become available. The best way 
to do this is to assign time attributes which can be sent to Excel and used to create 
Gantt Charts. These data points can then be used to calculate the utilisation of the 
equipment based on the actual processing time relative to the overall time to 
complete all batches. 
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Resource utilisation: Whether the resource is held in a pool or held as an item on a 
pallet, its utilisation can be monitored as with equipment. Alternatively Extend 
allows for the tracking of resource utilisation by connecting discrete even charts to 
the outputs of the resource blocks. The best option is to output the data to a software 
better suited to more comprehensive data analysis. Excel is perhaps the best 
candidate as most users will have a copy of the software readily available and data 
manipulation is relatively easy to carry out with intuitive chart outputs.  
Ticket Generation: The desired output here is the number generated, the maximum 
open at any one time and the average open at any one time. A chart profiling ticket 
generation is also useful.  
Lookahead 
This is rather a complex piece of logic which is useful in representing manufacturing 
processes as it considers the trigger times for events. In the case of the BIOSYNT 
system it was initially thought necessary to create a lookahead logic capable of 
calculating trigger times for the preparation of intermediates and of equipment (egg. 
Equilibration in the case of chromatography units). A logic capable of considering 
any delays which may occur due to constraints such as labour shortage or equipment 
failure.  However upon review of the series of constraints and rules under the model 
scope which determine the sequence of events, it was deemed that a look-ahead logic 
would be in effect redundant. 
Shifts 
There are two types of shift, that labour and operating. The labour shift can be 
modelled in two different ways based on the method of modelling the actual labour: 
Method 1: if the labour has been modelled in a resource pool then the pool can be 
directly linked to a block capable of outputting a signal at particular points in time (in 
Extend this is the Value Schedule block which can in turn be linked to the database). 
This will control the availability of the labour based on system time or shift. 
Method 2: if the labour has been modelled as an item then a gating system can be 
used to stop it from proceeding based on the shift times. 
The operating shift can take many forms, for example the whole system will run on a 
particular shift pattern or individual equipment will have their own. Under both 
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circumstances, the two methods described for the labour shift can be considered, 
using the same selection criterion. 
Data Transfer 
Data generated by the model should be transferred to other software such as Excel 
for analysis. This is due to three reasons: 
 
1) simulation modelling platforms do not offer the most intuitive methods of data 
analysis 
2) charts and data stored in the model will add unnecessary complexity. 
3) it is often best that the user not see the actual model, rather the inputs and outputs, 
which can be held elsewhere 
In terms of data input, there must be sufficient complexity and data input to be 
relevant and useful to the user.  It is only necessary to have user defined inputs where 
they will fall within the scope of the model. In other words the inputs required are 
those which allow the model to calculate/output parameters such as cost, time, 
yield/throughput and resource utilisation all of which have been listed under Model 
Logic. Input parameters should also be accessible without going deep into the model.  
There are two ways of achieving this  
Method 1: input parameters can be entered into the database, either in Excel or 
Extend. The problem with the latter is that the user will be introduced to the 
underlying data source of the model.  
Method 2: by creating a notebook level where all input locations are cloned from 
block dialog boxes. The user will only see the notebook containing a list of inputs 
and their meanings. The most important outputs can be cloned onto the notebook in 
the same way. This method is simple and user friendly, and does not require the 
opening of additional files such as the original database, thus making it the better 
option.  
Database 
The database will be used to hold all model parameters required for running. The 
best way to enter and manipulate the data is to first work in Excel. As a data handler 
the Excel software is much more equipped and user friendly. Furthermore it is more 
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or less universal software and therefore almost all users will have access to and 
knowledge of it (for purposes of future model changes). The data can then be 
imported into Extend and used for the running of the model. However difficulties 
arise when changes are made to the database in both Excel and Extend. It is 
important that the two be synchronised, or better still, for all changes to be made in 
Excel. Such problems can be altogether limited if all variable parameters (those 
likely to be changed at least) are entered into the notebook. 
What’s more, in order to achieve a greater level of standardisation, the database input 
can also be standardised whereby a template can be used each time. For example all 
manufacturing systems can use the same database template assuming that they all 
have activities, resources and entities. The database created for this model will most 
likely act as a template for future models. 
 
USING THE STANDARDS STRUCTURES AND METHODS 
The standards and methods proposed speed up the process of model development, 
making it easier to construct system representations by following the set guidelines.  
The top level of the model was structured according to the standard in order for the 
system representation to be more intuitive to the user.  
The next level is where the specific manufacturing process can be found. Figure B.1 
shows the main activity blocks. Each contains the standard structure shown in Figure 
B.2, consisting of a set of sub-activity blocks which when linked to together form the 
overall main activity.  
 
 
Figure B.1 Showing the BioSynT system product stream created by connecting 
together the main activity block 
 
The order of activities runs from left to right and uses the IDEF0 convention of boxes 
and connectors. The connectors are labelled ItemIn and ItemOut rather than 
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BatchInand BatchOut as in manufacturing models the primary item may not be a 
batch (it may be a campaign or vial for example). 
 
 
Figure B.2 Showing structure of a main product handling activity block. The blocks 
shown are (a) sub-activity block, (b) equipment hold, (c) labour pull, (d) labour 
release, (e) ticket tracker, (f) time stamp block. 
 
The sub-activity blocks are quite generic and only adopt identity when a number is 
assigned corresponding to their position. For example, the first sub-activity will be 
given the identity number ‘1’, the second ‘2’ and so on. The database aware block 
then recognises the address of the parameter it must look up according to this 
identity.  
There are two types of labour block, labour pull and labour release, which are 
generic in that the same block is used everywhere. The positioning of the labour 
blocks determines where the labour is pulled and where it is released back to the 
pool.  
Once all activities have been completed the equipment is thrown to the external CIP 
block where it is cleaned before being sent back to be held in caustic.  
In terms of pulling buffer material, for each step that requires a buffer, there is a 
‘buffer’ block which uses flow to represent the filling activity of the material. For 
example, taking the same main activity block shown in Figure B.2, the equilibration 
a c 
b 
d 
e f 
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sub-activity requires the buffer Tris20. As Figure 6 shows, this buffer is pulled using 
a flow catch block and is received before the equilibration activity begins. The 
invisible link between the flow throw and catch blocks can be thought of as the 
piping which connects the buffer hold and column. Figure 7 shows the transfer out 
sub-activity block where the throw block connected to this catch is located. The 
Tris20 holding tank fills with the made-up buffer. When the column gets to its 
equilibration step, it requests the Tris20 which then flows to it. Once the amount 
required has been transferred, based on the column volume, flow is redirected to the 
waste tank to empty the remaining contents of the buffer hold tank. Using the flow 
method ensures that the holding tank is held up for the correct transfer period making 
the model far more representative of the real system making it more intuitive and 
relevant.  
 
Figure B.3 Sub-Activity block with a ‘Buffer’ block which receives flow from the 
Tris20 holding tank 
   
 
Figure B.4 Transfer-out Sub-Activity block where buffer is transferred from its 
holding tank to the receiving column. 
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The key inputs to the manufacturing model are categorised within the Excel 
database. These categories and data are summarised under ‘inputs’ in Figure B.5. 
The outputs of the model are also summarised. It should be noted that those shown 
here are specific to the scope of the capacity management issue addressed in this 
particular case study and will vary depending on the question being asked.  
 
 
 
Product Information 
Demand 
Inventory 
Equipment Information 
Reliability 
Volume 
Scheduling Information 
Operating shifts 
Labour shifts 
Scheduled Outages 
Activities Information 
Buffer activities 
Main product handling 
activities 
Cycle times 
 
 
InputsOutputs 
 
 
 
 
 
 
 
Manufacturing 
Model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Throughput 
Overall cycle time 
Facility utilisation 
Equipment utilisation 
Labour utilisation 
Ticket generation profile 
Equipment activity 
profiles 
Labour activity profiles 
Buffer activity profiles 
 
 
Figure B.5 Inputs to and outputs from the BioSynT model. The key inputs are 
product, equipment, scheduling, and activity information. The key performance 
measures are throughput, overall cycle time, resource utilisation and activity profiles 
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Data for Chapter 6 
 
 
Four different scenarios were run for the case study presented in Chapter 6. These were: 
 
1) Synchronised Turnaround procedure with 18 hour, 7 day operating shift 
2)  Synchronised Turnaround procedure with 24 hour, 7 day operating shift 
3) Rolling Turnaround procedure with 18 hour, 7 day operating shift 
4) Rolling Turnaround procedure with 24 hour, 7 day operating shift 
 
The following tables show the results of those scenario runs 
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Appendix C.1Results of different campaign schedules for synchronised turnaround 18hr7d shift 
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Appendix C.2Results of different campaign schedules for synchronised turnaround 24hr7d shift 
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Appendix C.3Results of different campaign schedules for rolling turnaround 18hr7d shift 
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Appendix C.4Results of different campaign schedules for rolling turnaround 24hr7d shift 
 
